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ABSTRACT 
Vasoconstrictors either stimulate or inhibit oxygen consumption (V02) in 
perfused, but not in incubated or perifused, skeletal muscle. The mechanism of this 
phenomenon is not fully understood. This thesis attempted to investigate the 
implication of vasoconstrictor-mediated control of V02 (thus thermogenesis) in 
perfused muscle as well as other tissue beds, and the mechanism involved. 
Effects of vasoconstrictors on V02 were examined in the perfused hindlimbs 
of rats, Tasmanian bettongs (Bettongia gaimardi) and toads (Bufo marinus) as well as 
in the perfused rat kidney, intestine and mesenteric artery. In line with in vitro 
experiments, the effects of adrenergic agonists on thermogenesis were further studied 
in conscious adult bettongs, an endothermic animal without detectable brown adipose 
tissue. 
Norepinephrine (NE) and vasopressin (VP) stimulated, but serotonin (5-HT) 
inhibited V02 in both constant-flow and constant-pressure perfiised hindlimbs when 
causing vasoconstriction. In the constant-flow (once-through) perfusion, these 
changes were blocked by vasodilators (ie. nitroprusside) but not by tubocurarine. 
Vasoconstrictor-mediated changes in muscle metabolism were observed in the 
hindlimbs of all the three species. a-Adrenoceptors were shown to be responsible for 
NE-stimulated increase in V02. Increasing the perfusion flow by resetting at different 
rates also stimulated changes in V02 in the constant-flow perfused rat hindlimb, which 
could be augmented by NE but inhibited by nitroprusside. 
Similarly, a vasoconstriction-associated increase or decrease in V02 was 
observed in the constant-flow perfused rat kidney and intestine although the effect of 
a given vasoconstrictor to stimulate or inhibit V0 2 was not necessarily the same as 
that in the perfused hindlimb. In the perfused rat mesenteric artery all vasoconstrictors 
stimulated increases in V0 2 in parallel with the increased perfusion pressure. 
By contrast, in the constant-pressure (recirculated) perfused rat hindlimb, 13- 
adrenergic agonists, isoproterenol and BRL3 5135A were also found to stimulate V0 2 
in addition to a-adrenergic agonists and VP. 
During the induced vasoconstriction or vasodilation, creatine phosphate 
(CrP), AMP, ADP, ATP and lactate remained normal in all the perfused mammalian 
tissues. In skeletal muscle, the energy status, as indicated by energy charge, was not 
significantly different among the normal (both in vivo and control perfusion), perfused 
(high flow plus NE) and ischemic (for 60 min) muscles. In contrast, CrP and Cr 
differed in the three oxygenation states. 
Consistent with the observations in the perfused hindlimbs in vitro, NE and 
isoproterenol elicited an increase in heat production in the intact bettong. 
Adrenergic agonists, phenylephrine and naphazoline were also found to stimulate heat 
production which was not blocked by propranolol. 
These results taken together suggest that skeletal muscle is a potentially 
thermogenic tissue under the control Of vascular functioning. Vasoconstrictor-
mediated V02 seems to be widespread across species and tissues. This control may 
play an important role in the regulation of non-shivering thermogenesis. 
The results support the notion that working blood vessels may partially 
account for vasoconstrictor-stimulated changes in V02 . However, the data do not 
exclude the hypothesis that vasoconstrictors act on site-specific receptors on 
arterioles to redistribute flow to areas or cells that are metabolically more active. The 
results of this thesis can not definitively distinguish between these two hypotheses. 
They may not be mutually exclusive. 
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CHAPTER 1 
Thesis introduction 
1.1 General concepts and definitions 
1.1.1 Thermogenesis 
Endothermic animals are able to maintain a relatively constant body 
temperature in a wide range of environmental temperatures. Constant body 
temperature is achieved by balancing heat production and heat loss. In spite of 
voluntary adaptations in humans such as sheltering their bodies and adjusting the 
ambient temperature, maintenance of body temperature depends upon a high and 
controlled rate of heat production, or thermogenesis (Bligh & Johnson, 1973). 
Under normal conditions heat is produced in the body as a by-product of 
metabolism involving the transformation of one kind of energy into another. However, 
for the endotherm or warm-blooded animal, extra heat is produced when the ambient 
temperature falls below its thermoneutral zone (Jessen et al., 1980; Rothwell & 
Stock, 1980; Trayhurn, 1994). 
When exposed to cold, an endotherm can adopt two strategies to raise heat 
production: shivering thermogenesis and nonshivering thermogenesis (NST). The 
former refers to heat production derived from skeletal muscle contraction whereas the 
latter means heat production from 'sources other than skeletal muscle contraction 
(Bligh & Johnson, 1973). If an endotherm is continuously exposed to cold, shivering 
thermogenesis gradually disappears and is replaced by NST. During the process of 
this acclimation, a physiological change occurs within the body which reduces the 
strain caused by stressful changes in the cold (Bligh & Johnson, 1973). 
Heat production is also induced by dietary changes. During this process, 
extra heat (facultative thermogenesis) is generated besides the obligatory energy 
expenditure for the digestion (Rothwell & Stock, 1980; Webster, 1983; Astrup et al., 
1989). It is believed that diet-induced facultative thermogenesis (DIT) shares similar 
mechanisms with cold-induced NST (Rothwell & Stock, 1980). 
It is this extra heat (NST or DIT) that this thesis will focus on. The term of 
thermogenesis in the thesis refers to NST as commonly used in the literature 
(Trayhurn, 1994). 
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1.1.2 The rmogenesis and 0 2 metabolism 
A study of thermogenesis requires the measurement of heat emission. Direct 
calorimetry measures the transfer rate of heat between a tissue, an organ, or an animal 
and its environment (Bligh & Johnson, 1973). However, the most common method of 
estimating heat production is to use indirect calorimetry which is based on 
calculations relating heat production to the measurement of oxygen consumption 
(V02, the volume of oxygen consumed per unit time) and/or CO 2 elimination (Weir et 
al., 1949; Bligh & Johnson, 1973; Cassel & Casselman, 1990). Thus V0 2 in a tissue, 
an organ, or a whole animal is regarded as a synonymous parameter to heat 
production. In fact, V02 is usually the most applicable indicator to assess the 
thermogenesis of a tissue. 
1.2 Implications of vascular control of 02 metabolism 
1.2.1 Evidence to support this concept 
The vascular control of blood supply to a tissue as a whole and at the onset 
of ischemia is relatively well understood. However, the role of vascular control of 02 
metabolism in the context of thermogenesis has only been put forward in the last 
several years (Colquhoun & Clark 1991; Clark et al., 1994). This concept arose 
largely from comparing the effects of vasoconstrictors on Vo2 (as well as other 
metabolites such as lactate efflux) in perfused muscle preparations and in non-
perfused (incubated, perifused, superfused or homogenized) muscle preparations 
(Colquhoun et al., 1988; Dubois-Ferriere & Chinet, 1981; Hettiarachchi et al., 1992; 
Dora et al., 1994). The major difference between perfused and non-perfused muscle 
preparation is the involvement of the vasculature. A significant difference in V0 2 
exists between these two preparations in response to vasoconstrictor exposure. 
When infused via a vascular route (ie. in the perfused muscular bed), 
norepinephrine (NE) stimulates V02 muscle thermogenesis by 60-100% (Grubb & 
Folk., 1977; Dubois-Ferriere & Chinet, 1981; Cote et al., 1985; Colquhoun et al., 
1988). In contrast, NE has little effect on muscle V0 2 if applied directly to a perifused 
or incubated preparation (Dubois-Ferriere & Chinet et al., 1981; Hettiarachchi et al., 
1992). Other vasoconstrictors such as angiotensin H (AT II) and serotonin (5-HT) 
also affect muscle 02 metabolism or muscle performance in perfused rat hindlimb, but 
do not show a direct effect on muscle themselves (Hettiarachchi et al., 1992; Dora et 
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al., 1994). These findings seem to imply a key role for vascular functioning in muscle 
thermogenesis. 
With a similar extrapolation, one would expect that vasculature may exert 
control of 02 metabolism in other tissues as well. Thus, if these mechanisms apply to 
V02 in vivo, it would suggest an important role for vascular function in whole body 
thermogenesis. 
1.2.2 Metabolism and vascular system 
Clinical observations have indicated links between metabolic disorders and 
vascular diseases. For example, obesity is a typical metabolic disorder related to a 
decrease in thermogenesis (Ravussin et al., 1988). Yet, it is also a risk factor for 
cardiovascular diseases (e.g. hypertension) and diabetes mellitus (MacMahon et al., 
1987; Daly & Landeberg, 1991). Population studies have shown correlations between 
body weight and blood pressure in humans (Hall, 1993). Weight loss seems to 
attenuate the blood pressure of obese patients with hypertension (Reisin et al. , 1978). 
The concept of vascular control of metabolism could reveal the hitherto 
unrecognized importance of the vascular effects of some hormones. For instance, 
insulin is known to mediate glucose uptake in skeletal muscle, but it has recently been 
shown to dilate blood vessels in the human leg (Baron, 1993). Likewise, glucagon 
was shown to induce NST in the bird (Barre etal., 1987a; Duchamp et al., 1993), yet 
it is also a strong vasodilator (Kazmers et al., 1981). Similarly again, thyroid 
hormones are reported to reduce peripheral vascular resistance and raise cardiac 
stroke output (Klein, 1990). 
Skeletal muscle is the largest tissue in the body (Elia, 1992). If its metabolism 
is largely controlled by vasculature, the impact of vascular functions on whole body 
metabolism would be expected to be significant. 
1.3 Methodology for the study of thermogenesis 
Theoretically, a direct measurement of increased temperature or heat efflux 
should be an ideal indicator of thermogenesis. In whole body studies, the 
measurement of body temperature is often conducted for this purpose. As 
temperatures differ at different parts of a body, the core temperature (often measured 
in the rectum) is perhaps most representative. The most accurate measurement of 
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thermogenesis would be the heat efflux. Unfortunately, this has proven to be difficult 
to measure in many cases, particularly at tissue, cellular or subcellular levels 
(Duchanne 1990). 
For most endotherms, heat production (therefore thermogenesis) is coupled 
with V02 since aerobic metabolism is the predominant pathway to generate heat. As 
mentioned earlier (Section 1.1.2.), V02 is probably the most commonly employed 
parameter used to judge thermogenesis (Cassel & Casselman, 1990). This 
measurement can be readily undertaken at each level: whole body (Bligh & Johnson, 
1973), isolated organs and tissues such as skeletal muscle (Bonen et aL, 1994) and 
subcelluar mitochondria (Cassel & Casselman, 1990). During the process of the 
conversion of substrates to products in aerobic metabolism, many intermediate 
metabolites (such as lactate, pyruvate, free fatty acid and glycerol, etc.) are involved. 
Thus the measurement of these substrates, intermediate metabolites and end products 
can provide important information for evaluation of metabolism and the mechanisms 
involved (Bonen etal., 1994). 
At the subcelluar level, the mitochondrion is the subcellular apparatus where 
a proton concentration gradient across the inner mitochondrial membrane that carries 
both potential and chemical energy is transferred to 02• In this biochemical process, 
02 is consumed with the energy transferred into a chemical bond ("high energy 
phosphate bonds") of adenine nucleotide triphosphate (ATP). Thus the oxidation of 
metabolic substrates is coupled with phosphorylation of ADP to ATP. Since oxidative 
phosphorylation hinges on the oxidative capacity of mitochondria, properties of 
mitochondria, such as mitochondrial volume in the cell, mitochondrial respiration rate, 
and mitochondrial cytochrome oxidase are considered to be crucial to allow an 
increase in V02 in a tissue (Jansky, 1973). 
1.4. Facultative thermogenesis and effector tissues 
For a particular biochemical system to contribute to facultative 
thermogenesis in the operational sense, Trayhurn (1994) proposed four criteria be 
fulfilled: 
1. there should be the capacity for generating a considerable amount of heat; 
2. the mechanism should be rapidly turned on or off 
3. there should be long-term adaptive changes consistent with variations in the 
requirement for thermogenesis; 
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4. the mechanism should be located in a tissue which physiological studies 
clearly indicate as being directly involved in facultative heat production. 
Furthermore blood flow to this tissue is critical as a high blood flow enables 
heat to be rapidly distributed to the body core, and also ensure that the substrates 
(including 02) required to fuel thermogenesis are provided at rates appropriate to the 
exceptional demands of the tissue. 
1.4.1 Brown adipose tissue (BAT) 
BAT has been found to be present in most small rodents and newborn 
mammals including humans. So far, BAT has been generally recognized as a 
specialized heater tissue which seems to fill all the criteria suggested by Trayhurn 
(1994). Histological study reveals that BAT is mainly located around the aorta, the 
heart and kidney vessels and within the interscapular, subscapular and axillary regions 
as well as at the nape of the neck (Himms-Hagen, 1990). Unlike white adipose tissue, 
which stores large amounts of triglyceride but contains very little mitochondria, BAT 
is rich in mitochondria as well as triglyceride stores.. 
In the rat, the estimated mass of BAT is 1-3% of the body mass (Foster & 
Frydman, 1978; Astrup, 1986; Himms-Hagens, 1990). The measured basal V02 in the 
perfused BAT was reported to be 50-64 Amols -1 .h-1 (Foster et al., 1980; Matthias et 
al., 1994) and increased to 2121 ilmols -1 -h-1 in response to various stimulations 
including NE (Foster et al., 1980). In small rodents, BAT is estimated to account for 
approximately 60% of cold-induced thermogenesis (Foster et al., 1980; Astrup et al., 
1986). Measurement of blood flow to BAT with radioactively-labelled microspheres 
reveals cold exposure can increase blood distribution to BAT by more than 30 fold 
(Foster and Frydman 1979). 
A recent study, by detecting the expression of uncoupling protein (UCP) 
mRNA, indicates that some of the rat white adipose tissues, such as periovarian 
adipose tissue, express UCP following exposure to 4°C for three days (Cousin et al., 
1992). This change is associated with an increase in the density of mitochondrial 
cristae. Cold exposure or hyperphagia can stimulate the hypertrophy of BAT 
(Webster, 1983; Astrup, 1986; Himms-Hagen, 1990). 
However, in larger animals the quantitative contribution of BAT to 
thermogenesis is yet to be fully elucidated. BAT is thought to be absent in pigs 
(Trayhum et al., 1989) and birds (Trayhum, 1994) and has become functionally 
unimportant in the adult human even though NST still exists (Jamieson et al., 1984; 
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Astrup, 1986; Duchamp et al., 1993). Clearly, other tissues must contribute 
significantly to NST in these animals (Trayhum 1994). 
1.4.2 Skeletal muscle 
Skeletal muscle might at first sight look unlikely to be a thermogenic effector 
because of its low resting metabolic rate (Ruderman et al., 1971) and little increase in 
V02 when exposed to NE in an incubated or perifused muscle preparation (Hannon et 
al., 1963; Eaton, 1964; Dubois-Ferriere & Chinet et al., 1981; Hettiarachchi et al., 
1992). In spite of its low energy cost at rest, resting skeletal muscle as a whole is 
thought to contribute to 20-40% of the whole body metabolic rate because of its large 
proportion in the whole body mass [approximately 40% (Astrup, 1986; Zurlo et al., 
1990; Elia, 1992)]. 
A number of research groups (Grubb & Folk., 1976, 1977; Richter et al., 
1982a, 1982b; Cote et al., 1985; Chinet et al., 1989; Colquhoun et al., 1988, 1990) 
have clearly demonstrated that NE is able to elicit V0 2 60-100% above the basal level 
when administered via a vascular route to the tissue, such as in the constant-flow 
perfused hindlimb. Other thermogenic agents such as ephedrine, also stimulate V0 2 in 
the constant-flow perfused skeletal muscle (Hettiarachchi et al., 1991). In contrast to 
BAT, a coordination of vasculature function appears essential for skeletal muscle to 
be thermogenically functioning. 
Perhaps, more direct evidence in vivo for muscle thermogenesis comes from 
the human muscle studies (Lundholm & Svedymr, 1965; Astrup etal., 1985 & 1989). 
Lundholm & Svedymr (1965) found that administration of epinephrine (E) stimulates 
forearm V02 by 50% at the peak. A similar result was observed in human legs when 
ephedrine is infused intravenously (Astrup et al., 1985). More recently, Astrup et al. 
(1989) demonstrated that a carbohydrate diet significantly stimulates 02, glucose and 
lactate uptakes by the forearm, which correlated well with the increase in whole body 
metabolism and with increases in plasma NE and E. 
An increased blood flow distribution to skeletal muscle has been observed in 
various species during cold exposure. For example, when the ambient temperature 
was decreased from 25° C to 6 °C, the blood flow to non-respiratory skeletal muscle 
increased by 50% in rats. (Foster and Frydman, 1979). The blood flow to skeletal 
muscle doubled when exposed to cold in ducklings (Duchamp et al., 1993) and a 
marsupial, red kangaroo (Needham & Dawson, 1984). 
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Skeletal muscle is histologically and biochemically heterogenous. Vertebrate 
skeletal muscle fibres are classified into three types as illustrated in Table 1-1 
(Armstrong et al., 1984). They show heterogeneity in metabolite contents as well as 
V02. Slow-twitch oxidative muscle fibre (type I) has lower high energy phosphate 
(HEP) content but higher mitochondrial oxidative capacity. Conversely, fast-twitch 
glycolytic fibre has higher REP but lower mitochondrial oxidative capacity 
(Pagliassotti & Donovan, 1990b; Philippi & Sillau, 1993). Zurlo et al. (1994) have 
found that there is a positive correlation between total fast-twitch muscle fibres and 
the forearm V02. 
Table 1 -1 Classification of muscle fibre types 
Muscle type Colour Physiological Oxidative Glycolytic HEP 
feature enzymes enzymes enzymes 
Type I Red SO High Low Low 
Type Ha White FOG High High High 
Type Ilb Intermediate FG Low High High 
Modified from Armstrong et al, 1984; Zurlo et aL, 1994. SO: slow-twitch oxidative; FOG: fast-
twitch oxidative glycolytic; FG: fast-twitch glycolytic. HEP: high-energy phosphate. 
In the longer term, cold exposure has been shown to increase capillary 
density in skeletal muscle (Heroux & Pierre, 1957; Sillau et al., 1980) and NE 
turnover rate (Dulloo et al., 1988). Following cold acclimation at 4°C for 4 weeks, 
the activity of cytochrome oxidase increased by 34% per 100 g in the muscovy 
duckling, an animal devoid of BAT (Barre et al., 1987b). Therefore it is likely that 
these changes can have an impact on whole body metabolic rate. However, the 
involvement of adrenoceptors in catecholamine-mediated muscle thermogenesis is still 
controversial. Most studies in human forearms show the stimulatory effect of only 13- 
adrenergic receptors (Astrup et al., 1985 & 1989; Blaak et al., 1993). In contrast, 
results from the constant-flow perfused hindlimb seem to suggest that a-
adrenoceptors are mainly responsible. In a constant-pressure perfused rat hindlimb, 
Hardeveld et al (1980) observed inhibitory effect of NE on V02. There seems to be a 
need to further clarify the effect of a-adrenoceptors on muscle thermogenesis. 
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1.4.3 Working microvasculature 
Smooth muscle is the contracting apparatus of blood vessels. The attachment 
of myosin with actin is regulated by the phosphorylation of the myosin light chain 
MLC. ATP is consumed during the phosphorylation of MLC (Hai & Murphy, 1988, 
1989). Myosin light chain kinase (MLCK) which catalyses MLC phosphorylation is 
activated by Ca2+-calmodulin complex. Compared with skeletal muscle, the work 
production of vascular smooth muscle is much less efficient when it contracts. 
However, during the maintenance of contraction, "latch-bridges" (attached 
dephosphorylated cross bridge) form and less ATP is required in the swine carotid 
artery (Hai & Murphy, 1988 &1989). The notion for working vasculature to be a 
thermogenic tissue resides in a fundamental principle: vasoconstriction costs energy. 
Evidence for working vascular blood vessels was initially derived from 
observations of perfused skeletal muscle bed in vitro. In the constant-flow perfused 
rat hindlimb, vasoconstrictors such as NE, a-adrenergic agonists and AT II stimulate 
V02 . The vasoconstrictor-induced V02 is tightly associated with an increase in 
perfusion pressure (Colquhoun et al., 1988 & 1990). Both the increased pressure and 
V02 are blocked by vasodilators, such as nitroprusside or isoproterenol. In addition, 
vasoconstrictor-mediated V02 is additive to that induced by skeletal muscle 
contraction during sciatic-nerve stimulation (Colquhoun et al., 1990). However, 
literature data for vascular V0 2 vary many folds from 3 to approximately 300 jamols -
1 .0, probably due to the vascular tissues used (Paul, 1980; Sussman etal., 1988). 
1.4.4 Liver 
Liver is the largest internal organ and has a high metabolic rate. In the rat, 
liver is approximately 2.5-5% of the body mass. The V0 2 in isolated rat liver cells is 
measured at 145 p.mol-g-1 -h-1 under basal conditions, and this value can increase by 
more than 100% when palmitate is added (Berry et al., 1989). After exposure to 4°C 
for 4 weeks, oxidative capacity, measured as mitochondrial cytochrome coddase, 
increases by 122% and 54% per 100 g body weight in rats and muscovy ducklings, 
respectively (Barre et al., 1987b). Measurement of blood flow with radio-labelled 
microspheres in muscovy ducklings showed a significant increase in blood flow to 
liver after cold adaptation (Duchamp et al., 1993). However, the study of cold-
induced NST in man shows that the splanchnic thermogenesis remains uninfluenced 
even though the whole body V02 and plasma NE level increased by 25% and 132%, 
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respectively (Jessen et al., 1980). In adult humans, the liver is estimated to contribute 
21% of the metabolic rate (Elia 1992) 
Table 1-2 Tissues considered to be responsible for NST in rats 
BATE 
	
Muscleb 	Liverc 	Microvesselsd 
Basal 	64 imnol-g-1 1-1 	25 inno1.g-1 1-1 	145 timo1-g-1 .11-1 	288 ilmo1-g-1 .11-1 
Max. 	2121 p.mol.gr 1 .11-1 40 p.mol.gl-h-1 	30011mo1.g-1 -1r 1 	? lAmo1-g4 .h-1 
% of body wt. 	— 1-3%? 	— 40% 	2.5-5% 	— 3%? 
NE stimulation 	V021' 	Vo2 1 	V02? 	V021- 
After CA 
Blood flow 	-H-+ 	 -H- 	++ 
Cyto. oxidase 	-H-1- 	 -H- 	-H- 	 ? 
CA: cold adaptation. Data were quoted for the rat except for microvasculature (bovine brain) from a 
Foster et al., 1980; Matthias et al., 1994; b Grubb & Folk, 1977; Foster et al., 1979; Elia, 1992 -,c 
Berry etal., 1989; Elia, 1992; d Sussman etal., 1988. 
1.5 Energy dissipating mechanism for NST 
While extensive attempts have been made to elucidate the biochemical basis 
for NST (Chinet, 1989; Colquhoun & Clark, 1991; Clausen etal., 1991; Block, 1994; 
Trayhum, 1994), the energy dissipating process accounting for thermogenesis apart 
from BAT is poorly understood. Table 1-3 lists various mechanisms that have been 
suggested in the literature. 
1.5.1 Oxidative phosphorylation uncoupling 
Among these putative mechanisms, only uncoupled oxidative 
phosphorylation in BAT has been widely accepted as a specialized thermogenic 
mechanism (Trayhum, 1994). The biochemical basis for this mechanism is the 
presence of a proton conductance pathway located in the mitochondrial inner 
membrane of BAT (Hinuns-Hagen, 1990). 
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Table 1-3 Putative mechanisms and sites for NST 
Mechanism 	 Tissue 	 Reference 
Sodium pump (Nat, K+-ATPase) 
Sarcoplasmic reticular Ca2+ cycle 
Microvasculature contraction 
Uncoupling 
Skeletal muscle 
Heater cells 
Working blood vessels 
BAT, 
Skeletal muscle (?) 
Shiota etal., 1988 
Block, 1994 
Colquhoun etal., 1991 
Himms-Hagen, 1990 
Barre etal., 1986 
Modified from Trayhurn, 1994. 
Under normal circumstances, V0 2 is coupled with the synthesis of ATP. This 
process is carried out by the respiratory chain in the inner membrane of mitochondria. 
When the electrons are transferred from NADH and FADH 2 to 02, protons are 
pumped across the inner membrane to the intermitochondrial space, thus forming a 
proton gradient. ATP is formed when these protons flow back to the mitochondrial 
matrix though ATPase (Stryer 1988). UCP works as a proton conductance pathway 
to dissipate the proton gradient across mitochondrial inner membrane (Trayhurn 1989; 
Hitnms-Hagen, 1990). When protons permeate the mitochondrial membrane through 
UCP, energy is released as heat rather than generating ATP. During uncoupling, the 
respiratory chain still carries the electrons from NADH and FADH 2 to 02 . Thus 02 is 
consumed to generate heat. This thermogenic process is controlled by sympathetic 
nervous system with free fatty acid involved (Astrup et al., 1986, 1989; Himms-
Hagen 1990). 
UCP is a dimer of 3.2-3.3 kd. Up until now, it has been identified exclusively 
in BAT. Tissue specificity of UCP has led Trayhurn and his colleagues (1994) to 
identify whether BAT is present or absent in a species by detecting UCP with 
molecular techniques such as western blotting or northern blotting. Following an 
intensive search in a wide variety of animals, they concluded that UCP (thus 
functional BAT) is restricted to mammals and the pig is the only mammal with no 
detectable BAT (Trayhum, 1994). 
When an animal is exposed to cold or the sympathetic nervous system is 
stimulated, the released NE acts on the 0-adrenergic receptor of the BAT and elicits 
the lipolysis of triglyceride via cAMP. Released free fatty acid then activates the 
function of UCP. When the proton conductance pathway is opened, the 
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electrochemical gradient across the inner membrane of the mitochondria is dissipated. 
Instead of coupled with the formation of ATP, heat is produced. The oxidative 
phosphorylation uncoupling is inhibited by purine metabolites such as ATP, ADP, 
GTP, and GDP (Hinuns-Hagen, 1990). 
The finding of uncoupling as the biochemical basis for BAT thermogenesis 
has provoked the prediction that uncoupling of oxidative phosphorylation might also 
be a mechanism of heat production in other potentially thermogenic tissue(s) such as 
skeletal muscle. When a similar approach was applied to the billfish ophthalmic 
muscle, a specialized heat tissue to maintain brain temperature, immunological studies 
ruled out the expression of UCP (Block et al. 1987; 1994). Hence it can be predicted 
that the basis of uncoupling in skeletal muscle, if present, might be different from that 
of BAT. 
1.5.2 Ion pumping 
Ion pumping is another hypothesized mechanism for NST (Shiota et al., 
1988; Block et al ., 1994). The energy cost accounting for cation transport in the 
process of thermogenesis has recently been extensively reviewed by Clausen et al. 
(1991). The major cation transport systems suggested to account for thermogenesis 
are N+-K+ transport across a plasma membrane and Ca2+ transport across the 
sarcoplasmic reticulum (SR) membrane. 
1.5.2.1 Na+ -IC+ transport 
The strongest evidence in favour of Na+-K+ transport as a muscle 
thermogenesis mechanism, so far, arose from the report of the ouabain blockade of 
NE-mediated V02 ( Shiota et al. 1988). In constant-flow perfused hindlimbs at 32°C 
with a medium free of red blood cells (RBC) and BSA, they found that NE-stimulated 
V02 was associated with a decrease in potassium efflux from cold-acclimated but not 
warm-adapted rats. The increased V0 2 and decreased potassium efflux were blocked 
by 1 mM ouabain. These results led the authors to conclude that Na+-K+ transport 
was the biochemical basis for NE-induced thermogenesis in skeletal muscle (Shiota et 
al., 1988). 
However, their findings are in discord, in many aspects, with the data 
obtained from similar perfiised muscle preparations by other groups who reported that 
NE is able to stimulate V0 2 in the perfused muscle with RBC at 37°C (Grubb & Folk, 
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1977; Richter et al., 1982a) or without RBC at 25°C (Cote et al, 1985; Colquhoun et 
al., 1988, 1990) of warm-adapted animals. 
Clausen and his colleagues (1991) estimated that the intact muscle utilizes 
only 4-10% of its total energy turnover for active Na+-K+ transport under basal 
resting or during contractile activity. In liver, Na+-K+ transport accounts for < 5% of 
its total V02 under basal conditions (Clausen et al., 1991). These data appear to 
suggest that Na+-K+ transport is not a major biochemical basis for NST. 
1.5.2.2 SR Ca2+ cycling 
Perhaps, the role of sarcoplasmic reticulum (SR) Ca2+ cycling is more 
attractive than Na+-K+ transport in terms of the role of cation transport in muscle 
thermogenesis. In normal muscle, intracellular Ca 2+ is controlled by the T tubule and 
SR Ca2+ concentration. In the endothermic fish such as tuna and bill fish, 
thermogenesis is thought to be of muscle-origin (Block, 1994). The author 
hypothesized an excitation-thermogenic coupling model in the billfish heater cell with 
Ca2+ to play a key role. The specialized skeletal muscles have an exquisite mechanism 
for depolarisation-induced Ca2+ release. Such control is combined with stimulation of 
oxidative phosphorylation and substrate catabolism via Ca 2+ release and reuptake at 
the SR in the heater cells. 
The key element in this hypothesis would be the increased permeability of the 
SR membrane to Ca2±. Immunological studies of the SR protein involved in Ca2+ 
cycling indicate that the heater cell has a unique expression pattern of the SR Ca 2+ 
release channel with two isoforms: a and 13 while mammalian skeletal muscles express 
a single isoform of the SR Ca2+ release channel (Block, 1994). However, it could be 
argued that mechanisms for the ATP-dependent Ca 2+ cycling in the SR membrane 
may only occur in the specialized skeletal cells such as heater cells in billfish. The 
specific inhibitor of Ca2+ release from SR through the ryanodine receptor/calcium 
channel, dantrolene, has no effect on V0 2 in the perfused rat hindleg preparation 
(Chinet & Mejsnar, 1989). In the non-perfused soleus muscle, dantrolene only 
inhibited heat production by 8-9% with a concomitant 4% drop in V02 (Chinet & 
Mej snar, 1989). 
Clausen et al (1991) concluded, based on an extensive review of literature 
data, that the energy cost of maintaining a steep Ca2+ gradient across the SR 
membrane is relatively small (5%) of the resting metabolic rate due to the low 
permeability to Ca2+ at rest and high thermodynamic efficiency of the Ca2+-ATPase. 
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1.5.3 Vascular smooth muscle contraction 
As vascular smooth muscle has mitochondria, contracting vasculature will 
consume 02 . V02 by working microvasuclature has also been considered to be a 
possible candidate contributing to NST (see Section 1.4.3.). So far, it is not known 
quantitatively how much the working microvasculature can contribute to NST. 
1.6 Endocrine control of thermogenesis 
NST is under the control of the endocrine system. Either cold exposure or 
diet invokes a response of the endocrine system which acts on each effector to 
generate heat. The endocrine system controls thermogenesis in two different but also 
interwoven ways: (i) accelerate heat production directly from pre-existing 
thermogenic tissues; (ii) promote structural hypertrophy and other adaptive changes ie 
increasing vascularity and mitochondrial function. 
1.6.1 Sympathetic system 
Both cold exposure and diet mediate the release of catecholamines into 
plasma. In the human, a carbohydrate diet raised plasma NE and E by 35-45% and 
130%, respectively (Welle & Campbell, 1983; Astrup et al., 1989). In guinea-pigs, 
urinary NE increased by 360% following 4 weeks of cold challenge at 4°C (Kinnula et 
al., 1983). The effect of NE on thermogenesis has been reviewed in previous sections 
(ie. Sections 1.4.1, 1.4.2 & 1.4.3). Most studies have demonstrated that 13-adrenergic 
receptors are responsible for NE-mediated thermogenesis (Rothwell & Stock, 1980, 
Astrup etal., 1989; Blaak et al., 1993). 
Several lines of evidence suggest that a-adrenergic receptors may also be 
involved in NE-mediated thermogenesis. Despite a-adrenergic stimulation of V0 2 in 
the constant-flow perfused muscle vascular bed, the results from Foster (1984) 
indicate an auxiliary role of aradrenergic receptors in rat BAT thermogenesis. The 
data from whole body metabolic rate studies in the rat (Rothwell, 1990), rabbit 
(Szreder, 1991) and dog (Liard, 1989) also indicate the involvement of aradrenergic 
receptors in NE-mediated metabolism. 
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1.6.2 Thyroid hormones 
The serum thyroxine (T4) and tri-iodothyroxine (T3) increased 85% and 
87%, respectively, in guinea pigs following 4 weeks of cold challenge at 4°C (Kinnula 
et aL, 1983). Raised serum T3 level has also been reported in rats exposed to cold 
(Jobin et al., 1973) or overfeeding (Rothwell & Stock, 1980). Isolated hepatocytes 
from rats treated daily with T3 have an elevated V02 .(Berry et al., 1989). In BAT, T3 
exerts a permissive effect for NE and is thought to be essential for UCP expression 
(Hinurts-Hagen, 1990; Nedergaard, 1994). Additionally, thyroid hormones increase 
cardiac output and reduce peripheral vascular resistance (Klein, 1990). However, the 
extent and significance of T3 and T4 on thermogenesis is not clear. 
1.6.3 Other hormones 
Other hormones involved in thermogenesis may include glucagon as well as 
insulin and glucocorticoids (Himms-Hagen, 1990). In muscovy ducklings, 
thermogenesis can be induced by a direct injection of glucagon (Barre et al., 1987a). 
In the same species, glucagon has also been shown to stimulate V0 2 of leg muscle, 
and increase blood flow to muscle and liver (Duchamp et aL, 1993). In man and rat, 
acute cold exposure induces a rapid rise in plasma glucagon (Seitz et al., 1981). In 
guinea pigs, there is a significant rise in serum cortisol (by 81%) after exposure to 4°C 
for 4 weeks (Kinnula etal., 1983). 
The effects of vasoconstrictive hormones on V02 and other metabolites in 
the constant-flow perfused rat hindlimb have recently been reviewed by Clark and 
colleagues (1994). Based on their effect on V0 2, vasoconstrictors can be classified as 
metabolically positive (type A) or negative (type B). Type A vasoconstrictors include 
NE at low concentrations (< 1.0 pM), a-adrenergic agonists, AT II, vasopressin 
(VP), whereas type B vasoconstrictors include NE at high concentration (> 2.5 p,M), 
serotonin (5-HT, > 0.1 MM). And yet, it has not been identified whether this 
classification applies to other perfused tissue preparations and ultimately to 
metabolism in vivo. 
1.7 Signalling system of thermogenesis 
Intracellular signals for thermogenesis are those coupled with specific 
receptors such as inositol tri-phosphate (0 3) with a-adrenergic receptors and 13- 
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adrenergic receptors with cAMP. In the perfused rat hindlimb, Dora (1993) has 
shown that NE-mediated V02 is Ca2+ dependent. In BAT, cAMP is an important 
second messenger for 13-adrenoceptor-mediated thermogenesis (Himms-Hagen, 
1990). When NE elicits thermogenesis in BAT, it acts on 0 3-adrenergic receptors to 
activate adenylate cyclase that catalyzes the formation of cAMP from ATP. The 
increased cAMP then elicits lipolysis of triglyceride to liberate free fatty acid. 
Free fatty acid, resulting from lipolysis of triglyceride, is of particular 
importance in NST. On the one hand, it acts as a messenger to trigger the operation 
of UCP in BAT that dissipates the proton gradient across the mitochondrial inner 
membrane to generate heat. On the other hand, free fatty acid provides energy as a 
fuel for this thermogenic process (Himms-Hagen, 1990). Although a direct effect of 
FFA on muscle thermogenesis has not been described, it is considered to be involved 
in the SR membrane ATP-dependent Ca2+ cycling heater cell (Block, 1994). In the 
liver from normal rats, free fatty acid doubles V0 2 (Berry et al., 1989). The evidence 
to support the role of free fatty acid in NST also includes its stimulatory effect on 
hepatocytes V02 (Berry et al., 1989) and a rise in plasma free fatty acid in human 
when stimulated by NE (Kurpad etal., 1994). 
1.8 Vascular control of 02 metabolism and thermogenesis 
A comparison of the effects of vasoconstrictors on V02 between the 
perfilsed and nonperfused muscle preparations has suggested a key role of vascular 
functioning in V02 . The following three issues will be addressed regarding the 
involvement of vascular system in thermogenesis. How does the vascular system 
control blood flow to increase V0 2? Does the vasculature release thermogenesis-
stimulating substance(s) to the supplied tissues? Can microvesels themselves consume 
enough 02 to become thermogenic? 
1.8.1 Structure of microcirculation 
A typical structure of microcirculation involves small arteries, arterioles, 
precapillary sphincters, capillaries, venules and small veins (Greenberg et al., 1983; 
Lundgren, 1984). The exchange between blood and the tissue occurs at the capillary 
level and largely relies on the access of blood flow to these areas. This is controlled by 
the upstream small arteries, arterioles and precapillary sphincters. The precapillary 
microvessels undergo regulation by the nervous system, blood hormones and intrinsic 
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mechanisms. The innervation of the microcirculation shown in Table 1-4 provides a 
structural basis for the control of microcirculation by the neuro-endocrine system. 
Table 	1-4 	Adrenergic 	innervation 	in 	splanchnic 
microcirculation 
and 	skeletal 	muscle 
Microvessel 
Evidence 
Electromicroscopic Histochetnical 
Small muscular arteries + + + + + + + + 
Arterioles ++++ +++ 
Terminal arterioles + + + + 
Precapillary sphincters + — 
Collecting venules — — 
Muscular venules + + 
Small veins + + + + 
+, Degree of innervation; —, lack of innervation. Modified from Altura et al., 1978a,b. 
1.8.2 Autoregulation and intrinsic control mechanism 
Autoregulation is defined as the tendency for blood flow to remain constant 
despite fluctuation in arterial perfusion pressure. This is a local property of the 
vasculature that exists in the absence of neural and humoral factors in most vascular 
beds. Three major mechanisms of the intrinsic vascular control include metabolic, 
myogenic and flow-dependent regulation (Meininger, 1991). Their interactions 
determine the blood perfusion in the microcirculation. 
The function of precapillary arteries is controlled by two systems: a remote 
system and a local system (Folkow, 1991). The remote control system includes 
vasoconstrictive nerve fibres, vasodilator nerve fibres (in some circuits only) and 
blood-borne excitatory and inhibitory influences. On the other hand, the local control 
system involves myogenic activity, positive feedback (by the continuous and pulsative 
stretch of blood pressure), negative feedback (by vasodilator metabolites), and 
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endothelial activity (Folkow, 1991). The interaction between these two systems exerts 
important control on the parenchymal tissue metabolism. 
In the resting state, some of the true capillaries are shut off by the upstream 
vasoconstriction of arteriole and precapillary sphincters predominantly controlled by 
remote vasoconstrictive nerves. The closure of the true capillaries leads to an 
accumulation of metabolites, such as H+, CO2, adenosine and an increase in 
osmolarity. As the concentration of these metabolites accumulates to a certain high 
level, their vasodilatory effect will override the vasoconstriction maintained by 
sympathetic nerves and dilates the closed blood vessels, thus opening the capillary bed 
for blood perfusion. When the blood flow washes away the accumulated local 
metabolites, the vasoconstrictive control becomes dominant again, thus closing the 
true capillaries (Folkow, 1991). 
Recent studies have shown that the vasodilation induced by local metabolites 
can be conducted upstream to the larger arterioles and feed artery, leading to an 
increase in blood flow to skeletal muscle (Meininger et al., 1991; Segal, 1992). The 
vasodilation is probably conducted along the arteriole wall via gap junctions between 
endothelial cells and /or smooth muscle cells (Segal, 1992). 
1.8.3 Blood distribution in microcirculation 
Heterogeneous perfusion of capillaries has been noted in the microcirculation 
of muscle (Lindbom & Arfors, 1985; Johnsson & Haraldsson 1988) and intestine 
vascular beds (Jacobson et al., 1982; Lundgren 1984). Microscopic observations 
suggest that blood flow in individual capillaries is intermittent with constantly shifting 
perfusion of a variable fraction of the microvascular network. In the rat gracilis 
anticus muscle, a study with fluorescein dye showed a fraction of 61% open capillaries 
at rest (Connolly, 1976). The open-capillaries increase during tetanic muscle 
contraction with all of the capillaries opened at 12 tetani/min. Honig et al. (1980) 
counted red blood cell-containing capillaries in a cross section of dog gracilis muscle 
quick-frozen at rest and at various times during twitch stimulation. The results show 
that the open-capillaries are 655/mm2 at rest and the recruited capillaries almost 
double after 15 min of contraction at 4 twitches/second. Hence, each true capillary 
bed maintains an interchanging state of opening-closing. 
Microscopic studies attempting to quantify microvascular flow patterns by 
measuring local RBC flow velocities were carried out by Johnson and Wayland 
(1967) who described five kinds of temporal flow variations in capillaries of cat 
mesentery. Pattern A is the thoroughfare channel where there is a high RBC velocity 
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with irregular and random variations. Pattern B is nonperiodic flow with large velocity 
variations. Pattern C is periodic flow. Pattern D is low RBC velocity with irregular 
and random variations. Pattern E is intermittent flow (on-off). The periodic and 
pulsatile flow patterns are attributed to the action of precapillary sphincters. In the cat 
sartorius muscle, Burton and Johnson (1972) described three RBC velocity patterns. 
Among them, 65% of capillaries maintain steady flow with small variations, 10% vary 
periodically in velocity and 25% fluctuate irregularly in velocity (going down to zero 
brief intervals). 
A functional shunt of blood flow in muscle capillaries has been proposed 
based on clearance of substance (antipyrine, urea, sucrose) and 24Na as well as inert 
gas studies (Renldn, 1971; Piiper, 1985). If there is such a physiological non-flow 
phenomenon which restricts 0 2 delivery to certain capillaries, the improvement of the 
flow to these capillaries should enhance VO2 provided a biochemical basis for the 
consumption of this 02 is present. 
1.8.4 Effect of vasoconstrictors onV 02 
As presented in Section 1.4.2, several studies in the constant-flow perfused 
muscle show that a-adrenergic receptors are responsible for NE-mediated V0 2 . In 
addition to NE, other vasoconstrictors such as VP and AT II also stimulate V0 2 and 
are associated with a rise in perfusion pressure. However, not all vasoconstrictors 
increase V02 in the perfused hindlimb. Dora et al. (1991) reported that 5-HT actually 
inhibits V02 during vasoconstriction. Thus, vasoconstrictors may work as a switch to 
turn on or off skeletal muscle thermogenesis. 
1.8.5 Relationship between perfusion flow andV 02 in skeletal muscle 
In the perfused rat heart, V02 increases when there is an increase in 
perfusion flow and therefore perfusion pressure (Sparks et al., 1983; Kojima et al., 
1993). There is little doubt that increasing perfusion flow above the basal level 
augments V02 in contracting skeletal muscle (Bocicman, 1983; Mohrman et al., 1988; 
Brechue et al ., 1993). Flow-induced V02 is also found in canine intestine (Jacobson 
et al., 1982; Gallavan etal., 1983). In these cases, perfusion flow would appear to be 
a decisive factor to limit the metabolism and performance. It is also generally agreed 
that V02 in resting skeletal muscle would be restricted when a perfusion flow falls 
below the critical level needed to meet basal aerobic metabolism. 
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Hence the concept of flow-induced 902 in the resting skeletal muscle here is 
defined as the flow range beyond the need to maintain its basal metabolism. Such a 
conceptual flow-902 relationship has thermogenic implications. Since no energy is 
spent in skeletal muscle contraction under these conditions, the increased 90 2 would 
become heat. This argument is strongly supported by a simultaneous measurement of 
flow-induced heat production and 90 2 in the perfused rat gracilis muscle (Chinet & 
Majsnar, 1989). More importantly, a better understanding of flow-induced 90 2 would 
provide insight into the role which the vascular system plays to control muscle 
thermogenesis. 
In the literature, reports on the effect of perfusion flow on 902 have been a 
matter of controversy. Listed in Table 1-5 are the results of many of these reports and 
the experimental conditions employed. In general, flow-induced 90 2 is more readily 
observed in small animals such as rodents and cats, but is not always seen in dogs. 
The reason for these mixed reports are not clear and may lie with the animals or 
experimental conditions employed. For example, in isolated autoperfused dog muscle, 
Stainsby (1964) and Kohzuki (1991) reported that 90 2 in the resting skeletal muscle 
remains at an almost constant value until blood flow reaches the critical 02 delivery. 
In the dog, this level was reported to be 0.45 ml.min -1 -100g-1 (Kohzuki et al., 1993). 
On the other hand, Pappenheimer (1941b) observed flow-induced 902 in the auto-
perfused dog hindlimb. 
One explanation for flow-induced 90 2 in resting isolated perfused skeletal 
muscle is that the increase in perfusion flow allows a perfusate or 02 to reach more 
capillaries (Chinet et al. 1989). In the isolated gracilis muscle from cold-adapted rat, 
flow induced 902 was parallel with heat production when perfused with RBC-free 
Krebs-Ringer buffer containing 5% BSA (Chinet et al. 1989). However, when 
perfused with the same medium with 20% washed RBC, the perfusion pressure was 
significantly higher at the same flow rate and 902 had little dependence on flow rate. 
Their data reveal that flow-induced 90 2 and heat production in the RBC-free 
perfusate still exist beyond the 902 values where an increase in flow could no longer 
elicit 902 with RBC-containing perfusate. 
More recently, Wu et al. (1993) compared various perfusion temperatures 
and perfusate containing BSA from 2%-7% and 1.18 mM CaC12 without RBC in the 
perfused rat hindlimb and found flow-induced 902 was present under all these 
conditions. However, when 20% RBC was added into the perfusate containing 2% 
BSA at the perfusion temperature of 37°C, 90 2 became independent of flow rate 
(Wu et al., 1993). The similar findings from these two groups would seem to suggest 
that RBC somehow inhibit flow-induced 902. 
Table 1-5 Literature reports on the effect of increasing perfusion flow rate on V0 2 in resting skeletal muscle 
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Animal Perfusion model Perfusate Metabolic change Author 
Rabbit G-P-S group, gracilis, 
and soleus at 37°C 
K-H buffer + RBC 
(2.5 mM CaC12) 
V02 Pagliassotti et al., 
1990a 
Rat Hindlimb at 37°C K-H buffer +4% BSA 
and RBC (2.5 mM CaC1 2) 
V02 1' in the limb; 
but not in the trunk 
Gorski et al., 1986 
CA rat Gracilis at 28°C K-R buffer containing 5% BSA Vo2 Chinet etal., 1989 
± RBC (2.5 mM CaCl2) 
Rat Hindlimb at 25°C, 
37°C and 42°C 
K-H buffer + 2, 4.7 
or 7% BSA 1.18 mM CaC12 
o2 T Wu et aL, 1993 
Hindlimb at 37°C K-H buffer +2% plus RBC V02 unchanged 
Cat Autoperfused soleus 
and gracilis at 35-39°C 
Blood V02 Whalen etal., 1973 
Dog Autoperfused hindlimb at 37°C Blood Vo2 T Pappenheimer, 1941b 
Dog Autoperfused G-P-S 
group at 35.5-37.5°C 
Blood V02 unchanged Stainsby et al., 1964 
Dog Autoperfused gracilis at 37°C Blood V02 unchanged Kohzuki et cd. , 1991 
CA rat: cold acclimated rat; G -P-S: gastrocnemius -plantaris-soleus; K-H: Krebs-Henseleite; K-R: Kreb-Ringer; BSA: bovine serum albumin; RBC: red blood cells. 
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However, flow-induced V02 is also found in isolated autoperfiised cat 
gracilis and soleus muscle (Whalen et al., 1973). More interestingly, in the same 
study, where Chinet at al (1989) found flow-induced V02 only in the rat gracilis 
perfused with RBC-free but not with RBC containing Krebs-Ringer buffer, heat 
production was clearly observed during a perfusion with heparinized whole blood. 
Therefore, flow-induced V0 2 in resting skeletal muscle does not seem to be an 
artefact resulting from the lack of RBC in the perfusate. 
In conclusion, the data from a variety of perfused muscle preparations (see 
Table 1-5) when taken together indicate that an increase in perfusion flow to muscle 
tissue can, under certain circumstances, stimulate thermogenesis in resting muscle. 
There appear to be some yet unknown mechanisms involved in the regulation of flow-
induced V02 in resting skeletal muscle. If, as proposed by Clark et al. (1994), an 
effective perfusion flow in the nutritive capillary bed is a major determinant for the 
ultimate V02 and metabolism in the muscle, an increase in global perfusion flow may 
not necessarily elicit V0 2 unless the increased flow reaches the nutritive capillaries. 
Over all, there must be a biochemical basis at cellular level to allow the increased flow 
to elicit V02 above its physiological demand. 
1.8.6 Coordination of vasculature and parenchyma in muscle thermogenesis 
Despite the metabolic autoregulation of microcirculation (Section 1.8.2), 
Clark et al. (1994) postulate that vasoconstrictors may act on site-specific receptors 
to control nutritive and non-nutritive capillaries. Type A vasoconstrictors act on site-
specific receptors of the arterioles or precapillary sphincters to close non-nutritive 
capillaries, thereby diverting flow to the nutritive capillaries. Conversely, type B 
vasoconstrictors shunt flow away from nutritive capillaries by closing the precapillary 
arterioles, thus leading to an inhibition of V0 2. Yet, the hypothesized signal(s) for 
type A vasoconstrictors to stimulate V0 2 is (are) not understood. 
1.9 Aims for the present study 
The role of the vascular control of V02 in thermogenesis has recently 
emerged as a novel concept from the study of muscle metabolism in constant-flow 
perfused muscle preparations. There is obviously a need to clarify whether 
vasoconstrictors affect V0 2 in other vascular beds. The classification of type A and 
type B vasoconstrictors from the results of constant-flow perfused hindlimb of rats 
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requires testing in other perfused tissues to assess their metabolic properties. In 
addition, a better understanding of changes in energy metabolites in skeletal muscle 
under different oxygenation states would appear informative in evaluating regulation 
of muscle thermogenesis. Overall, the ultimate effect of a vasoconstrictor on 
thermogenesis would need to be examined in vivo. 
Thus, the aims of this thesis were to answer the following questions: 
1. Is vascular control of V0 2 in skeletal muscle a general phenomenon across 
different species? 
2. Do vasoconstrictors mediate control of V0 2 in other tissues? 
3. Can flow-induced V02 be manipulated by vasoconstrictors and vasodilators in 
muscle? 
4. Can vasoconstrictors exert a thermogenic effect in a pressure-controlled 
perfiised muscle preparation? 
5. What are the characteristics of muscle metabolites in hypoxia and hyperoxemia? 
6. What are the implications of vascular control of thermogenesis in whole body 
metabolic rate? 
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CHAPTER 2 
Materials and methods 
2.1 Animals 
Male hooded Wistar rats housed at 20°C with a 12/12 h day/night cycle were 
used for the experiments. The animals were fed with a commercial diet containing 
21.4% protein, 4.6% lipid, 69% carbohydrate, 6% crude fibre with added vitamins 
and minerals (Gibson, Hobart) and allowed to access to water at libitum. 
Tasmanian bettongs (Bettongia Gaimardi) of either sex were obtained from 
the University's breeding colony (Dr. R.W. Rose, Department of Zoology, The 
University of Tasmania). The animals were housed in room-sized cages (approx. 6 m 
x 2 m) in an animal compound with free access to food and water. Diet was a choice 
of apples, bread, and Pal® dog pellets (Uncle Ben's of Australia), containing 15% 
crude protein and 10% fat. During the period of experiment, the seasonal temperature 
ranged between 18-28°C during the day time and 10-20°C at night. 
Cane toads (Bufo marinus) of both sexes weighing 129.4 ± 16.6 g from 
Queensland (Australia) were used for the experiments. The animals were kept at 20°C 
with a 12/12 h day/night cycle and fed with beetles for one or two months before use. 
The use of rats, bettongs and cane toads was both on the basis of 
phylogenetical classification and on the choice of the available species. Rats were used 
to represent endothermic animals with BAT and bettongs to represent marsupials 
which are thought not to have BAT. Cane toads were used to represent ectothennic 
animals. All experiments were approved by the Ethics Committee of the University of 
Tasmania under the Australian Code of Practice for the Care and Use of Animals for 
Scientific Purposes (1990). 
2.2 Tissue perfusions for the study of 02 metabolism 
The perfused hindlimb has proven to be a reliable preparation for the study of 
muscle metabolism and peripheral vascular functions (Bonen et al., 1994). The 
constant-flow perfused rat hindlimb at 25°C with cell-free medium at a flow rate in 
vivo [0.27 ml.g4 -min-1 (Armstrong & Laughlin, 1985)] was first described by Cote et 
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al. (1985) and confirmed by other researchers (Colquhoun et al., 1988; 1990; Wu et 
al., 1993; Dora et al., 1994; Rattigan et aL, 1994) to be a reliable model for the study 
of the effects of vasoconstrictors on muscle V0 2 . Comparisons with the perfusion by 
the medium containing erythrocytes at 37°C have demonstrated that the perfusion 
with cell-free medium at 25°C yielded similar results, given that Q i0=2.5 
(Hettiarachchi., Ph.D Thesis 1992; Wu et al., 1993; Bonen et al., 1994). The 
characteristics of the perfised hindlimb, including perfused rat hindlimb at 25°C, for 
the study of skeletal muscle metabolism have recently been reviewed by Bonen et al. 
(1994). Therefore, perfusions with cell-free medium were used for the present study 
in either constant-flow or constant-pressure model. The constant-flow perfusions 
were performed at 25°C whereas the constant-pressure perfusions were carried out at 
37°C. 
2.2.1 Constant-flow perfused hindlimbs 
2.2.1.1 Perfused rat hindlimb 
Sodium pentobarbital was injected intraperitoneally (i.p.) at a dose of 50 
mg/kg body weight to anaesthetise rats (180-200g). The surgical procedures were 
previously described by Ruderman et al. (1971) and Colquhoun et al. (1988). After 
anaesthesia, the tail and the tarsus were ligated and epigastric vessels, iliolumber 
vessels were all tied off. An incision was made along mid-line of the abdomen. 
Following ligatures placed around the duodenum and the rectum, the gut was 
removed. About 200 I.U. of heparin was injected into the vena cava followed by the 
carmulation of the abdominal aorta and vena cava. The right iliac artery and vein were 
ligated so that only left hindlimb was perfused. In order to avoid a possible spillover 
of the perfusate during changes in pressure, a ligature was paced around the abdomen 
at the level of L3-L4 . The rat was then killed with a further injection of sodium 
pentobarbital into the heart and placed onto a pad within the cabinet to start 
perfusion. Skeletal muscle in this preparation accounts for 60-70% of the whole 
perfused hindlimb (Ruderman etal., 1971; Gorski etal., 1986). 
2.2.1.2 Perfused bettong hindlimb 
As a result of successful breeding program, a limited number of bettongs 
which are under the protection of law, became available for experiment. Thus the 
experiments on the perfused bettong hindlimb were designed to make full use of these 
valuable animals. The animals (1.2 ± 0.11 kg) were anaesthetized with sodium 
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pentobarbital (i.p., 60 mg/kg). Additional injections were given to maintain the 
anaesthesia when required. 
An incision was made distal to the femoral artery and vein to expose these 
vessels. Heparin (1000 I.U.) was injected into the femoral vein at the level of the 
inguinal ligament, and an arterial carmula and a venous cannula were inserted into the 
respective vessels just below the branch point for the superficial iliac circumflex artery 
and vein. A tight ligature was placed around the thigh approximately 1 cm above the 
cannula, and another tight ligature around the tarsus, so that only the muscle bed 
distal to the inguinal ligament of the limb was perfused. The mass of muscle perfused 
was determined for the first three animals by excising and weighing dye-containing 
muscle from the contralateral limb that had been infused with the perfusion medium 
containing Evans blue (1% w/v) following the same surgical procedures and 
heparinization of the animal, but before the perfusion commenced on the remaining 
hindlimb. A regression formula was then calculated out as: the muscle mass perfused 
(g)= 31.87 x body weight (kg) - 9.05 (r= 0.9993, P<0.05, n=3) and applied to the 
following experimental animals assuming that both hindlimbs were identical in muscle 
mass. The animals were killed with overdose sodium pentobarbital immediately after 
the commencement of perfusion. The measurement by dissection showed that skeletal 
mass accounted for 67% of the whole perfused hindlimb. 
For the in vivo muscle metabolite measurement, gastrocnemius-plantaris-
soleus group was freeze-clamped from the contralateral hindlimb before the animals 
were killed. After the sampling, the femoral artery and vein were ligated together with 
a circumferential ligature about the thigh to prevent any haemorrhage. 
2.2. 1.3 Perfused toad hindlimbs 
Anaesthesia was introduced by sodium pentobarbital (i.p., 10 mg/100g), and 
additional injections were given when needed. In the amphibian, the venous system 
draining the hindlimbs consists of three main veins: an inferior abdominal vein running 
underneath the anterior abdominal wall and two renal portal veins. Therefore the 
surgical operations differed from those for the perfused rat or bettong hindlimb. 
Two incisions were first made in parallel with the abdominal middle line 
leaving a strip of the anterior abdominal wall with the vein intact. A ligature was 
placed around the strip in the upper part before it was cut free above the ligature to 
expose the abdominal cavity. After the removal of the abdominal contents, each 
visible vessel running to or from the cut edges was tied off to prevent leaks during 
perfusion. To avoid spillover of the perfilsate when the perfusion pressure rises, a 
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suture ligation was performed around the middle of the ilium and pubis bones. After 
the toad was heparinized by an intravenous injection of 200 IU heparin into a renal 
portal vein, both renal portal veins were tied off. An arterial cannula and a venous 
cannula were inserted into the dorsal artery and anterior abdominal vein, respectively, 
for the perfusion of both hindlimbs. The perfused muscle mass was measured by 
weighing the Evan's blue-dyed tissue at the end of the perfusion. 
2.2.2 Constant-flow perfused other tissues of the rat 
For the perfusion of kidney, intestine and mesenteric artery, 180-200 g male 
rats were used and anaesthetized as before (2.2.1.1). 
2. 2.2. 1 Kidney 
The abdominal aorta and vena cava were cannulated upward to the left renal 
vessels. The vessels to the adrenal gland and the surrounding fat tissue were tied off. 
A ligature was placed around the aorta and vena cava above the left renal vessels so 
that only the left kidney was perfused. The right kidney was weighed out to calculate 
the V02 with the assumption that both kidneys were equal in weight. 
2.2.2.2 Intestine 
The inferior mesenteric artery and vein were cannulated for the perfusion. A 
ligature was placed between the stomach and duodenum and the between the small 
intestine and the large intestine. The perfilsed intestine mass was measured by 
weighing Evans-blue dyed tissue at the end of perfusion. 
2.2.2.3 Mesenteric artery 
The initial operation was as same as perfused intestine. Following the 
cannulation, the intestine was cut off along the edge. The left mesenteric artery was 
then hung within a 10 ml syringe submerged with 2.0 ml perfusate. The perfused flow 
rate was 2.0 ml/min. The perfused tissue was measured as mentioned above (2.2.2.2). 
2.2.3 Perfusion system and medium 
The perfusion system (shown in Fig. 2-1) consisted of a perfusion pump, an 
artificial lung, a thermostatic bath, a glass heat exchange coil, a Clark-type 02 
Cazbogen 
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electrode, a pressure transducer, a magnetic stirrer, a chart recorder, and polyethylene 
tubing. The whole of the perfusion apparatus was set up in a thermostatic cabinet at 
25°C unless indicated elsewhere. 
The perfusion medium for the perfused mammalian tissues was modified 
Krebs-Ringer solution (Colquhoun et al., 1988) composed of (in mmol/L): NaC1 118, 
KCI 4.7, CaCl2 1.27, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25.0 and Glucose 8.3 and 
2% bovine serum albumin (BSA) unless indicated elsewhere. The perfusion buffer was 
filtered with a 0.45 pm pore filter under pressure after it was made to ensure that it 
was particle free. The perfu sate was saturated with a mixture of 95% 02 and 5% CO2 
by passing the artificial lung and the pH kept at 7.4. BSA (Sigma, Fraction V) was 
dialysed five times against distilled water before use. 
Fig. 2-1 Perfusion system for the constant-flow perfusion at 25°C. The same 
perfusion system was applied to the constant-flow perfused hindlimbs of rat, bettongs 
and toads as well as the rat kidney, intestine and mesenteric artery. 
28 
The toad hindlimb perfusion was conducted at 25°C with 02 saturated 
modified amphibian Hepes-buffer solution (Pelster et al., 1993) composed of (in 
mmoVL): NaC1 115, KC1 3.2, MgSO4 1.4, Hepes 10.0, CaC12 1.3, glucose 5.0 and 
1% BSA at pH 7.4. Whilst amphibian Ringer's buffer is used for many perfused 
amphibian tissues, Hepes buffer was employed in the present study for the perfused 
toad hindlimbs because it contains Mg 2+. As Hepes buffer does not contain HCO 3-, it 
was saturated by 02 to maintain a pH at 7.4 as reported by Pelster et al. (1993). The 
perfusion flow was set at a perfusion pressure of (15 ± 1.0 mm Hg) close to the 
physiological level in vivo (Altman & Dittmer, 1974; Withers et al., 1988; Pelster et 
al., 1993). 
2.2.4 Measurement ofV 02 
The 02 electrode was calibrated before and after each experiment with 
oxygen, air and nitrogen for each perfusion. Arterial P02 (Pa02) was obtained from 
the perfusate without passing through a perfused tissue but with the same length of 
polyethylene tubing so that any loss to the atmosphere was constant. The mean value 
of Pa02 was 697 ± 1.0 mmHg (Mean ± SE, n=20). Venous P02 (Pv02) varied with 
the change in VO2 by perfised tissues but was never allowed to fall below 200 
mmHg. VO2 by a perfused tissue was calculated from the arteriovenous difference of 
partial oxygen pressure and the flow rate according to Fick's principle as follows. 
Vo2 = 
!nag- 1. h-1) 
1.508 x (Pa02-Pv02) mmHg x flow rate (ml/min) x 60 (min/h)  
1000 ml x tissue (g) 
where, 1.508 0.tmol.L -1 .mmHg-1) represents the oxygen solubility calculated from 
Bunsen coefficient at 25°C; at 37°C it is 1.256 (Christoforides et al., 1969); 1000: 
1L=1,000 ml. 
2.2.5 Constant-pressure perfused hindlimbs 
2.2.5.1 Surgical procedures 
The constant-pressure perfusion of rat hindlimbs was performed at a 
physiological pressure of 80 mm Hg. Initial experiments showed that a high flow rate 
was required and 6% BSA was needed in order to prevent edema. Hence, smaller rats 
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(100 ± 5 g) were used for the study to reduce basal flow rate, thereby saving the cost 
of higher BSA expenditure. 
The general surgical procedures were similar to those described above for 
the constant-flow perfused rat hindlimb with the following modifications. After the 
evisceration of the abdominal cavity, the iliac artery supplying the right hindlimb was 
cannulated with a heparin-filled 16 G cannula (I.D. 0.6 mm) and was then connected 
with a blood pressure transducer linked to a chart recorder. The cannula tip was 
positioned as close to the abdominal aorta as possible without disturbing flow to the 
perfused hindlimb. All other major vessels to and from this hindlimb were ligated. 
Both abdominal aorta and vena cava were cannulated, respectively, as described in 
Section 2.2.1.1 for the perfusion of the left hindlimb. 
2.2.5.2 Perfusion system 
The perfusion system was similar to that for the constant-flow perfusion with 
the following modifications. A three way tap was placed just before the arterial 
cannula as a by-pass flow (illustrated in Fig 2-2) to lead the excess flow through a T 
junction back to the reservoir. One end of the T junction was exposed to the 
atmosphere so that the pressure was controlled at 80 ± 0.5 mm Hg via the height of 
the T junction. During the perfusion, the perfusate was pumped at an 20-30% excess 
rate over the actual flow entering the hindlimb. Perfusion flow rate was noted 
intermittently by collecting venous effluent with a measuring cylinder. Perfusion 
pressure was monitored from the contralateral iliac artery with modifications of the 
surgery as described in 2.2.1, similar to the method used by Johnsson et al. (1991) 
who measured pressure from the tail artery. 
In addition to the perfusion channel in the perfusion pump, a second channel 
was set up in a reverse direction to drain the venous perfusate, which was collected in 
a 100 ml beaker, back to the reservoir to form a recirculation. All metal needles and 
connections were replaced by polyethylene to eliminate a possible effect of trace metal 
elements on vasoactivity (Lew et al., 1987). The reservoir was accurately calibrated 
and volumes of the tubing in the whole system were measured accurately. These 
volumes were taken into account when adding drugs into the reservoir to achieve a 
known concentration. As the total volume of the perfusate varied at times because of 
the perfusate samples taken, the calibrated reservoir allowed estimation of the actual 
volume at any given time. 
TEMPERATURE- CONTROLLED CABINET 
Atmosphere 
Pressure 
8OntntlIg T junction 
Bubble Trap 
Heat Exchanger 
Overflow Bypass -1 
ARTERL  
VENOUS 
riA 
Lung 	Pump 
Recyling Line 
Lung Resenrour 
Constant-flow 
Water Jacket 
Oxygen 
Electrode 
Chart Recorder 
30 
Fig. 2-2 Diagram for the constant-pressure perfusion system. The perfusions 
were conducted at 37°C in a recirculation model. 
Two artificial lungs were used in series to ensure full saturation of the 
perfusate with 95% 0 2 and 5% CO2. Despite the lung normally used for constant-
flow perfusion sitting (see Fig. 2-1), the other lung was before the pump and kept in 
ice. For each perfusion, 400 ml buffer was used and the first 50 ml venous effluent 
discarded. Pa02 was obtained by measuring the perfusate before and after each 
perfusion at different flow rates. Pv02 was continuously monitored by an in-line 
Clark-type 02 electrode. V02 was calculated from steady-state arteriovenous 
differences and the flow rate measured at the same time. Samples of arterial and 
venous perfusate were periodically taken and measured with an 02 analyzer (TasCon, 
Department of Physiology, University of Tasmania) to check the results of from the 
in-line Clark-type 02 electrode at different flow rates. Arterial perfusate pH was 
checked before and after recycling perfusate and no statistically significant difference 
was found. 
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The experiments were conducted at 37°C within a cabinet. As the ambient 
temperature, usually lower than 30°C, could still more or less affected the temperature 
within the cabinet, the animal was placed in another 37°C thermostatic water jacket 
during the perfusion. The composition of the perfusate was the same to that used for 
constant-flow perfused rat and bettong hindlimbs as mentioned in 2.2.1.3 except for 
6% BSA and 2.5 mM CaC12 . 
2.3 Metabolite assays 
For the assay of lactate, pyruvate and glycerol release from the perfused 
tissue, 2.0 ml of venous effluent was collected either at each new steady state, or at 
nominated times for the time-response curves. The collected perfusate was then 
centrifuged for 5 min at 3,000 rpm to remove any washed-out erythrocytes and frozen 
(-20°C) until assay. The arterial perfusate was used as the blank in the assays. 
As preliminary experiments had shown that sampling procedures were 
extremely crucial for obtaining the closest bioenergetic data in vivo, special attention 
was paid to this process. Usually, the normal tissues (unless indicated elsewhere) were 
freeze-clamped by a pair of aluminium tongs in situ before being removed, leaving no 
ischemic time to elapse. 
For skeletal muscle, gastrocnemius-plantaris-soleus muscle group was 
sampled for the assay. Studies by Armstrong & Phelps (1984) in the rat have shown 
that soleus muscle contains approximately 90% slow-twitch oxidative fibres (Type I) 
whilst plantaris muscle consists of 50% fast-twitch oxidative-glycolytic fibres (Type 
Ha), 40% fast-twitch oxidative fibres (Type lib) and 10% slow-twitch oxidative fibres 
(Type I). Gastrocnemius muscle is composed of the mixture of the above three fibre 
types. Thus, gastrocnemius-plantaris-soleus muscle group represents all three muscle 
types. The skin covering the calf muscle was surgically peeled off to expose the 
muscle group. The muscle group was then gently separated from other muscle groups 
without disturbing blood or perfusate to the tissue. Then, the muscle group was lifted 
above the others at the distal end and freeze-clamped in situ with liquid N2 precooled 
tongs before being cut free from the leg. The sampled gastrocnemius-plantaris-soleus 
muscle group consisted of (by mass) 7.0% soleus, 14.9% plantaris, 23.9% white 
gastrocnemius and 54.3% red gastrocnemius muscles. For the rat of 180-200 g, this 
muscle group was 1.25 ± 0.03 g (means ± SE, n=10), accounting for 0.62-0.69% of 
the body weight. 
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Other tissues except blood vessels were sampled in a similar way by freeze-
clamping in situ with liquid N2 precooled tongs before removal. 
2.3.1 Sample preparation 
The tissue samples were pulverised in liquid N2 with a mortar and pestle. 
Tissues beyond the clamp edges and distinguishable tendon and connective fibres 
were discarded during grinding. The tissue powder was thoroughly mixed and stored 
at -80°C before analysis. 
About 50 mg tissue powder was weighed out, dried in an oven at 100°C 
overnight and reweighed until of constant weight to determine the ratio of wet weight 
to dry weight. 
Approximately 200 mg frozen tissue powder (except for the aorta) was 
weighed out and homogenized immediately in 2.0 ml of ice-cold 0.42 M HC10 4 
(perchloric acid, PCA) with an electrically driven homogenizer (Ultra-Turrax 
Homogenizer) at 3/4 full speed for 30 seconds. 1.0 ml of the supernatant was 
transferred to another tube following centrifugation at 3,000 rpm for 5 min. The 
supernatant was titrated to pH 6.0-6.5 with K 2HPO4 (1.0 M) whilst constantly 
vortexing. The neutralized HC104 extract was placed in ice for 5 min before it was 
centrifuged again in the same conditions as mentioned above. The supernatant was 
recovered and kept in ice for assays of creatine (Cr), creatine phosphate (CrP), 
adenine nucleotides, glucose-6-phosphate (G-6-P), and pyruvate within 2 hours as 
well as of lactate and glycerol within 24 hours. 
For the assay of muscle glycogen, approximately 200 mg muscle powder was 
weighed out and incubated in 0.3 ml of 30% KOH in a glass tube with screw cap in 
boiled water for 30 min. After it cooled down, 0.1 ml of 2% Na2SO4 was added 
followed by 0.93 ml 100% ethanol to give a final concentration by 70%. Thin glass 
rods were used for thorough mixing. After standing overnight at 0°C, the glycogen 
was removed by centrifugation for 15 min at 2,000 rpm. The supernatant was then 
decanted and the tubes left inverted to drain on filter paper. The tubes were placed in 
ice for 1 hour before the wall of the tubes and the precipitate was washed with 0.5 ml 
65% ethanol. After leaving the precipitate in ice for 15 min the tubes were centrifuged 
again (10 min at 2,000 rpm) to separate the glycogen. The supernatant was decanted 
and tubes left to drain as previously on to filter paper. The last traces of ethanol were 
expelled by evaporation in a water bath at 70°C and by lightly blowing carbogen into 
the tubes. The pellet was dissolved in 1.2 ml distilled water. 0.5 ml of the dissolved 
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sample was pippeted into a test tube containing 0.5 ml H20 and 1 ml enzyme solution 
(4 mg amyloglucosidase/ml sodium acetate/acetic acid buffer, pH 4.5). The test tube 
was centrifuged (2,000 rpm, 5 min) following an incubation at 45°C for 2 hours. 
0.025 ml supernatant was used for the assay of glucose 
2.3.2 Enzymatic assays 
Lactate, pyruvate, glycerol, glycogen. G-6-P and CrP were assayed with the• 
method in "Methods of Enzymatic Analysis" edited by Bergmeyer (1974). Lactate, 
pyruvate, G-6-P and CrP were calculated as the follows: 
gmol/g dry wt = 	AE x cell (ml) x total neutralized vol.(m1) x wet wt 
6.21 x tissue (g) x sample (m1) x recovery (%) x dry wt 
where: 6.21 (ml.gmol -1 .cm-1) represents the extinction coefficient for NADH or 
NADPH at 340 rim (Bergmeyer, 1974) 
For glycogen, a standard curve for glucose was prepared using 25, 50 and 
100 gl aliquot of 0.505 mM glucose. Calculation: 
gmoUg thy wt = 	gmol glucose (from Std) x 2.0 x 1.2 x wet wt. 
0.025 x 0.5 x muscle powder (g) x dry wt. 
where 2.0 (ml): the total volume in the incubated test tube; 1.2 (m1): the volume of 
H20 dissolving the pellet; 0.5 (ml): the volume of dissolved sample added into the 
incubated test tube; 0.025 (ml): the volume of supernatant used for the assay of 
glucose. 
Glycerol was enzymically measured, essentially as described by Wieland 
(1974), using the change in fluorescence of NADH measured with an Aminco-
Bowman spectrophotofluorometer set at 340 nm (excitation) and 460 nm (emission). 
The change in fluorescence intensity (AI) was used for the calculation of sample 
concentration from the standard solutions. 
(gmol/g dry wt) = 	gmol/m1 (from Std) x total neutralized vol.(m1) x wet wt 
tissue (g) x dry wt x recovery (%) 
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2.3.3 HPLC determination of high energy phosphate compounds 
2.3.3.1 Anion exchange method 
For the first part of this thesis (Chapter 3), adenine nucleotides were 
determined in Waters high performance liquid chromatography (HPLC) using an 
anion exchange Pharmacia Mono Q column as described by Colquhoun et al. (1990). 
The mobile phases included solution A and solution B. Solution A was 20 mM Tris-
HC1 buffer pH 8.0 and solution B was made up by adding 150 mM (NH 4)2SO4 into 
solution A. The buffers were filtered and degassed under vacuum before use. 
HPLC settings: absorbance unit of full scale (AUFS) 0.5, chart feed 0.5 
cm/min, flow rate 1.0 ml/min; wavelength 254 nm. A linear gradient elution started 
from 4.5 to 150 mM ammonium sulphate in 20 mM solution A. After all peaks were 
eluted (normally within 15 min), 5 min was given to regenerate the solid phase. 
2.3.3.2 Ion-pared reversed phase method 
In order to improve analytical efficiency, simultaneous determination of 
creatine compounds and adenine nucleotides (Shellevold et al., 1986) were employed 
for the rest of the thesis after the instrument and column became available. A radial 
compression cartridge column (Radial-Pak, C18, 4 pm, 10 cm x 8 mm, Waters, USA) 
was connected with a HPLC (Waters or LKB). Both channels were used with the one 
at 210 nm for creatine compounds and adenine nucleotides and another at 254 nm as a 
reference for adenine nucleotides. AUFS was adjusted according to peak heights of 
creatine compound and adenine nucleotides. Isocratic elution was performed at a flow 
rate 1.5 ml/min and recorded at chart feeds of 20 or 40 cm/hour. All of the assayed 
compounds were washed out within 12 min. The mobile phase consisted of 
K2HPO4/KH2PO4 buffer (220 mM, pH 6.25), 3 mM tetrabutylanunonium hydrogen 
sulfate and 5% acetonitrile. Usually, 10-20 p.1 of the neutralized HC104 extract was 
injected to HPLC. The contents of high energy phosphate compounds were. 
calculated according to following formula: 
gmol/g dry wt = 	peak height (or area) of sample x Standard  concentration 
Standard peak height (or area) x inject sample(m1) 
x total neutralized volume (ml) x wet wt 
x muscle powder (g) x recovery (%) x dry wt 
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Since preliminary tests showed that standard CrP converted to Cr by 
approximately 10% within 1 hour in the PCA solution, the recovery was used for the 
calculation. A batch of mixed standards of Cr, CrP, inosine, AMP, ADP and ATP 
were made in PCA solution and underwent exactly the same procedures as for the 
samples to work out the recovery for each compound. 
Adenine nucleotide energy charge which reflects the energy state of a tissue 
was calculated as follows (Atkinson, 1968): 
Energy charge (EC) = 	[AMP] + 0.5 [ADP] 
[AMP] + [ADP] + [ATP] 
2.4 Metabolic rate studies on intact conscious animals 
2.4.1 Calorimetric measurement on conscious animals 
Bettongs of either sex (1.67 ± 0.10 kg) were used. The experiments were 
carried out between 10 am and 6 pm, which is in the bettong's normal sleep and 
quiescent phase. The animals were placed in a well-ventilated coarse-woven jute bag, 
to reduce ambient light influences to a minimum, and then moved into the respiratory 
chamber maintained at 25°C which is a thermoneutral zone for marsupials (Nicol, 
1976, Wallis et al., 1992) and the rat (Foster &Frydman, 1979, Maxwell et al., 1987). 
The resting metabolic rate was taken as the minimum 5 min average value when the 
animal stayed quiet. For the administration of drugs to the bettong, a venous 
indwelling cannula (A 0.8/25 mm) was inserted into the tail vein with 0.9% NaC1 
solution continuously infused by a pump (LKB, Bronuna) at a flow rate of 0.02 ml.kg-
I - min- 1 . The drugs were freshly made in sterile physiological NaC1 before use. 
Normally, animals had settled down within 15 min, but 30 min was allowed to elapse 
before collecting data. For comparison, metabolic rates were also determined on 
conscious rats (250 ± 10 g) in the same system but a smaller animal chamber. 
2.4.2 Indirect calorimetry system 
Heat production was determined by measuring V02 of the whole animal in an 
indirect calorimetry apparatus. The system was composed of a sealed respiratory 
chamber sitting in a water bath, a coil of copper piping placed in the water bath to act 
as a heat exchanger for the inlet air, a vacuum pump for controlling air flow through 
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the chamber, a sampling pump, and a modified 0 2/CO2 gas analyzer (Datex, Labtech, 
Finland). 
Fig. 2-3 Diagram of indirect calorimetry system for whole animal metabolic rate 
study. 
The sealed chamber was temperature controlled (25°C) and at negative 
pressure with a water trap on the exit line. The air flow was controlled by a needle 
valve and measured by a rotameter on the exit line. The flow rate of air through the 
chamber was adjusted to a level to keep the expired CO 2 below 0.2%. A sample was 
drawn off by the sampling pump and passed through a T-junction containing a 
humidity and temperature probe to give correction to the flow figure from the 
rotameter. The sample then travelled through a drying column (CaSO4) and into a 
constant pressure head device (Barostat) where it was sampled by the 0 2/CO2 
analyzer. A peristaltic pump sampled the air and passed it through a drying column to 
the reference air inlet of the 02/CO2 analyzer. The main source of vacuum for the 
system was a large diaphragm pump that has sufficient power to extract air from a 
hood for 100 L/min. 
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Data from the electronic device were controlled via interface boxes by an 
A/D board on an IBM compatible computer, and processed by the program "Labtech 
Notebook" and stored in a file form compatible with "Lotus". The expired air was 
continuously monitored with the gas analyzer, and the data collected and stored in a 
computer for every 1 mm interval during the period of experiment. 
2.4.3 Calculation 
Whole body heat production was calculated from V02 measured under 
conscious conditions by an indirect calorimeter according to the method of Weir (33). 
The standard average energy yield from mixed food per liter of oxygen consumed was 
assumed to be 4.83 kcal (9). Thus, the formula was modified as: 
Heat production = 
(kJ-kg4 .day-1 ) 
0.2088 x (O T - OE) x V x 60 x24 
Body weight (kg) 
where 0.2088 is a constant calculated from Weir's formula (33) using 4.83kcal/L V0 2 , 
V= flow (L/min) at STP (dry), (0 1 - 0E)= the difference in oxygen content between 
incoming air and exiting air, 60=60 min, 24= 24 hours. 
For comparison between the bettong and other species, the metabolic body 
size of 0.75 power of body weight (W 0 . 75) was used. The proportional change in 
metabolic rates to W °-75 of adult animals is recommended by the International 
Commission of IUPS for Thermal Physiology for comparison to be made between the 
metabolic levels of different animals (Bligh & Johnson, 1973). 
The proportion of metabolism that skeletal muscles contribute to the whole 
body metabolic rate was estimated according to the equation (Flanigan etal., 1991): 
% contribution = 
	Muscle V02 x Entire muscle mass  
Whole body V02 
where the proportion of muscle mass relative to total body mass was obtained from 
literature reports for the rat (Grubb & Folk, 1976) and for the red kangaroo (Tribe & 
Peel, 1963). 
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2.5 Chemicals, instruments and statistics 
2.5.1 Chemicals 
Sodium pentobarbital (Nembutal) was obtained from Boehringer Ingelheim 
(Australia) and heparin sodium (porcine mucous) from David Bull Laboratories Pty. 
Ltd (Australia). H-Norepinephrine bitartrate, L-phenylephrine-HC1, naphazoline-HCI, 
H-isoproterenol-HC1, phentolarnine-HC1, DL-propranolol-HC1, Arginine-vasopressin, 
5-hydroxytryptamine creatinine sulfate, nifedipine-HC1 and Evans-blue were obtained 
from Sigma (USA). Nitroprusside sodium was purchased from E. Merck (Germany). 
BRL 35135A was a gift from SmithKline Beecham Pharmaceuticals, UK. BSA 
(Fraction V) was obtained from Boehringer Mannheim Biochemicals (Indianapolis, 
USA). 
AMP-Na2 , ADP-Na2, ATP-Na2 , inosine, creatine phosphate-Na2, NAD, 
NADH, NADP, LDH, a-glycerophosphate dehydrogenase, glycerol kinase, 
hexokinase, creatine Icinase, G-6-P dehydrogenase, almyglucoase, and GOD-Perid 
agent were purchased from Boehringer, Mannheim (Germany). Creatine was provided 
by BDH (England). Tetrabutylammonium hydrogen sulfate was obtained from Aldrich 
Chemical Company, Inc. (USA). Other chemicals were analytical grade from Ajax 
Chemicals (Australia). 
Gases including 0 2 , carbogen (95% 02 and 5% CO2), N2 and the calibration 
gases for the 0 2/CO2 analyzer were purchased from Commonwealth Industrial Gases 
Limited, Australia. 
2.5.2. Instruments 
Perfusion apparatus included a perfusion pump (Masterflex, Chicago In, 
USA), infusion pumps (2132-Microperpexe LKB, Bromma), a thermostatic 
circulator (TE-8J, LKB), an artificial lung, a Clark-type 0 2 electrode, a pressure 
transducer (Department of Biochemistry, University of Tasmania), and a chart 
recorder (Omniscribe, D5000, Houston Instrument, Austin, Texas, USA). The oxygen 
content analyzer (TasCon) was manufactured by Department of Physiology, 
University of Tasmania. The electrical stimulation system consisted of a square-wave 
stimulator (USE, NERV-MUSKEL-REIZGRAT, Germany) and an isometric 
transducer (Harvard, Bioscience). 
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Analytical instruments used in the study included an electrically driven 
homogenizer (Ultra-Turrax Homogenizer), centrifuges [DPR-6000, ICE (USA); 
Eppendorf], spectrophotometers [Cary-219, Varian (USA); DU-30, Beckman (USA); 
Spectronic 3000 Array, Milton Roy (USA)] and a spectrophotofluorometer (Aminco-
Browman, American Instrument Company). 
High performance chromatography (HPLC): a) Waters-HPLC (USA) 
consisted of four 6000A pumps, an U6K injector, a 440 absorbance detector, a 660 
solvent programmer, and a SP 4100 computing integrator; b) LICB-HPLC included 
four 2150 pumps, a 2141 variable wavelength monitor, a 2152 LC controller and a 
2210 recorder. 
2.5.3 Statistical analysis 
Data are presented as means ± standard error (SE). Student's t-tests were 
used for the statistics of the study. A paired t-test was used when indicated. P<0.05 
was regarded as statistically significant, P<0.01 as extremely significant. 
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CHAPTER 3 
Flow-induced increase in V02 is inhibited by vasodilators and 
augmented by NE in the perfused rat hindlimb 
3.1 Introduction 
Thermogenesis in the resting skeletal muscle has been long considered as a 
significant contributor to whole body heat production (Jansky 1971; Mejsnar et al., 
1980; and Astrup et al., 1986). Indeed data of Foster and Frydman (1979), which 
focus on the role of BAT, were also indicative of a substantial role for skeletal 
muscle. Their findings showed that for warm-adapted and normal rats NE 
administration resulted in a 30% increase in skeletal muscle blood flow and a 60% 
increase in V02. Such data suggested that muscle could produce equal amount of heat 
to brown fat, even though V0 2 was very much less per gram of tissue. 
Attempts to address the issue more directly by using the perfused rat 
hindlimb have supported the above conclusion. The perfused rat hindlimb has been 
found to respond reproducibly to NE administration with a marked increase in V0 2 
(Mejsnar et al., 1973; Grubb & Folk, 1976; Richter et al., 1982b; Cote et al., 1985; 
Colquhoun et al., 1988). This response occurred at rest when the hindlimb was 
perfused with erythrocyte-containing medium at 37°C (Mejsnar etal., 1973; Grubb & 
Folk, 1976; Richter et al., 1982b) or medium without erythrocytes at 25°C (Cote et 
al., 1985; Colquhoun et al., 1988, 1990; Hettiarachchi et al., 1992). A surprising 
finding has been that the V02 was mediated by an a-adrenergic receptor mechanism 
that was invariably associated with a rise in perfusion pressure. Other vasoconstrictors 
such as VP and AT II also stimulated V02 during vasoconstriction with both effects 
being blocked by nitroprusside, thereby supporting the possibility that perfusion 
pressure (possibly flow) controls V02 of the skeletal muscle (Colquhoun etal., 1988). 
As reviewed in Chapter 1 (Section 1.8.5), many studies have shown flow-
induced V02 in resting skeletal muscle. Yet the mechanism underlying it remains 
unclear. In addition, it is not known whether flow-induced V02 is affected by 
vasoconstriction or vasodilation. Thus in the present study, perfusion flow and 
pressure have been varied over a wide range and the effects of NE and vasodilators 
compared during varied flow. 
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3.2 Methods 
3.2.1 Hindlimb perfusion 
180-200 g male rats were used for the experiments. The method for the 
hindlimb preparation is described in Chapter 2 (Sections 2.2.1 & 2.2.3). The 
perfusions were conducted at 25.0 ± 0.2°C using Krebs-Ringer buffer containing 1.27 
mM CaC12 and 4% BSA. 
For perfusions where pressure was varied stepwise, the perfilsate was 
allowed to flow under gravity from a reservoir kept at 4°C. The pressure was adjusted 
by relocating the perfusate reservoir to predetermined positions above the hindlimb. 
Flow was monitored by collection into a fraction collector set on time mode. V0 2 was 
calculated from arteriovenous difference in P02 and flow rate after allowing a time 
delay in Pv02 measurement due to electrode characteristics and tubing volume. 
For perfusions where flow was varied, the hindlimb was initially equilibrated 
at 4 ml/min (per 15 g fresh weight of muscle) for 40 min. Flow was then adjusted to 
2.0 ml/min using a calibrated pump and maintained at that rate for 30 min. The flow 
was then subsequently adjusted to 4, 6, 8, and 18.5 ml/min maintaining constant flow 
until steady-state pressure and Pv0 2 were achieved. These set flow rates were noted 
by collecting the effluent in a measuring cylinder over a prescribed period of time, 
usually one minute. 
3.2.2 Electrical Stimulation 
An incision was made in the back of the thigh, and then the superficial gluteal 
muscles were carefully separated in parallel with the sciatic nerve to expose this nerve. 
The proximal portion of the nerve was divided and the distal end sucked into a saline-
filled plastic syringe mounted with silver electrode probes. The gastrocnemius-
plantaris-soleus muscle group was then stimulated to contract by electrically 
depolarizing the sciatic nerve. Twitch tension was recorded via a force transducer 
during electrical stimulation (200-ms trains of 100 Hz applied every 2 s; each impulse 
in the train being of a duration of 0.1 ms) and the voltage was adjusted (15-20 V) to 
attain full fibre recruitment as shown by maximal contraction. Muscles were 
stimulated for three periods of 2 min each with a rest period of 30 min between 
consecutive runs. Pv02 was monitored continuously and maximum V02 noted; this 
occurred 1-2 min after commencement of stimulation. 
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3.2.3 Metabolite assay 
The production of lactate and pyruvate were determined from arteriovenous 
differences and the flow rate of the perfiisate. The gastrocnemius-plantaris-soleus 
muscle group was removed and then freeze-clamped for the measurement of muscle 
metabolites. The detail of the mass and fibre types of the gastrocnemius-plantaris-
soleus muscle group was outlined in Section 2.3 (p. 31-32). Lactate, pyruvate, 
glycogen, and CrP were enzymatically assayed as described in Section 2.3.2. AMP, 
ADP, and ATP contents were determined by anion-exchange column with HPLC 
(Waters Associates) according to the method described by Colquhoun et al. (1990) 
and Section 2.3.3.1. 
3.3 Results 
3.3.1 Pressure-induced changes inflow andV 02 
These experiments were conducted to assess the effects of pressure on flow 
and V02 . The conditions chosen were considered likely to minimize autoregulation of 
flow and the related control of capillary density. Fig 3-1 shows the effect of 
periodically varying the perfusion pressure from high to low while allowing flow to 
self-regulate. Initially the rat hindlimb was perfused at a pressure of 44 mm Hg for 30 
min to allow complete equlibration; a constant flow rate of 5.4 ml/min was attained 
and the V02 was 7.0 prnols -1 .11-1 . The perfusate reservoir was then raised to a new 
level to give a pressure of 82 mm Hg. Perfusate flow immediately increased to 13 
ml/min then, over the next 30 min, gradually decreased to 11 ml/min. Vo 2 , calculated 
from the arteriovenous difference and flow rate, peaked at 19.5 jimol-g -1 .10, then 
gradually decreased over the next 30 min to 8 gimo1.g -1 1-1 . When the pressure was 
decreased from 82 to 28 mm Hg by lowing the pressure reservoir, the flow decreased 
to 1.5 ml/min and then increased marginally to 2.0 ml/min. V02 decreased 
immediately following the fall in pressure and flow to 0.5 umol•g -1 •h-1 but then 
increased over the next 30 min to 3 punols -1 .11-1 . A similar relationship between 
pressure, flow, and V02 as described above was again evident when the pressure was 
reset to 44 mm Hg. 
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Fig. 3-1 Effect of perfusion pressure on flow and V02 of the perfused rat 
hindlimb. Data are means ± SE, n=4. 
3.3.2 Flow-induced changes in V02 and pressure 
The relationship between flow, steady-state V0 2 and pressure development, 
as well as the effect of vasodilators and NE on these latter parameters is shown in Fig. 
3-2. Perfusate flow was set at 2, 4, 6, 8, and 18.5 ml/min for at least 15 mm and 
sometimes 40 min during which time pressure and V02 were recorded. Fig. 3-2A 
shows that V02 increased as the flow increased and this increase was further 
augmented by 50 nM NE. Conversely, nitroprusside (acting via cyclic GMP) inhibited 
the pressure and V02 induced by flow. However, a combination of three vasodilators, 
nitroprusside, nifedipine (a Ca+2 channel blocker), and isoproterenol (acting via cyclic 
AMP) did not further inhibit pressure and V0 2 compared with nitroprusside alone 
(Fig. 3-3). 
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Fig. 3-2 Effect of perfusate flow, NE, and NP on pressure and V02. Additions to 
the perfusate were none (0, n=6-7), 50 nM NE (0, n=6) and 0.5 mIVI NP (A, 
nitroprusside, n=6). * P<0.05, ** P<0.01, vs no addition. Means ± SE. 
Fig. 3-3 Effect of NP 
alone and a combination 
of vasodilators on V02 
and pressure. A: 0.5 mM 
NP (nitroprusside, n=6); V 
: a combination of 0.5 mM 
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3.3.3 Vasodilators and working skeletal muscle 
Since V02 in the hindlimb at all flow rates was markedly inhibited by the 
vasodilators, it was considered relevant to assess the effects of these agents on 
working skeletal muscle V0 2 . Table 3-1 shows that neither nitroprusside alone nor 
the combination of nitroprusside, nifedipine, and isoproterenol had any significant 
effect on the increase in V02 by the perfused contracting hindlimb at constant flow (4 
ml/min). More importantly, the twitch tension force development was also unaffected 
by the vasodilators. 
Table 3-1 Effect of vasodilators on twitch tension development and V0 2 of the 
rat perfused hindlimb 
Addition Twitch tension (g) A V02 
0 min 2 min (p,mol h-1 g-1) 
None 3 603 ±132 220 ± 49 3.90 ± 0.38 
NP 3 641 ±75 ns 200 ± 64 ns 4.50 ± 0.34 ns 
NNI 3 547 ± 51 ns 217 ± 47 ns 3.86 ± 0.42 ns 
Note: NNI = NP (nitroprusside, 0.5 mM) + nifedipine (1 1.LI ■4) + Iso (isoproterenol, 1 p.M). ns, not 
significantly different from the "none". The perfusions were conducted at 4 ml/min. Data are means 
± SE. 
3.3.4 Muscle metabolites 
The experiments recorded in Table 3-2 were conducted to assess whether 
NP-inhibition of hindlimb V0 2 was associated with a decrease in high energy 
phosphates in muscle. Table 3-2 shows metabolite concentrations for the 
gastrocnemius-plantaris-soleus muscle group from the hindlimb freeze-clamped before 
surgery (in vivo) and following perfusion for 120 min with no additions, 0.5 mM 
nitroprusside, and a combination of nitroprusside (0.5 mM), nifedipine (1 1AM), and 
isoproterenol (1 pM). None of the differences between muscle perfiised with or 
without the vasodilators and muscle in vivo was significant. However, NE 
significantly reduced lactate content and lactate/pyruvate ratio in the muscle and 
tended to increase CrP. 
Table 3-2 Metabolite contents in the gastrocnemius-plantaris-soleus muscle group of the rat hindlimb. 
Muscle origin n Wet/dry wt ATP CrP Lactate Pyruvate LIP 
umol/g dry wt 
In vivo 3 4.4 ± 0.1 27.3 ± 1.1 71.9 ± 4.1 10.5 ± 1.6 0.7 ± 0.1 16.8 ± 5.3 
Perfused 120 min 
No additions 5 4.5 ± 0.2 29.7 ± 0.9 72.5 ± 1.9 9.2 ± 1.0 1.0 ± 0.1 9.2 ± 1.1 
NE 3 5.4 ± 0.2* 30.2 ± 1.2 80.6 ± 4.1 2.5 ± 0.5** 0.8 ± 0.1 3.1 ± 0•7** 
NP 5 5.3 ±0.3 27.2 ± 1.7 70.1 ±2.3 9.7 ± 1.2 1.1 ±0.1 8.9 ± 1.3 
NNI 4 4.9 ± 0.2 26.0 ± 0.9 63.3 ± 0.9 9.0 ± 0.9 0.9 ± 0.2 10.3 ± 2.0 
Note: Perfusions were conducted at 8.0 ml/min. NNI, combination of nitroprusside (0.5 mM), nifedipine (111M) and isoproterenol (1 i.M). * P<0.05, ** P<0.01, 
vs no addition. The gastrocnemius-plantaris-soleus muscle group was removed and then quickly freeze-clamped. Neutralized HC104 extract was enzymatically 
assayed (see Sections 2.3.1 & 2.3.2) for CrP, lactate and pyruvate. ATP was measured by an anion exchange method in HPLC (Section 2.3.3) 
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3.3.5 Perfusate lactate/pyruvate ratio 
The lactate/pyruvate ratio is considered a reliable indicator of muscle 
oxygenation (Bylund-Fellenius et al., 1981; Shiota & Sugano, 1986) and was thus 
used in the present study. 
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Fig. 3-4 Effect of vasoactive substances on flow-induced lactate and pyruvate 
release as well as the ratio of lactate/pyruvate. Additions to the perfusate were 
none (0, n=6-7), 50 nM NE (0, n=6) or NP (A, nitroprusside, n=6). Data are the 
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Fig 3-4 shows lactate and pyruvate release at each flow rate with and 
without addition of NE or nitroprusside. Lactate release increased as the perfusate 
flow was changed from 2 to 18.5 ml/min (Fig. 3-4 A). Pynwate release also increased 
over this range of flow rates (Fig. 3-4B). Addition of 50 nM NE significantly elevated 
lactate and pynwate release. The increases became larger at higher flow rates. In 
contrast, the vasodilator, nitroprusside, had no significant effect on either lactate 
release or pyruvate release. Thus the net effect of changing flow rate from 2 to 18.5 
ml/min was to lower the perfu sate lactate/pyruvate ratio from approximately 15 at 2 
ml/min to a constant value of approximately 9 at 4 ml/min and beyond. In addition, 
and as shown in Fig 3-4C, the ratio was shifted up in parallel by NE but not affected 
by the presence of nitroprusside. Overall these data suggest that inadequate 02 supply 
to the resting perfused rat hindlimb at 25°C occurs only at flow rates less than 4 
ml/min. 
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Fig. 3-5 Dose-response curves for the effect of VP and NE on perfusion pressure 
and VO2 at a high flow rate. The rat hindlimb was perfused at a constant-flow rate 
of 18.5 ml/min. •: VP, •: NE. Data are means ± SE, n=3. 
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3.3.6 Dose-response curves of V02 and pressure for NE and VP at high flow rate 
These experiments were carried out to compare results with those obtained 
at low flow rate under the same conditions in the same laboratory (Colquhoun et al., 
1988 & 1990). VP was employed here as another example of the effect of a 
vasoconstrictor on V02 and perfusion pressure. As illustrated in Fig. 3-5, the dose-
response curves of V02 and perfusion pressure induced by VP and NE at 18.6 ml/min 
were essentially similar, in both the response dose ranges and proportion, to those at 4 
ml/min with ED 50 for V02 at 0.06-0.10 nIVI for VP and 10 nIVI for NE (Colquhoun 
et aL, 1988 & 1990). There were no significant differences in maximal increase in 
V02 and perfusion pressure induced between NE and VP. 
3.3. 7 Effect of tubocurarine on V0 2 mediated by NE and sciatic nerve stimulation 
In order to assess the possibility that NE increases V0 2 by increasing the 
skeletal muscle tension, tubocurarine, a drug which paralyzes skeletal muscle, was 
also infused during NE infusion. Fig. 3-6 demonstrates that 1 uNI tubocurarine had no 
effect on either V02 or pressure induced by NE. By contrary, the same dose of 
tubocurarine completely blocked both V02 and skeletal muscle contraction produced 
by sciatic nerve stimulation. 
3.4 Discussion 
In the present study, the effects of flow, NE and vasodilators on V02 has 
been assessed using a system where rapid autoregulation has been avoided (Fig. 3-1). 
A principal finding was that the V02 by the perfized rat hindlimb increased as flow 
was increased to approach a plateau at 18.5 ml/min or 1.3 ml.min -1 .g-1 (Fig 3-2). At 
flow rate less than 8 ml/min, the hindlimb data illustrate a widely noted property of 
perfused non-contracting skeletal muscle preparation where V0 2 increases with an 
increase in perfusion pressure or flow. This relationship has been reported for rat 
gracilis muscle (Honig et al., 1971), dog gastrocnemius-plantaris muscle group at low 
but not high blood flow levels (Stainsby & Otis, 1964), dog hindlimb both with NE 
(Coburn & Pendleton, 1979) or without NE (Pappenheimer, 1941b), isolated perfused 
cat soleus and gracilis muscles (Whalen et al., 1973), resting and isolated gracilis 
muscle of dogs (Beer & Yonce, 1972), and hindlimbs of lemmings and rats (Grubb & 
Folk, 1978; Shiota & Sugano, 1986). The relationship appears to be readily observed 
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in rat hindlimb preparations without exception (Honig et a/. 1971; Grubb & Folk, 
1978; Shiota & Sugano, 1986) but, for as yet unknown reasons, is not always 
apparent in dogs (Duran & Renldn, 1974; Honig etal., 1971; Chapler etal., 1980). 
To date, the dependence of V02 on blood flow has been interpreted as a 
physiological limitation of V02 in resting muscle by 0 2 transport, owing to the 
inhomogenity of capillary functions (Lindbom & Arfors, 1985) and uneven 
distribution of 02 within an organ (Honig et aL, 1971; Shiota & Sugano, 1986). To 
address this issue, a range extending from half to four times the normal hindlimb 
blood flow rate of the conscious rat (Armstrong & Laughlin, 1985) has been used in 
the present experiment. Under these conditions it was noted that nitroprusside 
inhibited V02 and pressure at all flow rates, in particular at the highest flow where 
tissue perfusion could be expected to be approaching the maximum. Furthermore, the 
effect of NE increasing V02 and pressure was greater at high flow rates than at lower 
flow rates. This reasoning is based on the notion that NE results in increased perfusate 
02 delivery to previously underperfused regions of skeletal muscle and that these 
regions are more extensive at low pressure. 
The question of underperfusion was also addressed by assessing the 
biochemical indices of hypoxia. Poorly perfused muscle has a lower CrP concentration 
and increased tissue lactate concentration (Ruderman et aL, 1971; Challisss et al., 
1986). The sensitivity of CrP concentration measurement to evaluate ischemic muscle 
is further supported by the study on the bioenergetic profiles of skeletal muscle during 
ischemia (shown in Chapter 7), where CrP content is reduced by 18% of the original 
level following 5 min of ischemia. Thus, to address the possibility that nitroprusside-
induced inhibition of V02 resulting from tissue underperfusion, a representative 
sample of muscle (the gastrocnemius-plantaris-soleus group) was freeze-clamped and 
assayed for the content of adenine nucleotides, CrP, lactate and pyruvate. If the 
vasodilators decreased V02 by decreasing the area of skeletal muscle actually 
perfused, it could be expected that CrP level would be lower following this treatment. 
Despite the fact that the vasodilators had resulted in a 40% inhibition of V02 under 
the conditions chosen, there was no significant difference between vasodilator-treated 
and untreated muscle with respect to metabolite concentration (Table 3-2). On 
contrary to vasodilators, NE reduced lactate content in the muscle and tended to 
improve CrP concentration. The latter is consistent with the observations in the 
constant-pressure perfused rat hindlimb where CrP was significantly improved by NE 
(Chapter 6). 
The lactate/pyruvate ratio is a sensitive index of hypoxia (Bylund-Felleneius 
et al., 1981) and was also used in the present study to assess whether the increase in 
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V02 by the hindlimb induced by the increase in flow rate was the result of elimination 
of previously underperfused muscle regions. Since the ratio was higher at 2 nil/min 
per hindlimb than at all other flow rates and was constant at rates equal to or greater 
than 4 ml/min per hindlimb, it appeared unlikely that hindlimb tissue was 
underperfused at flow rates other than 2 ml/tnin per hindlimb. It is also worthy of note 
that 0.5 mM nitroprusside which inhibited V0 2 at 18.5 ml/min per hindlimb to a value 
similar to that of the untreated hindlimb perfused at 5 ml/min had no effect on the 
lactate/pyruvate ratio at high flow rate. Although NE increased the lactate/pyruvate 
ratio, the change also reached the steady state at 4 ml/min and remained unaffected at 
flow rates beyond. Lactate is transported across the cell membrane and its gradient 
between muscle and blood drives its release or uptake. Pyruvate is also thought to 
cross the cell membrane in the same way (McDermott & Bonen, 1992). These data 
taken together imply that flow- and agonist-induced V0 2 results from processes other 
than simply supplying flow and 02 to hypoxic regions of skeletal muscle fibres. 
It appears that NE-mediated increase in lactate release in the effluent 
perfusate was associated with a lowering lactate content in the muscle. The higher 
lactate/pyruvate ratio in the presence of NE may be due to NE-induced high 
production in lactate from blood vessels (Hettiarachchi et al., 1992). The similarities 
of the profiles of lactate and perfusion pressure induced by NE (Fig. 3-2A and 3-3A) 
appear to be supportive of this argument. Alternatively, if NE redirects the perfusate 
to more nutritive capillaries (Clark et aL, 1994) or increases the perfused capillary 
surface areas, a lower lactate in the tissue associated with a higher washout of lactate 
could be expected. However, the present data are not sufficient to identify the exact 
mechanism for the opposite effects of NE on lactate efflux and intracellular lactate 
concentration. Further studies are needed to address this observation. 
Another finding in the study was that vasodilator nitroprusside did not inhibit 
V02 and tension development by the perfused working skeletal muscle. Recently, 
Murrant et al., (1994) found that in the superfused mouse soleus muscle, prolonged 
muscle contraction is improved by addition of 3 mM of nitroprusside. This contrasts 
with its marked effect to inhibit V0 2 and pressure induced by vasoconstrictors 
(Colquhoun et al., 1988) and pressure (Fig. 3-2) where dilation of thoroughfare 
channels might have occurred. However, the opening of thoroughfare channels would 
be expected to compromise 02 availability to working skeletal muscle and thereby 
reduce working skeletal muscle V02 and twitch-tension development. Clearly, this 
was not evident from the present experiment (Table 3-1). and thus further 
investigations are required. 
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A direct effect of NE on skeletal muscle to increase V02 would be consistent 
with the observation made in the present study. However, it must be kept in mind that 
the effect of NE is mediated by a-adrenergic receptors (Grubb & Folk 1977; Richter 
et al., 1982b; Chapter 4) and V02 is also increased by VP and angiotensin H 
(Colquhoun, et al., 1988; Fig. 3-5). There are relatively fewer a-adrenergic receptors 
on striated muscle cells (Rattigan et al., 1986) and the majority of these receptors are 
located on blood vessels (Martin et al., 1990). A biochemical mechanism or reaction 
of skeletal muscle to account for such a large increase in V0 2 is yet to be defined. 
Working muscle is capable of high rates of "0 2 and rates of approximately 6 
umol.g-Emin-1 (Stainsby et al., 1984) have been reported for contracting dog 
gastrocnemius muscle in situ. But the data from Fig 3-6 show that NE stimulates V02 
without affecting basal skeletal muscle tone. More importantly, the increased V0 2 is 
entirely distinguishable from muscle contraction-induced increase in V02 by 
tubocurarine that blocks only sciatic nerve stimulation-induced, but not NE-induced, 
Vo2 . 
The increase in perfusion pressure (Fig. 3-1) or flow (Fig. 3-2) would have 
two hemodynamic forces on vascular walls: stretch or pressure, acting perpendicular 
to the surface, and shear stress, a tangential, dragging component resulting from 
friction with the endothelial surface (Davies 1989; Meininger et al., 1991). These two 
effects on vascular vessels may be involved in the flow (pressure)-induced V0 2 of the 
perfused hindlimb. The transient large increase in V0 2 is probably due to a delay of 
the response of the 02 electrode to a sudden increase in flow rate. In addition, blood 
vessels are known to consume more 02 during the process of contracting (Murphy, et 
al., 1983). 
It is well established that the V02 of vascular smooth muscle is proportional 
to its active tension (Paul et al., 1975; Paul, 1980). The increased stretch pressure on 
vascular walls as a result of increase in perfusion flow (or pressure) could be expected 
to elevate vascular wall tension. The latter would enhance vascular myogenic 
responsiveness and work load, thus stimulating vascular VO2 ("hot pipes") 
(Colquhoun et al., 1990; Colquhoun & Clark, 1991). In resting skeletal muscle, the 
myogenic mechanism acts as the more dominant form of local control of the 
resistance vasculature (Meininger et al., 1991). This probably explains the inhibition 
of flow-induced perfusion pressure by vasodilators (Fig, 3-2). The inhibitory effect of 
nitroprusside on flow-induced V0 2 may be attributed to its relaxation of blood vessels 
(Fig. 3-2) whereas NE enhances V0 2 by further increasing vascular tension. If flow-
or vasoconstrictor- induced V0 2 results from the increased active vascular wall 
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tension, it would be expected that vasoconstrictor-stimulated V0 2 is a general feature 
in muscle vascular bed and may occur in other perfiised vascular beds as well. 
Renkin et aL (1971) proposed that there are nutritive and nonnutritive 
capillaries in muscle. Some experiments suggested only a part of the nutritive 
capillaries is recruited under basal conditions (Burton & Johnson, 1972; Johnsson, 
1988). Thus, another possibility for flow-induced V02 may be due to an increased 
recruitment of nutritive capillaries as perfusion flow rate increases. The present 
perfusions show little autoregulation as indicted by a slow response of flow to a 
change in pressure (Fig. 3-1). The loss of autoregulation and presumably control of 
capillary distribution within the muscle may allow perfusate to reach more and more 
capillaries, thereby increasing V02. In addition, a dye-washout study (Dora et aL, 
1991; Newman, 1992) at 4 ml/min at 25°C suggested that NE increases perfused 
vascular volume. NE may redirect the perfusate to nutritive areas that consume more 
02 . Based on this hypothesis, the vasodilator-inhibited V0 2 could be interpreted as a 
result of redirecting perfusate to less nutritive muscle capillaries. This would imply 
that the increased flow of perfusate to nutritive capillaries somehow stimulates 
mitochondrial respiration to consume 02 or other yet unknown thermogenic process. 
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CHAPTER 4 
Vascular control of V02 in the perfused hindlimbs of a marsupial 
(beftong) and an amphibian (cane toad). 
4.1 Introduction 
Marsupials are a diverse group of mammals with well-developed 
thermoregulation. The Tasmanian bettong (Bettongia gaimardi) is a rat-kangaroo 
closely related to the larger kangaroos and wallabies. At birth, the bettong is 
ectothermic. The young becomes progressively endothermic before it finally vacates 
the pouch (Rose, 1987). Intramuscular injection of NE elicited a significant increment 
in V02 in vivo in the potoroo Potorous tridacodus (Kerr), a close relative of the 
bettong, and this increase was blocked by propranolol but not by phenoxybenzamine 
(Nicol 1978). Hayward and Lisson (1992) have presented strong anatomical and 
microscopical evidence that marsupials, including bettongs, do not possess BAT. The 
lack of BAT in bettongs is further supported by a recent molecular biology study 
using Northern blotting which failed to identify any UCP in this species (Trayhum, 
personal communication, 1994). This characteristic makes the bettong a valuable 
animal for the study of non-shivering thermogenesis occurring in tissues other than 
BAT. To date, no study on V02 in a perfused marsupial skeletal muscle has been 
found in the literature. Accordingly, the first aim of the present study attempted to 
examine whether the vasoconstrictive hormones, NE, VP and 5-HT, have any effect 
on V02 , and lactate and glycerol efflux from the perfused hindlimb of the bettong as 
an example of marsupial muscle metabolism. 
By comparison, amphibians are typical ectothermic animals with a very low 
blood pressure of 15-30 mmHg (Withers et al., 1988; Pelster et al., 1993) and much 
lower V02 which ranges between 0.4-1.2 ml.kg -1 -min-1 (Altman & Dittmer, 1974; 
Degani & Meltzer, 1988). The acclimation of metabolic rate in amphibians is still 
controversial. The data from Feder et al. show an increase in metabolic rate of 
salamanders (Desmognathus) following cold exposure (reviewed by Lawrence et al., 
1992). Wood (1991) found no evidence for thermal acclimation of V0 2 in the 
salamander (Traricha granulosa). In a small frog (Neobatrachus pelobatoides), the 
measured muscle VO2 varied between 2.0-5.6 umol-g-1 -h-1 , and contributed 60-77% 
of the whole body metabolic rate with a total mass of 35% of the body weight 
(Flanigan etal., 1991). Yet little is known about the effect of vasoactive hormones on 
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muscle metabolism in amphibians. Hence, comparisons of vasoconstrictor-mediated 
alterations in skeletal muscle 02 metabolism between the endotherms (rats and 
marsupials) and ectothermians (toads) will provide useful information for addressing 
the role of the vascular system in controlling or contributing to muscle thermogenesis. 
To this end, the cane toad (Bufo marinus) was used as a representative of ectothermic 
amphibians in the present study. Therefore the second aim in this study was to 
examine the effect of NE on V0 2 in perfused toad hindlimbs to observe whether the 
relationship between vascular function and V0 2 was universal regardless of whether 
an animal is endothermic or ectothennic. 
4.2 Methods 
The experiments for both species were performed in a constant-flow (once-
though) model at 25°C. The bettong hindlimb was perfused with modified Krebs-
Ringer buffer with 1.27 mM CaC1 2 and 2% BSA whilst the toad hindlimbs were 
perfused with modified amphibian Hepes buffer containing 1% BSA and 1.3 mM 
CaCl2 . The details for the perfusion were described in Chapter 2 (Section 2.2). The 
efflux of lactate and glycerol was measured enzymatically as previously described 
(Section 2.3). Muscle metabolites of bettongs were measured in freeze-clamped 
gastrocnemius-plantaris-soleus group. High energy phosphate compounds were 
determined by HPLC (Waters Associates, USA) with a Radial-Pak column (C18, 4 11 
m) according to the method of Shellevold etal. (1986, see Section 2.3.3.2). 
4.3 Results 
4.3.1 Validation of perfusion for the perfused hindlimb 
Table 4- 1 summarize the mean values for body weight of these animals, the 
mass of perfused skeletal muscle, as well as the perfusion pressure, V02, and the rate 
of release of lactate and glycerol. V0 2 as well as lactate efflux was maintained stable 
in the perfused hindlimb(s) of both species throughout the experiment. At no stage did 
the Pv02 in the perfilsed hindlimb(s) during the maximum 02 extraction decline below 
200 mm Hg for the bettong perfused hindlimb or below 400 mm Hg for the perfused 
toad hindlimbs. Both the basal V02 and lactate efflux of the toad muscle were lower 
in comparison with those of the bettong. 
Flow 
0.28 ± 0.02 
Pressure 
(mm Hg) 
32.0 ± 2.30 
Table 4-1 Basal measurements for the perfused bettong and toad hindlimb(s) 
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Perfused muscle 
(g) 
25.0 ±2.3 
Lactate 	Glycerol  
(p.mo1.g- i.h-1 ) 
	
4.18 ± 0.35 	4.41 ± 0.39 	0.28 ± 0.03 
1.36 ±0.10 	0.70 ± 0.17 	not done. 
Species 	n 	Body wt. 
(g) 
Bettong 	7-8 	1200 ±110 
(B. gaimarch) 
Cane toad 	5 	129.4 ± 16.6 18.4 ± 3.2 
(Bufo marinus)  
0.20 ± 0.02 	15.8 ± 3.2 
Table 4-2 Metabolites of bettong gastrocnemius-plantaris-soleus muscle group 
Lactate Cr CrP AMP 	ADP ATP EAN Cr+CrP EC CrP/ATP 
(pmol/g dry weight) 
In vivo 
Perfused 
5 
5 
14.02 
±2.74 
6.55** 
± 0.59 
318.4 
±6.08 
324.2 
± 12.50 
99.78 
± 1.84 
126.6** 
± 4.45 
0.16 
±0.01 
0.16 
± 0.02 
2.63 
±0.06 
2.58 
± 0.09 
23.09 
±0.64 
25.28 
± 0.79 
25.87 
±0.66 
28.03 
± 0.80 
418.2 
±6.58 
450.8 
± 14.03 
0.943 
±0.002 
0.948 
± 0.002 
4.33 
± 0.10 
5.03* 
± 0.21 
EAN: total adenine nucleotides, Cr: creatine, CrP: creatine phosphate. * P < 0.05; ** p < 0.01, vs in vivo. Data are means ± SE. 
* * * 
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Measurement of metabolites in the frozen bettong gastrocnemius-plantaris-
soleus muscle group at the end of the perfusion period showed that there were no 
significant statistical differences of adenine nucleotides between the muscle samples 
obtained in vivo and after perfusion. In fact, the concentration of lactate decreased 
(P<0.05), and the CrP concentration and the CrP/ATP ratio were both improved 
(P<0.01) after the perfusion (Table 4-2). These results show an essentially normal 
metabolite profile of the perfused muscle without evidence of hypoxia. 
4.3.2 Actions of vasoconstrictors 
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Fig. 4-1 Dose-response curves for vasoconstrictor-mediated changes in pressure, 
V02, lactate and glycerol efflux in the constant-flow perfused bettong muscle. 
Significance for 5-HT data is indicated: * P<0.05, ** P<0.01. Data are means ± SE. 
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As shown in Fig. 4-1, NE, VP and 5-HT each exerted a qualitatively similar 
dose-dependent vasoconstrictive effect in the perfused bettong hindlimb. Their other 
effects on V02, lactate and glycerol efflux aggregated into two different sets of 
responses. Thus qualitatively, NE and VP induced increases in V02, lactate and 
glycerol efflux which appeared to be closely associated with the changes in perfusion 
pressure. NE-induced changes attained a maximal value at approximately 1.0 pM NE 
with increases greater than 100% over the basal in the three variables. Above this 
dose, values of V02 tended to decline, although the perfusion pressure continued to 
rise. 
Similarly, VP stimulated, but to a lesser degree, the VO2, and the efflux of 
lactate and glycerol with maximal values occurring at approximately 25 nM. Perfusion 
pressure continued to increase with dose. In contrast to NE and VP, 5-HT 
significantly inhibited V0 2 (P<0.05) in the concentration range 0.1-2.5 uM during 
vasoconstriction. After termination of infusion of each of the vasoconstrictors, values 
for Pv02 and perfusion pressure returned to basal values throughout the periods of 
perfusion which lasted at least 3-4 hours. 
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Fig. 4-2 Representative tracing of the effect of NE on Pv02 and perfusion 
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In the perfused toad hindlimbs, the infusion of NE increased both the 
perfusion pressure and V02 . The changes in perfusion pressure and V0 2 responded to 
the infusion of NE rapidly in the onset, stayed steady during the infusion period and 
returned to the basal state within 10 min after terminating the administration (Fig 4-2). 
These responses were readily repeatable during each perfusion. As shown in Fig. 4-3, 
NE started to have effect on V02 at a concentration of 10 nM and attained the 
maximum effect onV02 at 0.3 1.1.M. The change in perfusion pressure was closely 
associated with the changes in V0 2 but did not reach a plateau within the dose ranges 
applied. The maximal increase in V02 reached approximately 28% above the basal 
value, and stayed around that level without an appreciable trend of inhibition up to 
NE concentrations of 30 1.1.M. Lactate initially showed no significant change followed 
by a significant decline (P<0.05). 
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Fig. 4-3 Dose-response curves of NE on perfusion pressure, V0 2 and lactate in 
the constant-flow perfused hindlimbs of toads. The basal values are shown in Table 
4-1. * P<0.05, **P<0•01 vs the basal values (Paired t test). 
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4.3.3 Effects of a- and fi-adrenergic antagonists on NE-mediated effects on the 
perfused bettong hindlimb 
Prop. 
Time (min) 
Fig. 4-4 Effects of a- and 0-adrenergic antagonists on NE-mediated changes in 
perfusion pressure, V02, lactate and glycerol efflux in the constant-flow 
perfused bettong hindlimb. Prop.: propranolol (10 pM, racemic), Ph.: 
phentolamine (10 1AM), NE (0.1 JAM). The length of each bar represents the duration 
of infusion of a given drug (mean ± SE, n=3). 
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Changes in perfusion pressure, V02, lactate and glycerol release in response 
to NE were rapid in onset, sustained and rapidly reversible (Fig. 4-4). In the presence 
of the 0-adrenergic antagonist propranolol (10 p.M D,L-racernic), NE-induced 
perfusion pressure tended to be higher, but none of V0 2, and lactate and glycerol 
release were statistically different when compared to NE alone. However, the 
additional infusion of the a-adrenergic antagonist, phentolamine (10 JIM), almost 
completely blocked the rise in perfusion pressure as well as the increases in V0 2, and 
lactate and glycerol release elicited by NE. 
4.3.4 Effect of nitroprusside on the perfused bettong hindlimb 
Fig. 4-5 shows a representative tracing of changes in perfusion pressure and 
Pv02 induced by VP, NE and 5-HT. These changes were rapid in onset and sustained. 
The infusion of nitroprusside (1.0 mM) completely blocked the rise in perfusion 
pressure and the changes in V02 stimulated by NE, VP and 5-HT (Fig. 4-5). 
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tracing of the inhibitory effect of nitroprusside Fig. 4-5 
perfusion pressure and Pv02 mediated by vasoconstrictors in the constant-flow 
perfused bettong hindlimb. Nitroprusside (NP), 1.0 mM, NE: 0.1 pM, VP: 25 nIVI 
and 5-HT: 2.5 ptM. Two to three perfusions were performed. 
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4.4 Discussion 
In the present study, bettong hindlimbs were perfused at 25°C at flow rates 
chosen to give a constant flow per unit mass of muscle of 0.28 mlnin -1 .0 (Table 4- 
1). This constant flow rate was the same as that employed for rat hindlimb perfusions 
at the same temperature (Colquhoun et al., 1988; 1990, Dora et al., 1991, and 
Hettiarachchi et al., 1992). 
Whilst resting hindlimb perfusion pressures are at first sight low, arterial 
pressures will necessarily be lower than in vivo when employing a cell-free, low 
viscosity perfinate. In addition, there is neither resting sympathetic tone nor 
circulating vasoconstrictors in the perfused hindlimb. Thus the arterial tree is almost 
fully relaxed as shown by the fact that nitroprusside does not lower the perfusion 
pressure (Fig. 4-5). The in vivo blood flow rates to the skeletal muscle of the 
bettong's larger relative, the red kangaroo (Macropus rufus), at rest under different 
environmental temperatures ranged from 0.010 to 0.053 ml-mirr 1 .g-1 (Needham & 
Dawson, 1984). Thus if similar flow rates apply to the bettong, the flow rate we 
employed is approximately 5 to 28 times greater than in vivo. Furthermore, because 
there is little diminution of pressure on progressive passage through the dilated 
arterial and arteriolar beds, the capillary exchange pressures should be similar to those 
occurring in vivo. Adequate perfusion and 02 delivery to the hindlimb preparation at 
rest and under the maximal vasoconstriction or V02 are indicated by the normal 
values for intracellular lactate, high energy phosphate compounds and the calculated 
energy charge in perfused muscle (Table 4-2). This is further supported by values for 
Pv02 which at no stage fell below 200 mm Hg. 
As for the perfused toad hindlimbs, the basal perfusion pressure of 15.8 ± 3.2 
mm Hg was close to the blood pressure of 20-30 mm Hg in vivo (Withers et al., 
1988) of this species. Although the number of the toads was not available for a similar 
metabolite analysis for the perfused muscle, the lower requirement for 02 as shown by 
the basal V02 (Table 4-1) and higher Pv0 2 (compared with the bettong perfused 
hindlimb) indicated an adequate 02 supply to the hindlimbs had been achieved. Hepes-
buffer containing 1.4 mM rather than amphibian Ringer buffer was employed in the 
present experiment and is the same as that used for the perfused bullfrog heart 
(Pelster et al., 1993). 1% BSA was added to this perfusate to prevent edema. In the 
bullfrog tadpole, plasma protein concentration was 0.2 nuno1/1 (Just et al., 1977). If 
this value applies to the cane toad as well, the concentration of albumin used in the 
perfusate would be similar to the concentration in vivo. 
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The basal VO2 of 4.18 ± 0.35 p.mol-g-1 -h-1 for the perfused bettong hindlimb 
is approx. 65% that of perfused rat hindlimbs of 6.4 limol.g -1 .h-1 (Colquhoun et al., 
1988; 1990; Hettiarachchi at al., 1992). An even lower V02 of the perfused toad 
hindlimbs (1.36 ± 0.10 punol-g -1 -h-1) was noted (Table 4-1). These relativities were 
expected when the whole body metabolic rates of these species were considered. The 
whole body V02 (see Table 8-1, Chapter 8) for 250 g rats ranged 19.0 ± 1.3 ml-kg -
1 -min-1 (51 ± 3.5 1.trnol-g -1 -h-1) whereas the V02 of the intact bettong (1.7 kg ) 
attained 8.6 ± 0.7 ml-kg - 
 
1 -min-1 (23 ± 1.9 iAmol-g -1 -h-1). At the same temperature (25 
°C), the whole body V02 of toad (Bufo marinus, 88.7 g) was reported to be 1.2 
ml-kg-1 -min-1 [3.2 Amol-g-1 -11-1 , (Altman & Dittmer, 1974)]. Thus the basal V02 of 
the skeletal muscle paralleled body metabolic rates across the eutherian, marsupial and 
amphibian. 
Skeletal muscle has been thought to be a thermogenic tissue in mammals. 
The lower muscle metabolic rate in the toad perfiised hindlimb is consistent with the 
fact that the toad is a ectothermic species and there is no need for its skeletal muscle 
to be thermogenic. The differences in skeletal muscle mitochondria between mammals 
and reptiles reported in the literature (Else & Hulbert, 1985) seem to support this 
argument. In that study, the mitochondrial cell volume density of reptile skeletal 
muscle was 0.89% compared with the 8.16% reported in mammals and the 
mitochondrial surface area (m 2) per volume of mitochondria (cm3) was also lower in 
reptiles (93.2 in reptiles and 110.0 m2/cm3 mitochondria in mammals). These 
mitochondrial characteristics in reptiles are consistent with the lower muscle 
metabolic rate seen in perfused toad hindlimbs in the present experiments. 
Although there are a number of reports on the effect of infused NE on V0 2 
in the perfused muscle in eutherian mammals such as the rat (Grubb & Folk, 1977; 
Dubois-Ferriere & Chinet, 1981; Richter, 1982b, Cote etal., 1985; Colquhoun etal., 
1988 & 1990), and the dog (Pappenheimer, 1941a), to the best of my knowledge, this 
is the first report on the effects of vasoconstrictors (ie. NE, VP and 5-HT) on V0 2 , 
and lactate and glycerol efflux in perfused marsupial hindlimbs and hence in a non-
eutherian homoeothermic species. 
In the perfused bettong hindlimb, increases in V0 2, and in both lactate and 
glycerol effluxes were observed in response to NE and VP, whereas decreases in V0 2 , 
and lactate and glycerol efflux were noted with 5-HT (Figs. 4-1 and 4-5). The 
changes in V02, and lactate in response to these vasoconstrictors were qualitatively 
similar to those observed previously in the perfused rat hindlimb (Colquhoun et al., 
1988; 1990; Dora et al., 1992). A new observation for muscle perfusion was that 
changes in the glycerol efflux closely paralleled the changes in the hindlimb V0 2 and 
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lactate (Figs. 4-1 & 4-4). The production of lactate and glycerol will have 
thermogenic potential in vivo if they are subsequently taken up by other tissues such 
as the liver and resynthesised to carbohydrate or lipid as these processes would 
require additional energy expenditure. 
Analysis of the dose response data (Fig. 4-1) for the perfused bettong 
hindlimb shows that the thermogenic response to NE started at 25 nM which is almost 
25 times higher than that required for the perfused rat hindlimb under the same 
conditions (Colquhoun et al., 1988). The increase in V02 stimulated by NE of 
approximately 100% above the basal value was greater than that of the perfused rat 
hindlimbs which increases by approximately 60-70% at the same flow rate 
(Colquhoun et al., 1988; Hettiarachchi et al.; 1992). At present, no data on 
circulating NE are available for the bettong and in general, data are sparse for all 
marsupials. However a small marsupial, the sugar glider (Stoddart et al., 1991), and 
the platypus (McDonald et al., 1992) show resting and stressed values of NE approx 
3-10 fold higher than those of the rat. The plasma levels of NE and E for the 
unstressed carnivorous marsupial [Antechinus stewartii (Bradley, personal 
communication, 1994)] is 4-5 times those of the rat (Eriksson & Persson, 1982). So 
that the present observations may be relevant to field conditions. 
Vasoconstrictor-mediated changes in V0 2 occurred not only in the perfused 
hindlimbs of endotherms as mentioned above but also in the toad perfused hindlimbs 
where NE stimulated V02 during vasoconstriction (Fig. 4-2). NE started to elicit V02 
changes at 10 nM and achieved the maximum effect with 28% increase above the 
basal at 0.33 12M. In the constant-flow perfiised rat hindlimb, NE stimulates V0 2 at 
low concentrations (0.01-1 tiM) and the increased V02 began to fall at the 
concentration higher than 1 i_tM (Dora et al., 1992). Fig. 4-1 shows a similar tendency 
of decline in V02 at 2.5 i.tM of NE. In contrast, the NE-mediated dose-response curve 
for V02 did not show a tendency to decline up to a dose of 33 1.1.M (Fig. 4-3). 
Compared with the bettong (or rat), NE-mediated a marked lower increase in V0 2 in 
the toad perfused hindlimbs. As argued above, the toad skeletal muscle is not as 
potentially thermogenic because of the significantly lower content of mitochondria 
and mitochondrial surface area (Else & Hulbert, 1985). A comparatively lower 
increase in NE-stimulated V02 in the perfused toad hindlimbs may result from their 
structural bases of skeletal muscle mitochondria. 
In amphibians, E is the sympathetic neurotransmitter whereas NE is the 
neurotransmitter in the higher vertebrates. Withers et al. (1988). reported plasma 
levels of 2.1 nM NE and 13.1 nM E in the toad (Bufo marinus) at rest. When the 
animal was continuously and repeatedly flipped onto its dorsum and then allowed to 
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right itself for 3 mirl„ the plasma levels for NE and E increased to 9.8 nM and 72 n1V1 
respectively, resulting in significant increases in the heart rate and blood pressure. 
Coinciding with the increased catecholamines was the maximal rate of VO2 in the 
animal (Hillman etal., 1979; Walesberg etal., 1986). As skeletal muscle is believed to 
be the greatest contributor to the whole body metabolism in vivo in amphibians 
(Flanigan etal., 1991), the present findings indicate the catecholamine-induced whole 
body metabolic rate may largely originate from skeletal muscle under the control of 
the vascular system in vivo. 
In the present study, lactate did not significantly increase during the infusion 
of NE and started to decline when the increased VO2 reached the maximum. The 
mechanism for the NE-induced dissociation of lactate release from V02 in the 
perfused toad hindlimbs (Fig. 4-3) is not known. Since the toad muscle metabolic rate 
is significantly lower compared with that of the eutherian mammals (Table 4-1), it is 
possible that an increased aerobic metabolism would accelerate lactate oxidation 
faster than glycolysis. 
Marsupials appear to have more skeletal muscle than eutherians. Red and 
grey kangaroos have 52% of body mass as skeletal muscle which is 6-8% more than 
in the wildebeest or Thomson's gazelle, and approx 20% more than in domestic 
eutherian species (Tribe & Peel, 1963). The blood flow to the marsupial skeletal 
muscle varies considerably in response to the environmental temperature. For 
example, the distribution of cardiac output to skeletal muscle increased from 4% at 37 
°C to 23% at 7°C (Needham & Dawson, 1984). When exposed to the cold, the 
maximal heat production of small marsupials can match or exceed that of rodents of 
similar size (Dawson & Dawson, 1982). Thus the present study, when taken in 
conjunction with these observations, suggests that marsupial skeletal muscle may 
contribute a larger proportion to whole body thermogenesis than the skeletal muscle 
in eutherian species. As the bettong and other marsupials have been shown not to 
possess histologically apparent BAT (Hayward & Lisson, 1992), the bigger relative 
increase in NE (or other vasoconstrictor)-induced energy metabolism and the greater 
proportion of skeletal muscle may compensate for the lack of BAT in these species. 
Unexpectedly, the NE-induced glycerol release was found to be mediated 
through a-adrenergic receptors as shown by its blockade by phentolamine plus 
propranolol but not by propranolol alone (Fig. 4-3). A recent study in the constant-
flow perfused rat hindlimb also revealed an increased glycerol efflux mediated by a-
adrenoceptors (Clark et al., 1994). Activation of lipolysis by epinephrine has been 
reported in the perfused mouse hindlimb and 0-adrenergic receptors were thought to 
be responsible (Chan et al., 1983). On the other hand, inhibition of adipose tissue 
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lipolysis has been associated with activation of the a2 -adrenergic receptor (Lafontan 
et al., 1992). 13-Adrenoceptors are known to be present in skeletal muscle (Martin et 
al., 1990) and some appear to be atypical or putative 133 subtype (Roberts et al., 
1993; Sillence et aL, 1993) whilst the a-receptors are much more sparse and are 30 
times more prevalent in arterioles than in the surrounding skeletal muscle (Martin et 
al., 1990). Nevertheless the NE-mediated increases in V02, lactate and glycerol 
effluxes in the present experiment are a-receptor dependent rather than 13-receptor 
dependent (Fig. 4-3), suggesting blood vessels are somehow involved in the increased 
metabolism. 
The close parallel relationship between vasoconstrictor-mediated glycerol 
release and V02 change implies that the vasoconstrictors may play a role in 
modulating lipid mobilisation either directly by receptor activation or indirectly by 
association with smooth muscle contraction to adjust the fuel sources for skeletal 
muscle thermogenesis. Chin et al. (1991) have shown that infused lactate can lead to 
increased glycerol production in the perfirsed rat hindlimb. Hence in the present study 
even though there is no recirculation of perfusate, another potential source of glycerol 
would be the conversion of a small proportion of lactate to glycerol via glycerol-3- 
phosphate and triacylglycerol. 
The lack of a 13-adrenergic stimulation of V02 in perfused bettong hindlimb 
(Fig. 4-3), which was also found in the perfused rat muscle (Colquhoun et al., 1988; 
Hettiarachchi et al., 1992), contrasts with the well-known stimulation of V02 by 13- 
adrenergic agonists in vivo in the rat (Rothwell, 1990) and in another marsupial rat-
kangaroo the potoroo (Nicol 1978). This discrepancy might in part be explained by 
noting that in general, 13-adrenergic excitation is known to elevate cardiac output and 
relax blood vessels in vivo. These effects could result in increased blood flow to 
skeletal muscle. Increased flow to skeletal muscle has been shown to increase V02 by 
perfilsed skeletal muscle in the rat (Chinet & Mejsnar, 1989; Chapter 3). In addition, 
other thermogenic tissues, such as liver, might also contribute to 13-adrenergic 
stimulation of the whole body metabolic rate (Ma et al., 1987). Alternatively, 13 -
stimulation leading to vasodilation in vivo may oppose a pre-existing pattern of 
vasoconstriction that inhibits V02 as observed with either 5-HT or high 
concentrations of NE in the perfused rat hindlimb (Clark et al., 1994). However, 13-
stimulation of V02 was observed in the constant-pressure (recirculated) perfused rat 
hindlimb (Hardeveld et al., 1980; Chapter 8). Chapter 9 will further discuss the 
different results obtained from these two models. 
The action of the nitric oxide generator, nitroprusside to block both 
vasoconstriction and the changes in V02 whether they be increased or decreased (Fig. 
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4-4), strongly suggests that vasoconstriction is tightly linked in some manner to these 
phenomena. Yet the mechanism for the vasoactive hormone-induced increase in V02 
is still controversial. Chapter 3 and 4 have discussed two possible mechanisms of 
vascular involvement in the vasoconstrictor-mediated increase in V02: direct vascular 
V02 and/or vascular-controlled muscle V02. Both interpretations appear to explain 
vasoconstrictor-induced V02 in the perfirsed hindlimbs of bettong and toad. Chapter 9 
will further discuss various possibilities of the observations along with the results from 
other Chapters. 
In summary, the present experiments show that vasoconstrictive hormones 
play an important role in controlling and/or contributing to V0 2, lactate and glycerol 
efflux in perfused marsupial (bettong) muscle and clearly have the potential to act in 
vivo. There appears to be a greater contribution from the skeletal muscle vascular bed 
to the whole body thermogenesis in the bettong than in the eutherian in response to 
NE, which may in vivo compensate for its lack of BAT. The responses, however, do 
not relate in a simple way to the degree of vasoconstriction, because there are both 
increases and decreases in the metabolic parameters depending on the vasoconstrictor 
employed. Vasoconstrictor-mediated increases in muscle V0 2 also takes place in 
ectothennic amphibians. The present findings on perfused bettong and toad muscle 
when taken together with other studies on perfused rat muscle raise the possibility of 
vasoconstrictor control of V0 2 and metabolism as an entrenched and widespread 
physiological mechanism across ectothermic and endothermic species that has 
developed in the process of evolution. 
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CHAPTER 5 
Vascular control of V02 in the constant-flow perfused rat kidney, 
intestine and mesenteric artery 
5.1 Introduction 
As presented in Chapters 3 and 4, vasoconstrictors such as NE and VP 
stimulate both V02 and increase perfusion pressure in the constant-flow perfused 
hindlimb of the rat, bettong, and toad. These data suggest that vasoconstrictor-
mediated control of skeletal muscle V02 appears to be universal across species, from 
ectothermic to endothermic animals. 
The evidence supporting a controlling role for the vasculature includes 
observations where each of the vasoconstrictors alters V02 as well as lactate and 
glycerol production by the hindlimb in conjunction with an increase in perfusion 
pressure (Colquhoun et al., 1988; 1990) whereas the vasodilators, nitroprusside, 
nifedipine and Iso, which each act by different mechanisms, oppose vasoconstrictor-
mediated changes in both V02 and perfusion pressure (Colquhoun et al., 1990; 
Chapter 44). The notion that the vascular tissue itself consumes 02 during 
vasoconstriction (Chapter 3) is indirect and based principally on data where V0 2 due 
to skeletal muscle contraction is additive to that produced by vasoconstrictors 
(Colquhoun et aL, 1990; Chapter 3) and on experiments where near maximal flow-
induced V02 by the hindlimb is further increased by NE and inhibited by nitroprusside 
(Chapter 3). 
If vascular tissue is largely responsible for the increase in V0 2 during 
vasoconstriction, rates of V02 per unit mass would approach that of the vigorously 
contracting skeletal muscle or cardiac muscle. This would assign a much higher 
respiratory rate to vascular tissue than has previously been estimated using fragments 
of large vessels, whether incubated or cannulated (Paul, 1980). Moreover, 
vasoconstrictor-induced V02 would be expected to similarly occur as a general 
feature in other perfused vascular beds, especially vascular tissues. 
In the absence of direct information on V0 2 by perfined vascular tissue in 
the presence of vasoconstrictors, the present experiments were undertaken to assess 
whether vasoconstrictors increase V02 in other perfiised organs in general. The 
kidney was chosen because of its unique and high vascular density, and the intestine 
was chosen for comparison between intestine and mesenteric blood vessels. 
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5.2 Methods 
Male Wistar rats weighing 180-200 g were used for the perfusions of kidney, 
intestine and mesenteric artery. The perfusion was carried out at 25°C with carbogen 
(95% 02 and 5% CO2) saturated Krebs-Ringer buffer containing 2% BSA and 1.27 
mM Ca2+ in a constant-flow (once-through) model. Further details are outlined in 
Chapter 2 (Section 2.2). For the perfused mesenteric artery, a careful dissection was 
conducted to separate blood vessels indicated by the infused Evans blue from the 
surrounding white fat and lymphnodes after perfusion. The measured blood vessel 
weight in this preparation accounted for 6% of the perfused mass. 
Venous perfilsate was collected for the determination of lactate and glycerol 
output. The tissue samples were freeze-clamped by a pair of aluminium tongs 
precooled in liquid N2 at the end of perfusion. For comparison, normal (in vivo under 
anaesthesia) and ischemic (5 min at 25°C after decapitation) kidney and intestine were 
also clamped and assayed. Both lactate and glycerol were measured according to the 
method of Bergmeyer (1974). Adenine nucleotides and creatine compounds were 
determined by ion-paired reverse phase column in HPLC (LKB) as described by 
Shellevold et al. (1986). Further details are given in Section 2.3. 
5.3 Results 
5.3.1 The perfused kidney 
5.3.1.1 Vasoconstrictor-mediated changes inV 02 and pressure 
The perfusion flow for the kidney was set to maintain a physiological 
pressure of approx. 90 mm Hg at 25°C. This was achieved at 4.7 ml/min per kidney. 
Under these conditions, the basal V02 of 70.3 ± 3.4 mmols -1 .h-1 compares 
reasonably well with published values of 171-425 mol-g -1 .11-1 (Cohen & Pendleton, 
1980; Franke et al., 1976) obtained at 37°C and at higher flow rate (approx. 25 
ml.min4 • -1 kidney) and therefore higher arterial pressure (112-120 mm Hg). The 
temperature difference could be expected to at least double the rate and the pressure 
difference of between 80 and 120 nunHg could be expected to increase V0 2 by a 
further 23% (Franke etal., 1976). 
Figure 5-1 shows dose-response curves for NE- and VP-mediated increase in 
V02 and perfusion pressure development. Although dose-dependent, the increases in 
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V02 and pressure did not reach maximal values for each agonist. However, it was 
apparent that changes in pressure and V02 followed each other closely; the shapes of 
the dose-response curves were similar for a given agonist. The highest value of V02 
attained was 102 gmol/h per kidney, representing an increase of 45% over the basal 
values. 
Concentration (log M) 
Fig. 5-1 Dose-response curves for VP and NE on perfusion pressure and VO2 in 
the constant-flow perfused rat kidney. The kidney (0.9 ± 0.1 g) was perfined at 25 
°C. •: VP; • : NE. Data are means ± SE, n=6. 
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5.3.1.2 Effect of vasoconstrictors and nitroprusside on pressure, V02, lactate and 
glycerol 
Time (min) 
Fig. 5-2 Effect of nitroprusside on NE-induced pressure, V0 2, lactate and 
glycerol release in the constant-flow perfused rat kidney. Perfusions were 
undertaken under the same conditions as shown in Fig. 5-1. NP: nitroprusside. Data 
are presented as means ± SE, n=4. 
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As illustrated in Figs. 5-2 and 5-3, both NE- an VP-induced V02 and 
perfusion pressure of the kidney were sustained. NE-elicited increases in V0 2 and 
pressure were accompanied by an increase in the release of lactate and glycerol (Fig. 
5-2). VP also stimulated V02 and lactate efflux in association with vasoconstriction. 
However, there was no significant change in glycerol efflux during the infusion of VP 
(Fig. 5-3). The infusion of nitroprusside significantly inhibited the changes in V0 2 , 
pressure, lactate and glycerol induced by NE or VP. 
" 
VP 1.0 nM  
NP 1 mM  
30 	40 	50 	60 	70 	80 
Time (min) 
Fig. 5-3 Effect of nitroprusside on VP-induced pressure,V02, lactate and 
glycerol in the constant-flow perfused rat kidney. Perfusions were conducted at 
the same conditions as shown in Fig. 5-1 (n=4). NP: nitroprusside. 
Table 5-1 Metabolites of perfused rat kidney 
n Lactate Glycerol Cr 	CrP 	Cr+CrP AMP 
umol/g dry wt  
ADP ATP 	EAD EC 	CrP/Cr CrP/ATP 
  
In vivo • 	5 
Perfused 4 
(180 min) 
Ischemia 5 
(5 min) 
7.03 
± 0.97 
7.12 
± 0.75 
22.09** 
± 0.63 
0.24 
± 0.07 
0.29 
± 0.08 
0.41 
± 0.11 
13.35 
± 2.09 
12.54 
+ 0.75 
24.49** 
± 1.35 
18.10 
± 2.16 
15.70 
± 0.75 
5.37** 
± 0.78 
31.45 
± 1.99 
22.60 
± 5.74 
29.85 
± 0.79 
0.13 
± 0.02 
0.23 
± 0.05 
6.33** 
± 0.60 
1.73 
± 0.19 
2.12 
± 0.42 
2.54 
± 0.79 
10.89 
± 0.80 
11.03 
± 0.2.26 
1.38** 
± 0.25 
12.75 
± 0.96 
13.39 
± 2.62 
9.50* 
± 0.71 
0.92 	1.47 	1.69 
± 0.01 	± 0.35 	± 0.22 
0.90 	1.27 	1.60 
± 0.01 	± 0.08 	± 0.31 
0.23** 	0.23** 	5.77 
± 0.02 ± 0.05 	± 2.60 
Table 5-2 Metabolites of perfused rat intestine 
n Lactate Glycerol Cr 	CrP 	Cr+CrP AMP 
pinol/g dry wt  
ADP 	ATP 	EAD 	EC CrP/Cr CrP/ATP 
  
In vivo 	4 
Perfused 8 
(180 min) 
Ischemia 5 
(5 min) 
19.74 
± 2.15 
11.43** 
± 1.04 
53.19** 
± 8.26 
1.24 
± 0.21 
0.44** 
± 0.08 
1.83 
± 0.53 
14.24 
± 1.31 
12.62 
± 1.04 
23.14** 
± 1.75 
16.02 
± 1.40 
15.19 
± 2.54 
2.39** 
± 1.01 
30.25 
± 2.71 
27.81 
± 3.26 
25.48 
± 2.56 
0.09 
± 0.02 
0.17 
± 0.05 
5.12** 
± 0.68 
1.38 	8.33 
± 0.06 	± 0.55 
1.70 	6.94 
± 0.30 	± 0.45 
3.22** 	1.66** 
± 0.34 	± 0.23 
9.80 
± 0.54 
8.81 
± 0.70 
9.84 
± 0.79 
0.92 
± 0.01 
0.89 
± 0.01 
0.33** 
± 0.02 
1.13 
± 0.01 
1.19 
± 0.15 
0.09** 
± 0.04 
1.92 
± 0.08 
2.18 
± 0.32 
1.22** 
± 0.53 
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Note for Tables 5-1 & 5-2: ** P<0.01 vs in vivo. Statistical tests were not made between the perfused and ischemia (5 min at 25°C after decapitation).data are means ± SE. 
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5.3.1.3 Metabolites of the perfused kidney 
Table 5-1 illustrates metabolites of the kidney in vivo, perfused for 180 min 
and ischemic for 5 min. The sensitivity of the kidney to ischemia (for 5 min) was 
demonstrated by marked decreases in CrP, CrP/Cr ratio, ATP and adenylate energy 
charge and increases in Cr. AMP and lactate. After perfusion, none of the parameters 
measured was significantly different from that obtained from kidneys in vivo. The 
calculated results did not show any significant difference in the EC and CrP/CR ratio 
of kidneys between the kidneys perfused and in vivo. These were totally different 
from the features following 5 min of ischemia where lactate and AMP markedly 
increased concomitant with a sharp fall in CrP, ATP, EAD, EC and CrP/Cr ratio. 
5.3.2 The perfused intestine 
30 	40 	50 	60 	70 	80 
Time (min) 
Fig. 5-4 Effect of nitroprusside on NE-induced pressure and VO2 in the 
constant-flow perfused rat intestine. The perfusion was conducted at 25°C at a 
constant flow of 8 ml/min (means ± SE, n=4). NP: nitroprusside. 
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5.3.2.1 Validity of the perfused intestine 
Intestine is extremely sensitive to ischemia. A dramatic change in the profile 
of metabolites immediately after ischemia or hypoxia (Chapter 7). These changes, 
which are shown in Table 5-2 for the ischemic group, include sharp falls in CrP, ATP, 
CrP/Cr and energy charge as well as accumulations of lactate, AMP and ADP. The 
results from Table 5-2 demonstrate that the perfused intestine at a constant flow of 8 
ml/min at 25°C is metabolically valid with no signs of ischemia. Thus the first part of 
intestine perfusions was carried out at 8 ml/min. 
The infusion of either NE or VP immediately caused vasoconstriction as 
indicated by the increase in perfusion pressure (Figs. 5-4 & 5-5). But their effects on 
V02 were completely opposite. NE inhibited V0 2 whilst VP showed a positive 
stimulatory effect. Even though the changes in V02 induced by NE and VP were 
totally opposite, nitroprusside infusion significantly reversed the changed V0 2 when 
blocking the increased perfusion pressure (Figs. 5-4 & 5-5). 
VP 1.0 nM 
I NP 1 mMI 
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30 	40 	50 	60 	70 	80 
Time (min) 
Fig. 5-5 Effect of nitroprusside on VP-induced pressure and V02 in the 
constant-flow perfused rat intestine. The perfusion was conducted at 25°C at a 
constant flow of 8 ml/min (means ± SE, n=4). NP: nitroprusside. 
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5.3.2.2 Effect of vasoconstrictors and nitroprusside on pressure and V0 2 
Experiments shown in Figs. 5-4 & 5-5 were conducted at 8.0 ± 0.1 nil/min to 
observe the relationship between intestine V0 2 and pressure produced by NE and VP, 
and the effect of the vasodilator, nitroprusside, on these changes. The intestine 
metabolites (Table 5-2) indicated sufficient 02 was provided for the intestine at this 
flow rate. Under these perfusion conditions, the basal V0 2 was 21.9 ± 1.3 ilmol-g -1 .h-
1 and the basal perfusion pressure was 54 ± 2 mm Hg (n=9). 
5.3.2.3 Vasoconstrictor-mediated changes in V02 and pressure at an increased 
perfusion flow rate 
In order to assess the effect of perfusion flow rate on vasoconstrictor-
mediated changes in intestine, the flow was raised to allow maintenance of a pressure 
approaching the physiological value. To achieve an arterial perfusion pressure of 82 ± 
2.4 mm Hg, the flow rate was maintained constant at 15.2 ± 0.1 ml/min per intestine. 
At this perfusion flow rate, the basal rate of V0 2 increased from 21.9 ± 1.3 'Imo's -
1 .h-1 at 8 ml/min to 33.3 ± 1.0 timols -1 -11-1 (P<0.01, n=7, Fig. 5-6). Given a Q 10 of 
2.5, this latter value is comparable with values of 98.5 and 150.4 timol-g- l-h-1 for 
fasted and fed rat intestine in vivo, respectively (Stevenson & Weiss, 1988) and 60 p, 
mol• -1 •11-1 for autoperfused dog intestine (Granger et al., 1982). As argued above 
(for kidney), the lower rate observed for intestine in the present study would largely 
be the result of the experiments being conducted at 25°C rather than 37-39°C. The 
slightly lower perfusion pressure (compared with 80-120 mmHg in vivo) could also be 
contributory. 
The effects of vasoconstrictors on intestine V0 2 was still maintained even 
though the basal value had been significantly elevated by increasing perfusion flow 
rate from 8 ml/min to 15 ml/min. Figure 5-6 shows dose-response curves for VP- and 
NE-mediated changes in V02 and pressure development at a perfusion flow rate of 15 
ml/min. VP is regarded as an intestinal vasoconstrictor (Richardson, 1984). It is 
important to note that VO2 increased uniformly over the dose range of 10 pM-3nM 
VP whilst pressure changes were relatively small at the lower doses and larger at the 
top end of the concentration range. The highest rate of V0 2 attained was 39 pmols -
1 •11-1 , representing an increase of 18% (P<0.05) over basal. By contrast, NE infusion 
resulted in a dose-dependent increase in perfusion pressure (+134%) which was 
accompanied by a decrease in V02 (-24%, P<0.01). 
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Fig. 5-6 Dose-response curves for VP and NE on perfusion pressure and V0 2 in 
the constant-flow perfused rat intestine. •: VP; •: NE (means ± SE, n=3). 
Perfusions were conducted at a constant flow of 15 ± 0.1 ml/min at 25°C. 
5.3.3 VO2 and pressure development by the perfused mesenteric artery network 
The mesenteric artery network was perfused via the superior mesenteric 
artery. Major arteries of this network were severed close to the intestine which was 
excised and the entire network perfiised in a sealed chamber so the effluent could be 
collected for P02 measurement. Because of the nature of the preparation it is likely 
that most capillaries and veins were not perfused as the intestine was removed. 
16 
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Consequently the perfusion pressure was quite low at the relatively high flow rate of 2 
ml/min per g artery network. Under these conditions the basal rate of V02 was 8.2 ± 
1.11.tmol-g-1 .h-1 (n=8). 
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Fig. 5-7 Effect of VP and NE on pressure and V0 2 in the constant-flow perfused 
rat mesenteric artery network. The perfitsed mesenteric artery network was 1.0 ± 
0.1 g. •: VP, n=3-4; • : NE, n=3-5. Data are presented as means SE. 
Figure 5-7 shows dose-response curves for NE- and VP-mediated increase in 
V02 and pressure development for the mesenteric artery preparation. NE infusion 
resulted in increase in V0 2 with a half-maximal effect occurring at 0.3 p.M. Pressure 
also increased in a dose-dependent manner but did not reach a maximal value and was 
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still increasing at the highest dose used of 3 ptM NE. VP also resulted in a dose-
dependent increase in V02 and pressure development. Half-maximal dose occurred 
for both at approximately 0.3 nM VP. VP tended to have the greatest effect on V02 
and at maximal dose the rate of V02 was 14.8 p.mols -1 -h-1 , representing an increase 
of 80% over basal (P<0.01). 
5. 4 Discussion 
The study reported in this chapter was undertaken to address the possibility 
that vasoconstrictor-controlled V0 2 was a general phenomenon in the perfused 
tissues. Two vasoconstrictors and one vasodilator were used and three tissues 
compared. In all cases except the perfused intestine, VP and NE increased V0 2 in 
association with an increase in perfusion pressure. nitroprusside blocked or 
significantly inhibited the changes in V02 and perfusion pressure induced by VP and 
NE. 
Chapter 3 and 4 have shown that NE and VP each stimulates 
vasoconstriction and V02 in the constant-flow perfused hindlimb. Both effects were 
blocked by vasodilators, eg. nitroprusside. The effect of vasoactive substances on 
V02 is a separate mechanism from muscle contraction, thereby reflecting the 
component of NST of skeletal muscle. Vasoconstrictor-mediated control of skeletal 
muscle V02 is supported by the evidence that V02 by electrically stimulated skeletal 
muscle was not inhibited by nitroprusside (Chapter 3) and was additive to 
vasoconstrictor-induced V02 (Colquhoun et aL, 1990). Tubocurarine does not affect 
NE-induced V02 and perfusion pressure when blocking the V02 produced by sciatic 
nerve stimulation (Chapter 3). When flow was increased (and therefore perfusion 
pressure) V02 also increased and the addition of NE or nitroprusside increased or 
decreased, respectively, the V0 2 at all flow rates (Chapter 3). Together, these findings 
led to the conclusion that vascular system plays a key role in the regulation of resting 
muscle thermogenesis (Chapter 3). Hence, it is proposed that blood vessels might be a 
major source for the increased V02 mediated by vasoconstrictors in the perfused 
hindlimb (Colquhoun & Clark, 1991). 
However, an inhibitory effect on V02 occurs in the perfused hindlimb (Dora 
etal., 1991) when 5-HT causes the increase in perfusion pressure. A similar inhibition 
in V02 in the perfused hindlimb can be induced by NE at high concentrations. These 
data taken together led Clark et al. (1994) to hypothesize that there are two 
metabolically distinct vasoconstrictors: type A and type B. In the constant-flow 
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perfused rat hindlimb, type A vasoconstrictors, such as VP, AT II, and low dose NE, 
stimulate V02, lactate and glycerol production whereas type B vasoconstrictors, 
including 5-HT and high dose NE, inhibit these parameters. 
The results from the perfused kidney and intestine show vasoconstrictors 
mediated the control of metabolism in these tissues as well (Figs. 5-1 & 5-6) and these 
effects were generally opposed by nitroprusside (Figs. 5-2, 5-3, 5-4 & 5-5). In the 
perfused kidney, both VP and NE stimulated V0 2 and lactate production whilst 
increasing the perfusion pressure. VP receptors are known to stimulate the absorption 
of water and sodium in the collecting tubule. A direct effect on the renal parenchymal 
tissues by these agonists can not be ignored. In fact, the direct effect of VP and NE is 
likely (Roobol & Mleyne, 1973) and may explain why nitroprusside failed to fully 
block some of the increased metabolism as it does in the perfused hindlimb 
(Colquhoun et aL, 1990; Chapter 4), in spite of the complete blockade of pressure. 
Nonetheless, the present results show that there is an obvious component of V0 2 
controlled by or associated with vasoconstriction. VP and NE clearly exert a positive 
control of metabolism in the kidney vascular bed. 
In the intestine, vasoactive agents are considered to have either direct or 
indirect effects on oxidative metabolism (Kvietys & Granger, 1982) although the 
mechanisms are not clear. In contrast to its effect in the perfused hindlimb, NE 
inhibited V02 thereby exerting a negative type B vasoconstrictor-controlled effect on 
the perfused intestine. In comparison, VP stimulated V0 2 of the perfilsed intestine 
(Fig. 5-5). Both NE- and VP- mediated changes in V0 2 were reversed by 
nitroprusside to various degrees when it blocked the increased perfusion pressure 
(Figs. 5-4 & 5-5). 
In the perfused rat hindlimb, increasing perfusion flow alone elevates V0 2 
and the flow-induced V02 can be further enhanced by NE (Chapter 3). Similarly, 
when the perfusion flow was increased from 8 nil/min to 15 ml/min in the perfused 
intestine, V02 was almost doubled with no significant influences on its responses to 
VP and NE (Figs. 5-4, 5-5 & 5-6). The flow-induced V02 in intestine was further 
augmented by VP. Fig. 5-6 shows that VP stimulated V0 2 during vasoconstriction at 
a similar dose range as it does in the perfused hindlimb (Chapter 3). 
The results of vasoconstrictor-elicited V02 in the perfused mesenteric artery 
network is of particular interest in terms of vascular V02 . This preparation allows the 
separation of the direct V02 from arterial system from the secondary V0 2 utilized by 
the intestinal tissues per se as a result of changes in flow pattern or a messenger-
metabolism communication between them. At the perfused organ level, 
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vasoconstrictors mediate either positive or negative regulation of 90 2, supporting a 
similar but also different classification of type A and type B vasoconstrictors to that 
proposed by Clark et aL (1994). However, in the mesenteric artery preparation, they 
all show a type A effect. For instance, NE and 5-HT inhibit 90 2 in the perfined 
intestine and hindlimb, respectively, but they all stimulate 90 2 in the perfused 
mesenteric artery network (Fig. 5-7; Dora et al., 1992). Anatomical vascular shunting 
has been suggested to exist in the intestine (Sherperd et al. 1976; Lundgren, 1984), 
thus the inhibitory effect of NE on 902 in the perfused intestine may be due to 
vascular shunting as suggested by Sherperd et al. (1976). 
The basal 902 of 8.2 gmol-g-1 1-1 of the perfused mesenteric artery arcade 
at 25°C is calculated to be 20.5 limol.g -1 .h-1 at 37°C using a Q 10=2.5 (Bonen et al., 
1994). From the estimate based on the dissected blood vessels in this preparation, 
blood vessels, vein included, account for 6% of the perfused mass. Other tissues are 
white adipose and lymphnodes. Assuming 902 by nonvascular tissues is negligible in 
this preparation, the vascular 90 2 would be 342 limo g- h- at 37°C. Thus the 
maximal 902 of 14-15 gmol.g -1 -11-1 at 25°C in the presence of NE or VP would be 
equal to 583-625 gmols- •h-1 at 37°C. Compared with most reported values in the 
literature (Paul, 1980), such an estimated value appears to be too high. However, it 
should be borne in mind that vascular metabolic rate in larger vessels is much lower 
than that in small and muscular vessels. For instance, 902 in rat portal vein is 20 fold 
the value of porcine carotid artery (Paul, 1980). An even higher basal 902 was 
observed in bovine cerebral microvessels and is calculated to be 288 pmols -1 -h-1 in 
the presence of succinate (Sussman et aL, 1988). Indeed, this estimate seems to match 
the value obtained from the perfused rat tail artery (Colquhoun & Clark, 1991). 
Reports for rat heart 902 at the perfusion pressure of 80-110 cm H20 at 35°C range 
between 556 to 655 gmol-g -1 .h-1 (Kojima et al., 1993) and 902 in contracting 
skeletal muscle (gastrocnemius-plantaris-soleus group) obtained in this laboratory is 
119 gmol-g-1 -11-1 at 37°C (Dora et al, 1994). Therefore, vascular 902 could be as 
high as working heart and vigorously-contracting skeletal muscle. When 
vasoconstrictors cause the blood to constrict in the constant-flow perfused mesenteric 
artery, the vascular wall tension is increased as a result of an increased perfusion 
pressure. Thus, more 02 is consumed by the blood vessel in response to the increased 
work to produce and maintain vascular contraction or wall tension (Colquhoun & 
Clark, 1991). Such a correlation between vascular 902 a.nd vascular wall tension has 
been revealed (Paul, 1980). Indeed, the research in the rat tail vascular smooth muscle 
in this laboratory has shown that the mitochondrial content accounted for 
approximately 8.4% of the cell volume, which is same to or greater than red striated 
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skeletal muscle (Peng, personal communication). The high tnitochondrial content in 
vascular smooth muscle is consistent with a high V02. 
The association between striated muscle and energy consumption is well 
established (Gibbs, 1978) and thus an analogous role for the vascular smooth muscle 
to use 02 during constriction or resisting pressure seems reasonable. Paul and 
Peterson (1975) showed that vascular V02 depends on the active wall tension of the 
smooth muscle. In the constant-flow perfused tissues, the vascular wall tension would 
be increased when vasoconstrictors increase the perfusion pressure. Accordingly, 
vasoconstrictor-stimulated increase V0 2 in the perfused kidney, intestine and 
mesenteric artery may result from the increased active wall tension of the vascular 
smooth muscle. However, there are properties of the vascular smooth muscle itself, as 
well as of the vascular tree of complex organs such as the hindlimb, intestine or 
kidney which make a simple relationship between perfusion pressure and putative V02 
by the vascular tissue inappropriate. Firstly, vascular smooth muscle is considered to 
have the potential for "latch bridge" formation. These are noncycling or very slowly 
cycling cross bridges formed when myosin is dephosphorylated (Murphy et al., 1983). 
Such "latch bridges" are envisaged as providing an internal resistance to shortening 
and thereby allow conservation of energy. Secondly vascular tissue is considered to 
undergo vasomotion (Wiedman, 1984) characterised by oscillatory constriction and 
dilation. Thirdly, if vasoconstrictors induced flow redistributions (Dora et al., 1992), 
the vascular surface areas could be altered. This could in turn affect the entire 
working vascular tissue mass. Consequently, the mean arterial pressure of a vascular 
bed may not necessarily reflect the energy consumption of the vasculature. In 
addition, the results from the perfused mesenteric artery indicated that vascular tissue 
may be energetically more expensive than previously recognized. 
Overall, these results together with the observations in the perfused 
hindlimbs of the rat, bettong and toad (Chapters 3 & 4) suggest that vasoconstrictor-
mediated control of metabolism is a general feature in constant-flow perfused tissues 
across species. A positive vasoconstrictor effect on V02 in one tissue is not 
necessarily positive in another. If these effects occur in vivo, vasoconstrictors will 
have important implications in the control of the facultative thermogenesis. 
84 
CHAPTER 6 
Vascular control of V02 in the constant-pressure perfused rat 
hindlimb 
6.1 Introduction 
Vasoconstrictors such as NE, VP, AT II and 5-HT all stimulate V0 2 in the 
perfiised rat mesenteric artery (Dora et al., 1991; Hettiarachchi etal., 1992; Chapter 
5). However, in the constant-flow perfused hindlimbs from rats (Chapter 3; Clark et 
al., 1994), bettongs and toads (Chapter 4) have reproducibly shown the effects of 
vasoconstrictive agents to either increase (type A) or decrease (type B) muscle V02 . 
The stimulation or inhibition by vasoconstrictors of V02 was also observed in 
constant-flow perfused rat intestine, although a type A vasoconstrictor in one tissue 
may not necessarily to be type A in another tissue (Chapter 5). For example, NE 
stimulates V02 in the perfused hindlimb and kidney but inhibits V02 in the perfused 
intestine (Chapter 3, 4 & 5). 
In vivo, the blood flow in skeletal muscle undergoes an autoregulation which 
tends to maintain a relatively stable flow to meet metabolic demands (Meininger, 
1991). The arterial blood pressure is maintained at a relatively constant level under 
resting conditions by complex mechanisms, such as the well-known baroreflexes of 
the aortic arcade and carotid sinus. Hence, the findings obtained from the constant-
flow perfused hindlimbs would only reflect the responses in vivo where blood flow to 
the tissue is not significantly changed. 
However, when vasoconstrictors are released or administered, both the 
blood pressure and perfusion flow to skeletal muscle can be affected. Thus, it might 
be argued that the effects of vasoconstrictors on V0 2 observed in the constant-flow 
perfusion may not necessarily represent the scenario in vivo if the perfusion flow is 
changed. Hence the aim of this Chapter is to examine the effects of vasoconstrictors 
on tissue V02 in the constant-pressure perfused rat hindlimb whilst the perfusion flow 
was permitted to change freely. The results were compared with those obtained from 
constant-flow perfused hindlimbs to further evaluate the effect of vasculature on 
muscle thermogenesis. 
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6.2 Methods 
Male rats (100-110 g) were used for the study. The hindlimb was perfused at 
80 ± 0.5 mm Hg in a recirculated model at 37°C similar to that described by 
Hardeveld et al. (1980). The perfusate was Krebs-Ringer buffer containing 6% BSA 
and 2.5 mM Ca2+. The details for the surgery and perfusion are described in Section 
2.2.4. V02 was measured by a in-line Clark-type 02 electrode. The values were 
regularly checked by measuring collected arterial and venous samples with an 02 
analyzer (TasCon, Department of Physiology, University of Tasmania). 
For the assay of lactate and pyruvate, both arterial and venous perfusate 
were collected simultaneously at the steady-state when the flow rate and Pv0 2 were 
taken. Lactate and pyruvate were enzymatically measured as described in Chapter 2 
(Section 2.3). The net production of lactate and pyruvate was calculated from the 
arteriovenous difference of the concentration in the perfusate and the flow rate. 
Creatine compounds and adenine nucleotides in gastrocnemius-plantaris-
soleus muscle group were determined by an ion-paired reversed phase column (Radial 
Pak, C18, 4 pm, 8 x 100 mm) with HPLC (Waters, see Section 2.3). 
6.3 Results 
6.3.1 Basal values of flow, V02, lactate and pyruvate 
The hindlimb perfusion was performed at a constant physiologically relevant 
pressure of 80 ± 0.5 mm Hg (mean ± SE, n=30). The pressure fluctuation was 
controlled by an overflow shunt and manual adjustment (when necessary) within 1.0 
mm Hg in each perfusion. At such a physiological pressure, the perfusion flow was 
measured at 19.7 ± 0.7 ml/min (means ± SE, n=30) for the hindlimb with 7.5-9 g 
musele (2.2-2.6 ml.min -1 -g-1 muscle). A high basal flow rate was expected because of 
the low viscosity of the perfusate and a low vascular tone of the hindlimb. This flow 
rate is comparable with the observations obtained by Johnsson et al. (1991) in the 
constant-pressure perfused rat hindlimb with cell-free 4% Dextran-Tyrode solution, 
where a flow rate of 2.75 ml-min-1 -g-1 muscle was recorded at 125 mm Hg. 
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Fig. 6-1 Time course of flow, V02, lactate and pyruvate efflux in the constant-
pressure perfused rat hindlimb. The rat (100-110g) hindlimb was perfused at a 
pressure of 80 ± 0.5 mm Hg with Krebs-Ringer buffer containing 6% BSA and 2.5 
mM Ca2+ at 37°C in a recirculating system. Art. lactate: arterial lactate concentration. 
Perfusion flow rate was permitted to change freely. Data are presented as means ± 
SE, n=5. *P<0.05, **P<0.0, vs the values at 30 min.(Paired t test). 
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Johnsson et al. (1991) found that in the constant-pressure perfused rat 
hindlimb blood vessel responsiveness could become "erratic" at a high flow rate for 
yet unknown reasons, sometimes showing only passive distension while a few 
preparations showed up to 50% resistance increases. In the present study, most of the 
hindlimbs showed a slight increase in flow rate after recycling the perfusate whereas a 
minority showed a slight reduction in flow rate. In general, it took 30 min to reach a 
steady state. Occasionally, a steady state flow rate could not be obtained. In these 
perfusions, there was always a dramatic fall in flow associated with deteriorating 
tissue edema within the equilibration time. In such cases, the experiment was 
abandoned. 
Under these conditions, the basal values at 30 min of perfusion for V0 2 and 
net release of lactate and pyruvate in the perfusate were 35.1 ± 0.5 (n=30), 36.5 ± 2.5 
(n=22), and 3.01 ± 0.24 (n=22) 1.tmol.h-1s-1 , respectively. The ratio of net lactate 
output to net pyruv,ate output in the perfusate was 12.0 ± 0.74 (n=22). The values of 
flow rate, V02 , and pyruvate remained steady for at least 120 min as demonstrated in 
Fig. 6-1. However, there was a gradual fall in lactate output when lactate 
concentration accumulated in the perfusate. Measurement of pH of the arterial 
perfusate at the end of perfusion showed a value between 7.35-7.40. 
6.3.2 Effects of a-adrenergic agonists on flow, V0 2 , lactate, and pyruvate 
NE started to have an effect on both flow and V0 2 at a concentration of 1 
nM (Fig. 6-2). Despite the decrease in perfusion flow, V0 2 showed a biphasic 
response. NE stimulated V02 in the range of 1 nM to 33 nM. The maximal increase in 
V02 (29%) occured at 3 nM where the flow declined by 16%. As the concentration of 
NE reached 0.1 uM, the flow rate was reduced to 8.0 ml/min (60% of the basal value) 
and V02 returned to the basal level with a trend of further decline. Lactate and 
pyruvate net production declined gradually (not corrected for the decline with time as 
shown in the control) associated with the increase in its accumulation in the perfusate. 
The ratio of lactate/pyruvate, however, was not significantly affected within the range 
of concentrations tested (1 nM-0.1 uM). 
Phenylephrine is an aradrenergic agonist. Compared with NE, 
phenylephrine-mediated changes in flow, V0 2 , lactate and pyruvate were similar, but 
the maximal V02 was only 18% above the basal. However, the difference between the 
maximal V02 induced by NE and phenylephrine was not statistically significant 
(P>0. 05). 
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Fig. 6-2 Effects of a-adrenergic agonists on flow, V0 2, lactate and pyruvate in 
the constant-pressure perfused rat hindlimb. The rat hindlimb was perfused under 
the conditions described in Fig. 6-1. •: NE (n=7 for flow and V0 2, n=4 for lactate 
and pyruvate); 0: phenylephrine (n=4). Art. lactate: arterial lactate concentration. 
Data are presented as means ± SE. * P<0.05, **13<0.01, vs the values before addition 
of agonists (Paired t test). 
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In contrast to NE and phenylephrine, isoproterenol stimulated increases in 
V02 , lactate and pyruvate production in association with a marked increase in 
perfusion flow rate (Fig. 6-3). The maximal increases in flow, V0 2 , lactate and 
pyruvate were around 30%, 30%, 107%, and 130% over the basal levels, 
respectively. Fig. 6-4 shows the effect of propranolol, a 13 1 and 132 adrenergic 
antagonist, on isoproterenol-induced flow, V02, lactate and pyruvate. Addition of 
propranolol (10 uM) blocked the increased flow, lactate and pyruvate induced by 
isoproterenol (1 uM). However, isoproterenol-increased V0 2 was not significantly 
affected by propranolol (P>0.05). 
Fig. 6-4 Effect of propranolol on isoproterenol elicited flow, V0 2, lactate and 
pyruvate in the constant-pressure perfused rat hindlimb. (DL)-propranolol: 10 II 
M; isoproterenol: 1 pM. Data are means ± SE, n=3-4. *P<0.05, "P<0.01 vs the no 
addition group; + P<0.05, +-F P<0.01, vs isoproterenol alone (Paired t test). 
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BRL35135A is a 13 3-adrenergic agonist (Cawthorne et al., 1992) and was 
used in the present study to assess the effect of 13 3-adrenergic receptors on muscle 
V02 . In order to prevent a possible cross reaction with other 13-adrenergic receptor 
subtypes, 1 or 10 [tM propranolol was added to the perfiisate before the application 
of BRL35135A. Fig. 6-5 shows that in the presence of 1 or 10 11M propranolol 
BRL35135A still stimulated V02 . The maximal increase in V02 was approximately 
17% above the level noted in the presence of propranolol alone. Neither perfusion 
flow rate nor lactate release was significantly affected by propranolol alone or a 
combination of propranolol and BRL35135A. 
Fig. 6-5 Effect of BRL35135A on flow, V02 and lactate in the presence of 
propranolol. The open bar represents the presence of propranolol in the perfusate 
and the filled bar represents the presence of BRL35135A in the perfusate. 0: 1 1.1A4 
DL-propranolol, •: 10 [tM DL-propranolol. Data are means ± SE, n=3. *P<0.05, 
vs propranolol alone (Paired t test). 
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Fig. 6-6 Effect of VP on flow, V02, lactate and pyruvate in the constant-
pressure perfused rat hindlimb. Art. lactate: lactate concentration in the arterial 
perfusate. Data are means ± SE, n=3-4. *P<0.05, "P<0.01 vs the basal values 
(Paired t test). 
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VP mediated a biphasic change in V0 2 . At low doses, VP stimulated V0 2 
associated with a trend of increased lactate and pyruvate release (Fig. 6-6) despite a 
fall in flow rate. The maximal V02 induced by VP reached 18% above the basal level 
(P<0.01) at 33 pM. At doses higher than 0.1 nM, VP began to inhibit V02, lactate 
and pyruvate output. As the changes in lactate and pynivate paralleled each other, the 
lactate to pynivate ratio was not altered until the VP reached 1 nM (Fig. 6-6). 
6.3.5 Effect of 5-HT on flow, V 0 2, lactate and pyruvate 
Unlike NE and VP, 5-HT mediated a vasodilation at low concentrations 
before it caused vasoconstriction at higher doses. There were biphasic changes in 
V02, lactate and pyruvate associated with the biphasic change in flow. At 
concentrations lower that 0.1 [IM, 5-HT increased flow rate and V0 2 associated with 
a dramatic reduction in lactate production (without a significant increase in lactate 
accumulation). During the vasodilation phase (as indicated by an increased flow), the 
maximal change was obtained at 33 nM 5-HT with increases in flow and V0 2 of 22% 
and 30%, respectively, as well as a 64% decrease in lactate release. As a result of the 
decrease in lactate and the rising trend of pyruvate, the lactate/pyruvate ratio dropped 
markedly (P<0.01). At the concentrations higher than 0.1 iiM, 5-HT reduced flow 
rate, V02 , lactate and pyruvate. At the turning point (0.1 1.IM) from vasodilation to 
vasoconstriction, there seemed to a rebound in lactate release. 
6.3.6 Muscle metabolites 
Table 6-1 shows the concentration of Cr, CrP, AMP, ADP, ATP and lactate 
in gastrocnemius-plantaris-soleus muscle group after constant-pressure perfusion. 
Following 120 min perfusion (perfusion control group), all of the measured 
metabolites were similar to those in the muscle sampled in vivo. 
The muscle samples were also taken and measured for the metabolites after 
the dose-response curve for each vasoconstrictor. In the presence of NE at the dose 
(0.1 pM), which does not inhibit V02 (see Fig 6-2), AMP and ADP were not 
significantly different from the control values whilst CrP/Cr, ATP and lactate showed 
a marked increase (P<0.05). Addition of phenylephrine showed similar results to 
those caused by NE except for ATP, which was not statistically different from the 
control. At a concentration of 1 nM where VP began to inhibit V0 2, there was a 
marked decrease in CrP/Cr. Similarly, when 5-HT inhibited V0 2 at 10 p.M, CrP/Cr 
decreased significantly (Table 6-1). 
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Fig. 6-7 Effects of 5-HT on flow, VO2, lactate and pyruvate in the constant-
pressure perfused rat hindlimb. Art. lactate: lactate concentration in the arterial 
perfusate. Data are presented as means ± SE, n=4-5. * P<0.05, ** P<0.01, vs the 
basal values (Paired t test). 
Table 6-1 Muscle metabolites in constant-pressure perfused rat hindlimb 
Cr CrP AMP ADP ATP EAN Lactate EC CrP/ Cr CrP/ATP 
p.mol/g dry wt. 
In vivo 5 111.6 119.3 0.23 2.69 28.18 31.10 9.31 0.952 1.07 4.24 
± 7.56 + 9.2 ± 0 03 + 0.21 ± 1.13 ± 1.34 ± 0.89 ± 0.006 + 0.02 ± 0.30 
Perfused 5 114.8 111.0 0.22 2.04 28.05 30.30 9.02 0.960 0.97 3.96 
(120 min) ±4.86 ±3.54 ±0.03 ±0.13 ±0.46 ±0.44 ±0.93 ±0.003 ±0.03 ±0.14 
NE 4 108.5 128.0 0.51 2.95 32.31 * 35.32* 16.40* 0.960 1.20* 3.98 
(0.111M) ± 6.89 ± 7.88 ± 0.03 ± 0.33 ± 1.25 ± 1.50 ± 2.23 ± 0.003 ± 0.10 ± 0.18 
Phenyl. 4 105.5 115.6 0.22 3.04 29.59 32.84 18.89* 0.946 1.10* 3.94 
(0.1 p.M) ±4.62 ±7.76 ±0.05 ±0.43 ±2.37 ±2.26 ±4.18 ±0.010 ±0.05 ±0.03 
5-HT 4 126.4 101.0 0.15 2.34 29.19 31.52 7.41 0.957 0.86* 3.60 
(3.3 pM) ±2.72 ±0.25 ±0.03 ±0.10 ±0.81 ±0.92 ± 1.36 ±0.001 ±0.03 ±0.03 
VP 3 125.5 99.5 0.11 2.43 28.82 31.39 9.43 0.957 0.81* 3.45 
(1.0 n.M) ±5.05 ±4.44 ±0.06 ±01.3 ±0.80 ±0.92 ±0.76 ±0.001 ±0.03 ±0.07 
Gastrocnemius-plantaris-soleus muscle group was freeze-clamped by N2-precooled tongs. The muscle in vivo was clamped under anaesthesia. Other muscle 
samples were taken at the end of the perfusion. No significant difference was found between the results from in vivo and control perfusion. Phenyl: phenylephrine; 
VP: vasopressin. Data are presented as mean ± SE. *: P< 0.05, vs control perfusion. 
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6.3.7 Comparison of flow, V02, lactate induced by the vasoactive agents 
Fig. 6-8 summarizes the changes in perfusion flow and V0 2 mediated by NE, 
phenylephrine, isoproterenol, VP, and 5-HT. There were two patterns of relationships 
between flow rate and V02 during vasoconstriction (Figs 6-8 & 6-9). At the early 
stages of fall in flow, NE, phenylephrine, VP stimulated V0 2 before inhibiting. In 
contrast, 5-HT inhibited V02 immediately when it reduced the flow. 
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Fig. 6-8 Effects of VP, NE, phenylephrine, isoproterenol and 5-HT on flow and 
V02 in constant-pressure perfused rat hindlimb. Combined data taken from 
perfiisions in Figs.6-2, 6-3, 6-6 & 6-7. Phenyl: phenylephrine, Iso: isoproterenol. 
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Fig. 6-9 V02 as a function of flow induced by NE, phenylephrine, isoproterenol 
and 5-HT in the constant-pressure perfused rat hindlimb. Original data are 
presented in Fig 6-8. 
6.3.8 Lactate accumulation and output 
Figs. 6-2, 6-6 and 6-7 have shown that lactate efflux decreased with different 
magnitudes of increase in arterial lactate concentration. As lactate output also 
declined in the control perfusion when lactate concentration in the perfusate 
accumulated after recirculation (Fig. 6-1), the true change in lactate efflux in the 
presence of vasoconstrictors can not be clearly seen in those figures. Thus, Fig. 6-10 
compares the effects of NE, phenylephrine, isoproterenol, VP and 5-HT on lactate 
accumulation and output after 120 min of perfusion. The results showed a trend of 
increased lactate accumulation in the presence of NE, phenylephrine and VP. These 
seem to correspond with a trend of decreased lactate output. Isoproterenol increased 
both the output and accumulation of lactate whilst 5-HT significantly inhibited them. 
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Fig. 6-10 Accumulation and efflux of lactate after 120 min of perfusion in the 
presence of vasoactive agonists. E (0.1 1AM), phenylephrine (Phenyl, 0.1 1.1.M), 
isoproterenol (Iso, 1 [tM), VP (33 pM), 5 -HT (1 iiM). Art. lactate: lactate 
concentration in the arterial perfusate. 
6.4 Discussion 
In earlier Chapters, vasoconstrictors have been shown to exert either 
stimulatory (type A) or inhibitory (type B) effects on metabolism in the perfused 
hindlimb and intestine in a constant-flow perfused model (Chapters 3, 4 & 5). Under 
normal resting conditions, the systemic blood pressure in vivo is controlled by the 
neuro-humoral system at a relatively constant level although autoregulation at the 
organ or tissue level tends to maintain steady perfusion flow. Hence, the present study 
was designed to keep perfusion pressure at a constant and physiological level of 80 
mmHg and allow the flow to change freely. 
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The basal V02 of 35 gmol-g-1 .1r 1 in the present experiments is generally 
comparable with the value (16 limol.g-1 .10) observed in a constant-flow perfused rat 
hindlimb at 25°C at 18.2 ml/min (Chapter 3), given that Q i0=2.5 (Bonen et al., 1994). 
This value is also similar to that (43.8 pmol.g - l.h-1) obtained in the rat hindlimb 
perfused at a constant pressure of 80 mm Hg with Krebs buffer containing 
erythrocytes (Hardeveld et al., 1980). However, lactate (36 p.mols-1 .h-1) and 
pynivate (3.3 Rmols-1 -11-1) appeared lower using the same estimate from data at 25° 
C where lactate and pyruvate outputs were 20.6 i_tmol-g -1 -11-1 and 2.2 gmol.g-1 .h-1 , 
receptively. This discrepancy may result from the recirculation of the perfusate 
adopted in the present experiment. 
As well as producing lactate, resting skeletal muscle is also able to utilize 
lactate (Mclane & Holloszy, 1979; Chin et aL, 1991; McDermott & Bonen, 1992). 
Lactate gradient between muscle and blood dictates whether lactate is taken up or 
released (Pagliassotti & Donovan 1990a; McDermott & Bonen, 1992). Data from 
Pagliassotti & Donovan (1990a) have clearly demonstrated that net lactate balance 
(lactate removal minus release) is proportional to arterial lactate concentration. When 
arterial lactate concentration exceeds 4-8 tnM, skeletal muscle begins to remove 
rather than release lactate. It is possible that skeletal muscle takes up some lactate and 
pyruvate from the recycled perfusate, thereby inhibiting the net production of lactate 
and pyruvate. Nonetheless, the ratio of lactate/pyruvate of 12 is close to the value of 
approximate 10 obtained in the constant-flow perfused rat hindlimb at 25°C (Chapter 
3). The metabolic parameters and perfusion flow remained steady for at least 120 min 
(Fig. 6-1) and muscle metabolites at the end of the perfusion showed similar results to 
those obtained from muscle taken in vivo (Table 6-1). These data indicate that a 
constant-pressure perfusion preparation of rat hindlimb has been established with valid 
physiological and metabolic characteristics. 
Consistent with the findings in the constant-flow perfused rat hindlimb 
(Chapters 3 & 4), NE-stimulated increase in V02 in the constant-pressure perfused rat 
hindlimb (Fig. 6-2). The similarities between NE and phenylephrine on flow, V0 2 , 
lactate and pyruvate would seem to indicate that a radrenergic receptors are mainly 
responsible for the effects of NE. In contrast to constant-flow perfused rat hindlimb, 
both lactate and pyruvate tended to decline when V02 was increased by NE and 
phenylephrine accompanied by a trend of greater accumulation of lactate in arterial 
perfusate (Figs. 6-2 & 6-10). Yet it is not known whether NE stimulates lactate 
uptake in the skeletal muscle. If so, when NE was added to the present recycling 
perfusion, the increased arterial lactate would probably impede the endogenous 
production of lactate in the muscle, thus inhibiting the net release of lactate. A similar 
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mechanism would possibly apply to the decrease in pyruvate during stimulation by 
NE. 
In addition to a-adrenergic receptors, 0-adrenergic receptors are also shown 
to be involved in NE-mediated increase in V0 2 in the constant-pressure perfused 
hindlimb. 13-Adrenoceptor-mediated increases in metabolism were first hinted at by 
the result that the maximal VO2 induced by NE appeared to be bigger (29%) than that 
(17%) induced by phenylephrine (Fig. 6-2) and was further supported by a direct 
stimulation of V02 , lactate and pyruvate net production by isoproterenol (Fig. 6-3). 
These results are consistent with the observations by Hardeveld et al. (1980) who 
found that isoproterenol stimulates V02 (20%) and lactate production (approximately 
400%) in a constant-pressure (80 mm Hg) perfused rat hindlimb with Krebs-Henseleit 
buffer containing erythrocytes. 
Recent studies have revealed that (3-adrenergic receptors can be classified 
into at least three subtypes: 13 1 , 132 and 133  (Challiss etal., 1988; Emorine et al., 1989; 
Roberts et al., 1993). It has been suggested that 13 3 -adrenergic receptors are the major 
subtype responsible NE-mediated increase in thermogenesis in BAT (Arch & 
Kaumann, 1993) and possibly in skeletal muscle (Challiss et al., 1988; Emorine et aL, 
1989; Roberts et aL, 1993). Ligand binding studies on soleus muscle suggest the 
existence of 13 3-adrenergic receptors in skeletal muscle (Roberts et al., 1993; Silence 
etal., 1993). 
In order to assess the possible role of the putative 13 3- (or atypical fl) 
adrenergic receptors in V02 , the 13 1 , 132-adrenergic antagonist, propranolol (Challiss et 
al., 1988; Cawthorne et al., 1992; Arch & Kaumann, 1993), was added in the 
presence of isoproterenol. The results in Fig. 6-4 demonstrated addition of that 
propranolol completely blocked isoproterenol-induced flow, lactate and pyruvate, but 
not V02 . These observations agree with the reports by Blaak et al. (1994) who found 
isoproterenol induced increases in blood flow, lactate and pynivate fluxes from the 
forearm skeletal muscle of lean men and these increases were inhibited by the 13 1 - 
adrenergic antagonist, atenolol. Although they did not attribute isoproterenol-elicited 
V02 to 133-adrenergic receptors (Blaak et al., 1993), administration of atenolol did 
not show a clear inhibitory effect on isoproterenol-increased skeletal muscle V02 . 
Interestingly, Fig. 6-4 shows that isoproterenol-stimulated V0 2 was not significantly 
inhibited by propranolol, thus suggesting that atypical 13-adrenergic receptors, possibly 
13 3-adrenergic receptors, are involved in mediating muscle V0 2 in the constant-
pressure perfused rat hindlimb. 
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Such a possibility is confirmed by the stimulation of V02 by the 03- 
adrenergic agonist, BRL35135A (Cawthorne et al., 1992; Arch & Kaumann, 1993) in 
the presence of propranolol (Fig. 6-5), although the maximal V02 produced by 
BRL35135A was not as big as that produced by isoproterenol. Coincidently, a similar 
increase in energy expenditure (10-23%) was also observed in a study of glucose-
induced thermogenesis in men when BRL35135 was administered (Cawthorne et al., 
1992). Abe et al. (1993) reported BRL35135A stimulates glucose uptake by 
approximately 20 % in rat soleus muscle. Thus these observations together with the 
findings of atypical 13- or 13 3-adrenoceptor-mediated V02 in constant-pressure 
perfused rat hindlimb suggest that skeletal muscle may contribute to the increased 
thermogenesis produced by putative 13 3 -adrenergic agonists. 
Similar to a-adrenergic agonist, VP stimulated VO2 by 17% at low dose (33 
pM) while it reduced perfusion flow rate in a dose-response manner (Fig. 6-6). At 
doses higher than 0.1 nM where the flow was reduced more than 40%, VP became 
inhibitory to V02 . The stimulation of V02 by VP, NE and phenylephrine suggests that 
type A vasoconstrictors stimulate VO2 in the constant-pressure perfused rat hindlimb. 
5-HT can have either vasodilatory or vasoconstrictive action in the human 
forearm dependent on the concentration (Bruning et al., 1993). At low 
concentrations, 5-HT exerts a biphasic vasodilation whereas at high concentration it 
causes vasoconstriction (Blauw et al., 1988). In the constant-flow perfused hindlimb 
of rats 5-HT inhibits V02 (Dora et al., 1991 & 1992) and skeletal muscle contraction 
during vasoconstriction (Rattigan et al., 1994). A similar inhibition of V0 2 was also 
observed in constant-flow perfined hindlimb of marsupial bettongs (Chapter 4). In 
these latter experiments, only a vasoconstrictive effect at high concentrations was 
observed. 
In the present chapter, 5-HT (Fig. 6-7) showed not only the expected 
vasoconstrictive effect but also a clearly vasodilatory effect at doses lower than 0.3 
M. Furthermore, there was an increase in V02 in parallel with the increased perfusion 
flow (Fig. 6-7). In contrast to isoproterenol which also increased perfusion flow (Fig. 
6-3), 5-HT significantly reduced lactate output and the lactate/pyruvate ratio (Fig. 6- 
7) when V02 reached the maximum. This difference would seem to suggest that 5-HT 
increases V02 during vasodilation in a mechanism different from 13-adrenergic 
stimulation. 
In incubated rat skeletal muscle, 5-HT does not inhibit contraction 
performance (Dora et al., 1994) or glucose uptake (Rattigan et al., 1994). However, 
when infused via vascular route in the constant-flow (once-through) perfused rat 
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hindlimb, 5-HT does inhibit exercised performance and glucose uptake (Dora et al., 
1994; Rattigan et al., 1994). Therefore, it is suggested that 5-HT affects muscle 
metabolism by changing blood flow patterns. The enhanced VO2 by 5-HT at low 
doses with constant-pressure perfusions would appear to be related to the increase in 
flow rate. As shown in Chapter 3, an increased flow to muscle can induce a rise in 
V02 by this tissue. Thus, the increase in V0 2 induced by low dose 5-HT in the 
constant-pressure perffised rat hindlimb may be due to the increased flow. However, 
when perfusion flow is increased (Chapter 3) without restricting perfusion pressure, 
there is a parallel rise in both lactate and pyruvate without affecting their ratio. The 
decrease in lactate/pyruvate ratio suggests 5-HT-induced V02 at low doses may also 
be associated with some changes in mitochondrial respiration. 
In agreement with the observations in the constant-flow perthsed rat 
hindlimb, 5-HT at concentrations higher than 0.1 11M caused both vasoconstriction as 
indicated by decreased flow and inhibition of V0 2 (Fig. 6-7). The pattern of V02 as a 
function of flow rate induced by 5-HT is different from that for type A 
vasoconstrictors such as NE, VP and phenylephrine (Fig. 6-9). Whilst type A 
vasoconstrictors stimulate V0 2 at low doses during the initial stage of decrease in 
perfusion flow, 5-HT does not show any trend of stimulation of V0 2 when it reduces 
flow rate below the basal level. Thus the distinction of their effects on V02 by type A 
and B vasoconstrictors in the constant-flow perfused hindlimb (Clark et al., 1994) 
appears to stand as well for the constant-pressure perfusion of hindlimb even though 
the effects are not identical. 
The mechanism accounting for the increased V02 mediated by type A 
vasoconstrictors in the constant-pressure perfused hindlimb may involve the energy 
cost of constricting blood vessels. As discussed earlier (Chapters 3, 4 & 5), V0 2 of 
vascular smooth muscle is dependent on the vascular wall tension (Paul, 1980). 
According to the Laplace law of tension-radius relationship (Tension = 
Pressure/Radius), vascular wall tension is proportional to its radius. Since the pressure 
was controlled at a constant level in the present experiments, a decrease in perfusion 
flow would seem to reflect a decrease in the radius (Flow oc P/r 4, according to 
Poiseuille's law). How could a decreased total vascular wall tension consume more 0 2 
if microvessels are responsible for the increased V02? 
It has been well established that the total vascular wall tension (It) consists 
of two components: active tension (Ta) and passive tension (Tp) (Paul & Peterson, 
1975; Mulvany & Warshaw, 1979; VanBavel & Mulvany, 1994). Tp reflects the 
properties of the elastic elements in vascular wall whereas Ta is produced by vascular 
smooth muscle contraction (Mulvany & Warshaw, 1979; VanBavel & Mulvany, 
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1994). Paul & Peterson (1975) have demonstrated in bovine mesenteric vein that 
vascular V02 is dependent on Ta rather than Tt. Consequently, the key issue for 
vascular V02 lies on its Ta. It is also known that the relationship between vascular 
radius and Ta is opposite below or above the optimal point. Below the optimal radius 
(or circumference), Ta falls linearly with decreasing radius. Above the optimal radius, 
Ta also falls with increasing radius (Mulvany & Warshaw, 1979). Hence, when 
vascular radius is reduced to the optimal by an activating agonist such as NE, Ta 
increases in a reverse proportion to the fall of Tt (Mulvany, 1991). Indeed, vascular 
V02 has been shown to match Ta very well below or above the optimal radius (Paul 
& Peterson, 1975). 
In the present constant-pressure perfused hindlimb, a suprabasal radius 
beyond its optimal level is likely to be present in the resistance vessels despite the 
physiological pressure because of the following reasons. Firstly, the basal flow rate of 
2.4-2.6 mIhnin per g muscle is 9-10 fold the value in vivo (0.27 ml/min per g). Such a 
supraphysiological flow would substantially increase the shear stress to the vascular 
endothelium, thereby releasing EDRF (Bevan, 1991) to relax vascular smooth muscle. 
Secondly, the viscosity of the perfusate is lower than blood because of the lack of red 
blood cells. In the arterial trees, viscosity is higher in upstream resistance vessels than 
it is downstream (Folkow & Neil 1971). Since viscosity is proportional to vascular 
resistance and the effect of high flow, the transmural pressure would be expected to 
be higher in the downstream arterial tree and to expand the vascular radius. At a 
similar perfusion of rat hindlimb with 4% Dextran-Tyrode solution, a high capillary 
filtration pressure has been noted (Johnsson et al., 1991). When type A 
vasoconstrictors elicit vasoconstriction (indicated as decrease in perfusion flow rate), 
Ta would be expected to increase in the early stages of vasoconstriction even though 
Tt decreases with the fall in flow. Accordingly, an increase in V02 in the constant-
pressure perfused hindlimb vascular bed would be expected before the optimal level 
or the decreased flow restricts the parenchymal metabolism. Such an interpretation 
seems in agreement with the fact that the maximal V02 produced by NE, 
phenylephrine and VP all lies at an approximately similar flow rate of 17 ml/min (Figs. 
6-4, 6-8 & 6-10). 
Alternatively, if nutritive and nonnutritive capillaries exist in skeletal muscle 
(Renkin et al., 1971; Clark et al., 1994), the eventual V02 would be dependent on the 
actual flow though nutritive capillary areas. Accordingly, a redirection of flow to 
these capillaries should increase V0 2 no matter how the total flow changes within the 
range of sufficient supply. Hence, in analogy to the argument for constant-flow 
perfusion (Chapters 3, 4 & 5), NE, phenylephrine and VP can increase V0 2 by 
104 
redistributing flow to the nutritive capillaries. Sufficient oxygen supply during the 
stimulation of V02 by NE, phenylephrine and VP was supported by the normal ratio 
of lactate/pyruvate (Figs. 6-2 & 6-6). Although the present experiments did not show 
direct evidence of the recruit rate of capillaries, partial opening of the muscle 
capillaries under basal conditions is indicated by the improved high phosphate 
compounds in the presence of NE and phenylephrine (Table 6-1). Such an argument 
appears to agree with the observation (Fig. 6-7) that 5-HT at low doses was able to 
increase V02 when it increased the flow rate, presumably increasing perfusion of 
nutritive capillaries as 'well. However, when the flow was further reduced by type A 
vasoconstrictors, V02 was depressed due to the insufficiency of 0 2 supply as shown 
by an increased perfusate lactate/pyruvate ratio (Fig. 6-6) and decreased muscle 
CrP/Cr ratio (Table 6-1) for VP at a flow rate of 4.8 ml/min. 
In contrast to the effects of NE, phenylephrine and VP, the inhibition of V0 2 
by 5-HT (>0.3 p.M) is probably due to the functional shunting of flow away from 
nutritive areas as suggested by Dora et al (1991). As shown in Table 6-1, CrP/Cr 
ratio is significantly inhibited by 5-HT although the flow rate, at which the muscle was 
sampled, was similar to that for NE or phenylephrine. Currently, it is not known how 
an increased flow to the nutritive capillaries would elicit skeletal muscle V0 2 above a 
normal level in the resting state. 
Similar to the classification of type A and type B vasoconstrictors, it could be 
postulated that each vasodilator may act on site specific receptors or utilize specific 
mechanisms so that the effect of vasoconstrictors on muscle metabolism would not 
be homogeneous. For example, NP relaxes vascular smooth muscle in general. 5-HT 
and isoproterenol vasodilate via acting on their specific receptors in blood vessels. 
This might explain why vasodilators such as NP inhibit V02 (Chapter 3) whereas 5- 
HT (<0.3 pM) increases V02 . 
Compared with the results obtained from constant-flow perfused hindlimbs in 
the same laboratory (Chapters 3 & 4; Colquhoun et al., 1988; 1990; Dora et al., 
1991; 1992), several new findings emerge from the constant-pressure perfused rat 
hindlimb as follows: 
1. Type A vasoconstrictors can stimulate V0 2 even though perfusion flow is 
slightly reduced; 
2. Both a and 0-adrenoceptors are involved in NE-mediated increase in muscle 
thermogenesis. a l-Adrenoceptor, the major a-adrenoceptor subtype 
responsible for the increased V02, may mediate muscle thermogenesis via 
vascular constriction; 
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3. For 0-adrenoceptors, atypical 13-subtype (or putative 03-subtype) is the 
major population to stimulate muscle V0 2 independent of vascular effect. 
However, other subtypes may also be involved in 0-adrenergic stimulation of 
muscle thermogenesis by increasing perfusion flow and lactate and pyruvate 
production; 
4. 5-HT exerts a biphasic action on flow and V0 2 . It increases both perfusion 
flow and V02 at lower concentrations (<0.03 0,4) but reduces V02 and 
flow at high concentrations (?0.3  pt,M); 
5. In the present recycling perfusion at a constant pressure, an increased V0 2 is 
not necessarily associated with parallel changes in lactate and pyruvate 
production. 
Taken together, the present findings confirm the previous observations in a 
constant-flow model that vasoconstrictors control or contribute to skeletal muscle 
V02 .(Chapters 3 & 4). In vivo, the perfusion of skeletal muscle is at neither constant 
flow rate nor at constant pressure, vasoconstrictor such as NE is released or 
administrated (Foster and Frydman 1979; Kurpad et al., 1994). While NE constricts 
blood vessels in the skeletal muscle, it also enhances the cardiac output (Foster and 
Frydman 1979; Liard, 1989) so that the actual blood flow to the skeletal muscle may 
not decrease dramatically to limit the V0 2 . Previous findings have revealed that V02 
is increased by type A vasoconstrictors associated with a rise in perfusion pressure 
when the flow remains unchanged (Chapters 3 & 4). The present study suggests that 
even though the perfusion flow is slightly reduced and the perfusion pressure remains 
unchanged, type A vasoconstrictors can still stimulate V02, thus confirming the 
argument for the important role of the vascular system in skeletal muscle, and thereby 
in whole body thermogenesis. 
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CHAPTER 7 
Bioenergetics of different muscle tissues during ischemia and its 
features in skeletal muscle during hyperoxemia 
7.1 Introduction 
High energy phosphate compounds (BEC) and lactate are well recognised as 
important metabolites of bioenergetics to evaluate the state of aerobic metabolism in 
living cells. In earlier Chapters, the mechanisms underlying vascular control of muscle 
thermogenesis have been discussed by using perfused hindlimbs, kidney and intestine. 
In those studies, bioenergetic metabolites have been repeatedly used to assess the 
validity of the perfused tissue preparations and the mechanism(s) involved. 
In the perspective of NST, both skeletal muscle and BAT are important 
contributors (Jansky, 1971; Foster & Frydman, 1978; Astrup et al., 1986). In BAT, 
NE elicits lipolysis in the brown adipocytes by I3-adrenergic receptors. The released 
fatty acid subsequently activates uncoupling protein in the mitochondria to decouple 
oxidation of substrates from phosphorylation of ADP, thus producing heat. Both ATP 
and ADP are involved in regulating the function of oxidative-phosphorylation 
uncoupling (Hinuns-Hagen, 1990). It has been shown in this laboratory that adenine 
nucleotides are very sensitive to ischemia in BAT (Matthias et al., 1994). Several 
studies suggest that decoupled oxidative phosphorylation may occur under certain 
conditions in skeletal muscle as a heat production mechanism (Barre et al., 1986 & 
1987b; Duchamp et al., 1992, Herpin & Lefaucheur, 1992; Matthias et al., 1993). A 
comparison between skeletal muscle to BAT in the aspects of bioenergetics would be 
informative of exploring the mechanism of muscle thermogenesis. 
As shown in the perfused hindlimb as well as in intestine and in kidney, blood 
vessels play a key role in vasoconstrictor-induced V0 2 (Chapters 3, 4, 5 & 6). The 
vascular tree appears to be an important source for vasoconstrictor-elicited 
production of lactate (Hettiarachchi et al., 1992) and purine/pyrimidine breakdown 
metabolites (Clark et aL, 1990). However, little is known about the catabolic kinetics 
of bioenergetics in vascular tissue. 
Ischemia of different periods is a useful model to observe kinetic changes in 
HEC and the intermediate metabolites. Thus the first purpose of this Chapter was to 
characterise the features of the bioenergetic kinetics in various muscle tissues during 
total ischemia. Based on the results, a second attempt was made to evaluate the 
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possible involvement of metabolites in controlling the respiratory rate by comparing 
them with those obtained from the resting muscle at a high V02 state. 
7.2 Methods 
7.2.1 Ischemia model 
Male rats weighing 180-200g were anaesthetised with an intraperitoneal 
injection of sodium pentobarbital (60 mg/k g body weight). Special care was taken to 
ensure that the animals were breathing normally with no signs of hypoxia before and 
during the surgery to sample the tissues. The ischemia model was produced by 
decapitating the animal with a guillotine under anaesthesia. The remaining carcase was 
wrapped in plastic bags to prevent evaporation of tissue water and kept at 37°C (or 
25°C when indicated ) before the samples were taken at the set intervals. 
7.2.2 Hyperoxemia model 
The high V02 state of skeletal muscle was obtained from at 25°C with Krebs 
buffer that contained 4% BSA and 1.27 mM Ca 2+. The perfusate was saturated with 
95% 02 and 5% CO2. Perfusions were performed at a constant flow of 18.5 ml/min 
for 20 min followed by an infusion of 50 nM NE for another 20 min. Previous data in 
the perfused rat hindlimb have shown that flow induces VO2 and NE augments this 
effect (Chapter 3). Hence the high resting skeletal muscle V02 was produced by 
infusing NE to the high flow perfilsed rat hindlimb. Other details for the surgery and 
perfusion were described in Chapter 2 (Section 2.2.1) 
7.2.3 Tissue sampling 
All the tissue samples were freeze-clamped by liquid N 2-precooled tongs. 
Gastrocnemius-plantaris-soleus muscle group was taken for the measurement of 
skeletal muscle metabolites. The heart was exposed by cutting the diagram and ribs on 
both sides. Immediately after the exposure, the heart was freeze-clamped prior to 
removal. The aorta was sampled from the abdominal section. After evisceration of the 
intestines, the abdominal aorta was separated from the vena cava and the surrounding 
tissues. Immediately following the dissection, a segment between the bifurcation of 
iliac arteries and the left renal vessels was rinsed with filter paper and freeze-clamped 
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as mentioned above. The procedure from dissection to the freeze-clamp was 
completed within 10 seconds. 
7.2.4 Determination of HEC, lactate and glycerol 
The tissue samples were extracted by HC104 as described in Chapter 2 
(Section 2.3). Creatine compounds and adenine nucleotides were determined 
simultaneously with ion-paired reverse phase chromatography (Shellevold et al., 
1986) by HPLC. The energy charge of adenylate pool was calculated according to the 
equation (Atkinson, 1968): 
[ATP] + 0.5 [ADP] 
[ATP] + [ADP] + [AMP] 
Lactate and glycerol were assayed enzymatically by a UV-spectrophotometer 
and spectrofluorimeter, respectively. Further details are outlined in Section 2.3. 
7.3 Results 
7.3.1 HPLC tracings of HEC in normal tissues 
Fig. 7-1 shows HPLC tracings of normal BEC and related metabolites for 
skeletal muscle, heart (Fig, 7-1A), abdominal aorta, and small intestine (Fig. 7-1B). 
Cr, CrP, AMP, ADP and ATP were all observed at 214 mn wave length. Since 
creatine compounds are 3-4 fold that of ATP in skeletal muscle under non-ischemic 
conditions and eluted earlier than adenine nucleotides, a wide diversity in the peak 
heights appeared on chart paper for the compounds measured, causing difficulty in 
adjusting each peak at a measurable height within one scale. Therefore a second 
channel was set at 254 nm, where there was no absorption for creatine compounds, to 
detect adenine nucleotides at another suitable sensitivity. 
As shown in Fig. 7-1, the compounds were well separated within 10 min. 
Each peak from samples was identified by comparing the retention time with the 
standard, and confirmed, when necessary, by addition of a known amount of the 
standard to the sample peak enrichment. The calculated contents of normal Cr, CrP, 
AMP, ADP, ATP, lactate, and glycerol was shown in Table 7-1. The energy charges 
were approximately 0.9 for each tissue except for aorta. These results together with 
high content of CrP indicate that a reliable sample processing had been achieved. 
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Table 7-1 Normal energetic metabolites of the rat skeletal muscle, heart, intestine and aorta 
n Lactate Glycerol Cr CrP Cr+CrP AMP ADP ATP EAD EC CrP/Cr CrP/ATP 
punol/g dry wt 
S. muscle 5 9.31 1.90 111.60 119.27 230.86 0.23 2.69 28.18 31.10 0.95 1.07 4.24 
±0.89 ±0.17 ±7.56 9.24 ± 16.71 ±0.03 ±0.21 ± 1.13 ± 1.34 ±0.01 ±0.02 ±0.30 
Heart 5 6.20 1.48 24.46 28.48 52.84 0.25 4.13 19.11 23.50 0.90 1.25 1.58 
±0.83 ±0.20 3.76 ±2.11 ±4.61 ±0.07 ±0.54 ±2.15 ±1.94 ±0.01 ±0.15 ±0.11 
Intestine 4 19.74 1.25 14.24 16.02 31.45 0.09 1.38 8.33 9.80 0.92 1.15 1.92 
±2.15 ±0.21 ±1.31 ±1.40 ±1.98 ±0.02 ±0.06 ±0.55 ±0.54 ±0.01 ±0.15 ±2.60 
Aorta 4-5 16.90 0.47 3.18 3.16 6.33 0.12 0.66 0.81 1.19 0.75 1.05 4.67 
±1.97 ±0.19 ±0.39 ±0.12 ±0.48 ±0.04 ±0.31 ±0.14 ±0.0 ±0.04 ±0.11 ±1.13 
Muscle tissues were freeze-clamped by a pair of tongs precooled in liquid N2 . HC104 extract was used for the measurements. EC: energy charge. 
EAD: sum of adenine nucleotides.Data are presented as mean ± SE. 
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Comparison of the data reveals that the smooth muscles generally had a 
higher level of lactate but lower concentrations of CrP and ATP than the striated 
muscles under aerobic conditions. Skeletal muscle contained the highest phosphagens 
among all of these muscle tissues whereas aorta contained the lowest level HEC and 
glycerol. 
7.3.2 Changes in creatine compounds during ischemia 
0 20 40 60 	0 20 40 60 
lschemic time (min) 
Fig. 7-2 Changes in creatine compounds in different muscle tissues in the time 
course of ischemia. Panel A: skeletal muscle (n=4-5); panel B: heart (n=4-6); panel 
C: aorta (n=4-5) and panel D: intestine (n=4-5). 0: CrP, • Cr. Data are presented as 
means ± SE. 
pm
ol
/g
  d
ry
  w
ei
gh
t  
250 
200 
150 
100 
50 
0 
6 
4 
2 
0 
pm
ol
/g
  d
ry
  w
ei
gh
t  
40 
30 
20 
10 
0 
2.0 
1.5 
1.0 
0.5 
0.0 
i i • I I I 	I I I I I I I 1 I 	II I 	• 	I 
0 20 40 60 	0 20 40 60 
25 
20 
15 
10 
5 
0 
10 
8 
6 
4 
2 
0 
pm
ol
/g
  d
ry
  w
ei
gh
t 
^ 
_ 
- 
- 	 - 
— OD--0 	o 
1. 
_ 
_ 
- 
- - _ 
- 
_ 
_ 
_ 
113 
As demonstrated in Fig. 7-2, after 5 min of total ischemia CrP decreased by 
18%, 46%, 88% and 85% for the skeletal muscle, aorta, heart and intestine, 
respectively. CrP completely converted to Cr before 30 min of ischemia in the heart 
and intestine whereas there were still 30% and 33% left for skeletal muscle and aorta 
each with proportionally increased Cr. 
7.3.3 Changes in adenine nucleotides during ischemia 
lschemic time (min) 
Fig. 7-3 Changes in adenine nucleotides of different muscle tissues during 
ischemia. Panel A: skeletal muscle (n=4-5); panel B: heart (n=4-6); Panel C: aorta 
(n=4-5) and panel D: intestine (n=4-5). 0: AMP; • ADP; 0: ATP and M: LAN. 
Data are means ± SE. 
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In contrast to creatine compounds, adenine nucleotides were sustained much 
longer in skeletal muscle and aorta. In skeletal muscle (Fig 7-3A), ATP decreased by 
only 14% (P<0.05) of the initial level without significant reduction in TAD (P>0.05) 
following 60 mm of ischemia. ADP did not show a marked change after 5 min of 
ischemia but doubled at 30 mm and thereafter (P<0.01). Interestingly, AMP did not 
alter appreciably during the period of ischemia examined. In aorta, ATP depleted 
faster than in skeletal muscle but more slowly than in the heart and intestine. 
The four tissues varied significantly in their degradation rate and catabolic 
products when subjected to ischemia as illustrated in Fig. 7-3. In the heart which 
continued to beat for about 2 min, ATP dropped substantially immediately after 
ischemia and was almost depleted within 30 mm. This was accompanied by a marked 
accumulation of AMP whilst ADP increased temporarily followed by a prolonged 
decline. When ischemia lasted to 60 min LAD fell to 43% of the preischemic value. 
Surprisingly, ATP depleted more quickly in the small intestine (where the 
auto-peristalsis was not controlled) than in the heart. About 80% ATP was 
hydrolysed after 5 min of ischemia whilst 40% ATP disappeared in the heart at the' 
same time. Concomitant with the changes in ATP content, AMP also differed 
considerably with a greater and quicker accumulation in the intestine, although the 
profiles of ADP and EAD appeared similar to those of the heart. 
7.3.4 CrP/Cr ratio and EC 
When CrP degraded, Cr was formed, leading to a larger change in CrP/Cr 
ratio than either CrP or Cr alone. After 5 min of ischemia, for example, CrP in skeletal 
muscle decreased by 18% (P>0.05, Fig.7-2), but the CrP/Cr ratio decreased 26% 
(P<0.05, Fig.7-4A). Calculated EC for the different muscle tissues (Fig.7-4B) 
together with the actual data (displayed in Fig. 7-3) indicated that the depletion rates 
of adenine nucleotides ranged in the order: intestine>heart>aorta>skeletal muscle (at 
rest). When compared to EC, the ratio of CrP/Cr altered earlier in each of tissues 
(Fig.7-4), especially in skeletal muscle. For instance, CrP/Cr ratio fell significantly 
(P<0.05) after 5 mm of ischemia in skeletal muscle whereas none of the measured 
HEC metabolites showed a statistical difference from the initial levels. EC did not 
change appreciably in skeletal muscle until after 60 min of ischemia. 
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Fig. 7-4 Comparison between CrP/Cr ratio and EC in different muscle tissues 
during ischemia. Panel A shows CrP/Cr ratio; panel B shows EC. 0: skeletal muscle 
(n=4-5), • : heart (n=4-6); 0: intestine (n=4-6) and M: aorta (n=4-5). Data are shown 
as means ± SE. The actual values were shown in Figs. 7-2 and 7-3. 
7.3.5 Changes in lactate and glycerol during ischemia 
Under in vivo aerobic conditions, lactate levels in striated muscles (9.31 ± 
0.89 and 6.20 ± 0.83 iznol/g dry weight for skeletal muscle and heart, respectively) 
were about half of those in the smooth muscles, being 19.74 ± 2.15 and 16.90 ± 1.97 
ilmol/g dry weight for intestine and aorta, respectively, (Table 7-1). After ischemia, 
lactate accumulated at a wide diversity of rates (Fig.7-5A). In the intestine, lactate 
rose at the fastest rate among all the tissue tissues with 75% of the maximum 
occurring at 5 min of ischemia and reached the plateau (69.6 ilmol/g dry weight, 3.5 
times of the basal) between 10 to 30 min. Similarly, lactate also increased quickly and 
to a larger magnitude in the heart with an almost 15-fold increase over the basal at 5 
mm (55% of the maximum), and reached a plateau around 30 min with a value of 175 
molig dry weight, 28 times that of the nonischemic control. 
In skeletal muscle, lactate increased to a large magnitude but at rather a slow 
rate. At 60 mm of ischemia, it amounted to 97.3 grnol/g dry weight and the plateau of 
around 210 mol/g dry weight (23 times of the basal) occurred at 120 mm (Fig.7- 
8A), at which 95% ATP has been consumed (Fig.7-7A). In aorta, lactate accumulated 
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at a rather quick rate but to a lesser magnitude than the other three muscles 
mentioned above. Its maximal values amounted to about 30 tunoVg dry weight at 30 
min, no more than twice the initial level. 
Fig.7-5B shows the scenario of glycerol, known as a catabolic product of 
triglycetide, in the time course of ischemia. It seemed to transiently decrease a little in 
all tissues followed by a slow and prolonged rebound without reaching a maximum 
within the period observed. After 60 mm of ischemia, glycerol amounted to 2.5 and 
3.0 timolig dry weight for the heart and intestine, respectively. Within this period, 
glycerol did not seem to change markedly in either skeletal muscle or aorta (P>0.05) 
but prolonged ischemia eventually resulted in significant buildup in glycerol in the 
skeletal muscle (P<0.05 in Fig. 7-8B). 
Fig. 7-5 Changes in lactate and glycerol of different muscle tissues during 
ischemia. Panel A: lactate; panel B: glycerol. 0: skeletal muscle (n=4-5), •: heart 
(n=4-6); 0: intestine (n=4-6) and •: aorta (n=4-5). Data are means ± SE. 
7.3.6 Effect of temperature on skeletal muscle metabolites during ischemia 
Fig.7-6 illustrates the effect of temperature on creatine compounds in skeletal 
muscle during ischemia. Lowering temperature to 25°C led to a marked delay for the 
catabolism of CrP after 60 min of ischemia. The protective effect of lowering 
temperature on adenine nucleotides was even more evident at 2 hours of ischemia 
300 
0 
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(Fig.7-6). The accumulation of lactate and glycerol were also delayed at 25°C (Fig.7- 
7). However these delays at 25°C were no longer sustained at 5 hours of ischemia, 
except for glycerol. But the time at which 50% IIEC depletion occurred could not be 
determined owing to the relative longer intervals set in the time course. It appeared 
that at least twice as long time was needed to reach the same degree of alteration. 
Clearly, each change observed at 37°C appeared similarly at 25°C only at a slower 
rate. 
Throughout the period of ATP depletion, no substantial increment in AMP 
or adenosine was observed in skeletal muscle at either temperature. Associated with 
the degradation was a rise in inosine at 2 hours of ischemia and thereafter (37°C). The 
value of inosine (3.65 ± 0.2 lamolig dry wt. at normal, n=5) started to increase after 1 
hour of ischemia (4.95 ± 0.66 p.molig thy wt., n=5, P<0.05) and attained plateau at 2 
hour of ischemia (23.47 ± 1.70 imnolig dry wt., n=4). 
0 
	
2 	3 	4 	5 
lschemia time (hour) 
Fig. 7-6 Effect of temperature on the breakdown kinetics of CrP of skeletal 
muscle during ischemia. •: Cr at 37°C, 0: Cr at 25°C, CrP at 37°C, and 0 CrP 
at 25°C. Data are means ± SE, n=4-6. 
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Isohemia time (hour) 
Fig. 7-7 Effect of temperature on the breakdown of adenine nucleotides of 
skeletal muscle during ischemia. Panel A: 37°C, and Panel B: 25°C. •: total 
adenine nucleotides, 0: ATP; •: ADP; 0: AMP. Data are means ± SE, n=4-5. 
Isohemic time (hour) 
Fig. 7-8 Effect of temperature on the accumulation of lactate and glycerol of 
skeletal muscle during ischemia. •: 37°C, and 0: 25°C. Data are means ± SE, 
n=4-6. 
Table 7-2 Skeletal muscle metabolites in different V0 2 status 
n Lactate Cr CrP Cr+CrP 	AMP ADP ATP EAD EC Cr13/Cr CrWATP 
vtmag dry wt 
In vivo 5 9.3 111.6 119.3 230.9 0.23 2.69 28.2 31.10 0.95 1.07 4.24 
±0.9 7.6 9.2 ± 16.7 ±0.03 ±0.21 ± 1.1 ± 1.34 ±0.01 ±0.02 ±0.30 
Ischemia 4 73.3** 199.1** 49.8** 248.9 0.15 4.69** 27.8 31.62 0.92 0.25** 1.79** 
(60 min) ± 16.6 8.9 ± 11.6 ± 13.4 ±0.03 ±0.30 ±0.6 ±0.94 ±0.01 ±0.06 ±0.40 
V02 max. 4 3.1** 98.2 148.0* 246.0 0.21 2.97 30.4 33.6 0.95 1.51** 4.85 
(20 min) ±0.4 3.2 ±6.4 ±8.5 ±0.02 ±0.27 ± 1.03 ± 1.15 ±0.01 ±0.08 ±0.11 
Both ischemia and maximal V02 were performed at 25°C. The maximal V02 was achieved by perfusing the hindlimb at 18.5 ml/min plus 50 nM NE. 
EC: energy charge. SAD: sum of adenine nucleotides. Dta are presented as mean ± SE. P>0.05, ** P<0.01, vs in vivo. 
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7.3.7 Skeletal muscle metabolites during ischemia and hyperoxemia 
This experiment was designed to assess the relationship between muscle 
thermogenesis and bioenergetic changes at rest. Data from 60 min ischernia at 25°C 
(no V02) were compared with those from the muscle in the perfused hindlimb at the 
same temperature where V02 was maximised, by a high flow plus NE, to 27.6 ± 1.2 
umo1s-1 1-1 . After 60 min of ischemia, CrP dropped nearly 60 % with substantial 
accumulations in Cr, lactate and ADP (Table 7-2). However, AMP, ATP and EAD 
still remained at preischemic levels and EC was unaltered. For the muscle perfused at 
high flow plus NE, CrP elevated by approximately 24% above the value in vivo and 
was associated with a dramatic decrease in lactate. Cr tended to decline, hence leading 
to a significant increase in CrP/Cr ratio (P<0.01). As yet, none of the adenine 
nucleotides were significantly different from the in vivo values although ATP tended 
to slightly increase (Table 7-2). 
7.4 Discussion 
Creatine compounds and adenine nucleotides were simultaneously 
determined by HPLC in this experiment to compare the degradation features of HEC 
in four different muscle tissues. Lactate and glycerol were enzymatically measured to 
assess potential de novo synthesis of the energy compounds from glycolysis and 
lipolysis of triacylglycerol. In the heart and intestine, ATP immediately falls when 
blood flow to the tissues reduces (Zager, 1991; Canada et al., 1993; Matherne et al., 
1993; ). Since metabolites such as HEC (high energy phosphate compounds) and 
lactate are extremely sensitive to ischemia in the heart, this tissue was used as a 
positive control for other muscle tissues. 
The results obtained from the normal tissues (Table 7-1) were comparable 
with reports for skeletal muscle of rats (Kushmerick et aL, 1992), rabbit (Pagliassotti 
& Donovan, 1990a), and dogs (Harris et al., 1986) as well as human skeletal muscle 
taken by percutaneous needle biopsy technique (Harris & Hultman, 1992), for the rat 
heart (Shellevold et al. 1986; Janier et al., 1993), and small intestine (Zager, 1991). 
The concents of HEC in the four tissues of muscles were in an order as follows: 
skeletal muscle>heart>intestine>aorta. Apart from aorta, which has been previously 
found to contain a lower level of ATP (Paul, 1980; Clark et aL, 1990), all other 
tissues showed a sound HEC profile with EC at 0.9 or above, suggesting that a 
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satisfactory sampling of heart, skeletal muscle and intestine has been achieved. The 
relative low ATP and CrP in aorta may result from the unavoidable time delay during 
sampling, but are comparable with the reports by blood vessels by Paul (1980). 
The value of skeletal muscle CrP was higher than that previously measured 
with enzymatic methods (Colquhoun et cd., 1990; Chapter 3). There are apparently 
two reasons for this difference. Firstly, the methods employed were different. The 
procedures for the enzymatic assay of CrP usually took a longer time to complete and 
no recovery was used to correct the value. As the standard CrP in HC104 solution 
was found to decline approximately 10% in an hour (see Method), a longer procedure 
would be expected to result in a lower value. If no corrections for the time lapse had 
been applied, the value of CrP would be about 90 1.1molig dry wt. Secondly, the 
sampling procedure was improved by freeze-clamping in situ whereas the muscle was 
clamped after removal from the body in previous experiments (Chapter 3). As shown 
in Fig. 7-2A, CrP immediately decreased as a result of ischemia. 
CrP immediately started to convert to Cr following the onset of ischemia in 
each tissue examined even though there were no significant changes in adenine 
nucleotides and lactate in some muscle tissues like skeletal muscle and aorta (Figs.7-2 
& 7-3). In the heart and intestine, the fall in CrP was immediately followed by a drop 
in ATP and a rise in lactate (P<0.05 at 5 min) whereas in skeletal muscle and aorta, 
levels of adenine nucleotides fell more slowly. In skeletal muscle and aorta, neither 
ATP nor lactate were significantly different from the normal values after 5 min of 
ischemia (P>0.05). ATP was stable in skeletal muscle for at least 30 min following 
ischetnia (Fig. 7-3A, P>0.05). Thus creatine compounds are more valuable measures 
to assess early ischemia in the tissues, as opposed to other HEC which are relatively 
imprecise measures of hypoxia in skeletal muscle and blood vessels. In heart and 
intestine all of the high energy metabolites and lactate are indicative of ischetnia. 
Among the normal muscle tissues, skeletal muscle contains highest levels of 
creatine compounds and ATP (Table 7-1) but the lowest basal metabolic rate (Paul, 
1980; Chapter 4). Moreover, this high level of ATP is well conserved in a large 
diversity of metabolic conditions. An unchanged ATP content of skeletal muscle was 
found by 31P nuclear magnetic (NMR) spectroscopy during 2 min electric stimulation 
following 6 min of ischemia even though more than 40 % of CrP was depleted (Blei et 
cd., 1993). In the present study, skeletal muscle showed a unique dynamic catabolism 
of adenine nucleotides. ATP dropped by only 14% from the initial level following the 
first hour of ischemia. This agrees with the observation in canine gracilis muscle, 
where ATP did not statistically change after 60 min of ischemia (Harris et al., 1986), 
and in the rat hindlimb adductor muscle, where ATP levels were unaltered even after 
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90 min of abdominal aorta clamping (Yoshioka et al., 1992). Unlike that in other 
tissues, AMP did not increase significantly during the degradation of ATP throughout 
the period (Fig. 7-3A and 7-7A) observed. In parallel with the fall in ATP there was a 
substantial accumulation of inosine. These results are consistent with the data from 
Terjung's group (Arabadjis et al., 1993) who showed that once AMP is formed in 
skeletal muscle it will almost exclusively be deaminated into IMP rather than be 
dephosphorylated to adenosine. In contrast to the heart and intestine where ATP is 
almost entirely depleted after 1 hour of ischemia, ATP still remained at 86% and 52% 
of the pre-ischemic level even in skeletal muscle and aorta, respectively. 
Deamination rather than hydrolysis of adenine nucleotides of skeletal muscle 
may imply a physiological significance. For example, adenosine is a potent vasodilator 
which modulates local vascular function to meet the 02 demand in most tissues. When 
coronary blood flow decreases, adenosine will rise as a result of adenine nucleotide 
breakdown. The increased adenosine will then act as a local metabolic factor to dilate 
the blood vessel to increase the coronary flow so that the heart will receive more 02 
and nutrient (Schrader & Deussen, 1988). In addition, recent studies have provided 
strong evidence that adenosine possesses protective effect on heart during ischemia by 
acting on its specific receptor (Janier et al., 1993). However, the vasodilatory effect 
of adenosine as a local metabolic control of microcirculation in skeletal muscle is still 
doubtful (Mohrman, 1991). Adenosine is rarely seen in the effluent from the perfused 
rat hindlimb during ATP-induced release of adenine nucleotide downstream products 
(Richards et al., 1993). These data together with the present results suggest that 
adenosine is unlikely to play an important role as a local metabolite to control blood 
flow in skeletal muscle vascular bed. So far, no report has been found in the literature 
which shows metabolites, such as IMP and inosine, from the deamination of adenine 
nucleotides have similar properties in skeletal muscle to those of adenosine in the 
heart. If the deaminated metabolites have vasoactive action or direct effect on skeletal 
muscle metabolism, they may influence muscle thermogenesis. 
The relatively stable ATP content in the skeletal muscle during hypoxia may 
be attributable to its lower resting metabolic rate, stronger buffer by a high storage of 
CrP (the CrP/ATP ratio is 4.24 ± 0.30; Table 1), and lasting compensation from de 
novo synthesis via glycolysis as indicated by the large amount of lactate accumulation 
(Fig 7-5A and 7-8A). This argument was supported by the data in Fig 7-6 and 7-7A at 
60 min interval that shows ATP level depleted quickly soon after the CrP/ATP fell to 
approximately 1.2 (as seen in normal heart and intestine, and diminished when 
glycolysis was exhausted at 120 min (indicated by the plateau of lactate accumulation 
in Fig 7-8A). The slower depletion of HEC and lower energy demand provide skeletal 
muscle with biochemical mechanisms for better tolerance to ischemia. 
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As expected, in the development of ischemia, lactate accumulated (Fig.7- 
5A), reflecting the capacity of glycolysis to generate HEC de novo. The accumulation 
of lactate amounted to a much higher level (20-30 fold of the basal) in the striated 
muscle tissues than in the smooth muscle tissues (2-3 fold of their basal) although 
lactate levels in the intestine and aorta were both similarly twice as high as those of 
the heart and skeletal muscle under non-ischemic conditions. The actual accumulation 
level of lactate in the plateau (ie. after 60 min of ischemia) was 4-7 times as high in 
the striated muscles as in the smooth muscle tissues (Fig. 7-5A). The maximal lactate 
in the present study is similar to the report (175 Amolig dry wt) by Harris (1986) in 
ischemic skeletal muscle. In general, the accumulation of lactate paralleled well with 
the depletion of ATP and changed earlier in skeletal muscle and aorta. Indeed, after 5 
min of ischemia, skeletal muscle lactate increased by 48% above the basal but did not 
reach statistical difference because of bigger standard deviation (P>0.05). 
It is interesting to note that glycerol also gradually accumulated at a slow 
rate in the tissues during the period of ischemia after a transient decrease or unaltered 
period (Fig.7-5B). The transient decrease or unaltered glycerol might be due to the 
oxidation of this metabolite by the residual myoglobin-bound 02 in the tissues through 
tricarboxylic acid cycle in mitochondria before new glycerol is formed. Similarly, an 
increase in glycerol release was shown in canine gracilis during reperfusion following 
two hours of ischemia (Harris et al., 1986). So far, the mechanism for increased 
glycerol has not been fully understood. In the heart, hypoxia is thought to stimulate 
the release of endogenous catecholamines which increase glycerol production by 
activating lipolysis (Karwatowska-Krynska & Beresewiez, 1983). However, neither 
-adrenergic antagonist nor pretreatment with 6-hydroxydopamine failed to completely 
inhibit hypoxia-stimulated glycerol production (Wardle & Riemersma, 1994). In the 
perfused rat hindlimb, infusion of lactate significantly increased glycerol release (Chin 
et al., 1991). Furthermore, the vasoconstrictor-altered glycerol parallels the changes 
in lactate release (Clark et al., 1994; Chapter 4). It is possible that the increased 
glycerol results from the enormous accumulation of lactate in ischemic tissues. This 
explanation is consistent with the evidence that an increase in glycerol is dependent on 
an intermediate of glycolysis, such as glycerol-3-phosphate, in the ischetnic or hypmdc 
rat heart (Trach et al., 1986 and Wardle & Riemersma, 1994). In addition, 
phospholipid breakdown may also contribute to the increase in glycerol after a long 
period of ischemia. 
Surprisingly, the bioenergetic kinetics changed faster in the intestine than in 
the heart. It would a priori appear more reasonable to expect a reverse result based 
upon the their basal metabolic rates. Comparison of the lactate time course during 
ischemia revealed a great distinction between these two tissues. Lactate accumulated 
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very quickly in both tissues, but it reached the plateau earlier in the intestine than in 
the heart (Fig.7-5A). In addition, the maximal value was four times as much in the 
heart as in the intestine, suggesting a greater compensation for HEC by de novo 
synthesis through glycolysis in the heart during ischemia. In contrast to the skeletal 
muscle, ADP and AMP, in particular, elevated enormously in the heart and intestine 
when ATP declined. 
The results in Table 7-1 show that aorta possessed the lowest concentrations 
of CrP, ADP and ATP, consistent with our earlier findings that shows lower 
concentration of ATP but higher UTP in the rat blood vessel (Clark et al., 1990). 
These data suggest that blood vessels have very little energy buffer and are more 
reliant on an external nutrient supply. When subjected to ischemia, HEC, lactate and 
glycerol staged a rather smooth and gradual change at a rate between intestine and 
skeletal muscle. However, it should be borne in mind that the aorta was relieved from 
blood pressure stretch in the present ischemic model, whereas the heart and intestine 
were still working under the control of autorhythmic system. 
Temperature has an important influence on metabolic rate and a Q 10= 2.5 
has been widely used to estimate metabolic rate from those obtained at various 
temperatures (Schmidt-Nielsen, 1974; Bonen etal., 1994). The results from Figs. 7-6, 
7-7 & 7-8 show that HEC were depleted much slower at 25°C than at 37°C. The 
measured metabolites differed significantly after 2 hours of ischemia but not within the 
first hour: This is probably because these metabolites, especially CrP declined at a 
faster rate in the earlier stage of ischemia (Harris et al., 1986) when the rat 
temperature had not cooled down. Nonetheless, these results indicate that at least 
twice as long a time is needed to degrade HEC at 25°C as at 37°C. 
In terms of the mechanism of vasoconstrictor-induced muscle thermogenesis, 
the present experiment confirms the previous argument that the vasoconstrictors-
mediated increase in V02 in the perfused hindlimb and other tissues does not result 
from attenuating ischemia or hypoxia (Chapter 3). If there was hypoxia or ischernia in 
a perfused preparation a marked drop in CrP or rise in Cr would be expected. As to 
vascular oxygen consumption, the energetic metabolites seem to change rapidly in the 
early stage of ischemia and then subsequently maintained a rather slow rate of 
degradation (Figs. 7-2, 7-3, 7-4). In aorta, The poor energy charge of adenine 
nucleotides (due to the delay in sampling; Table 7-1) and earlier plateau in lactate 
accumulation (Fig. 7-5C) suggest that the energetic turnover of blood vessels is 
higher than that of skeletal muscle in resting conditions and could be expected to be 
even higher when stimulated. 
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Although the present experiment did not show direct evidence for the 
hypothesized oxidative phosphorylation uncoupling as the possible mechanism of 
skeletal muscle thermogenesis, it provides relevant information for further 
investigating the mechanism. Firstly, degradation kinetics of adenine nucleotides in the 
skeletal muscle behaves very differently from those in BAT reported by this laboratory 
(Matthias et al., 1994) where ATP depletes very quickly associated with dramatic 
rises in both ADP and AMP. Therefore, if there is an uncoupling process induced by 
vasoconstrictors in skeletal muscle, the control mechanism might also differ from that 
in BAT. Secondly, in searching for the uncoupling or recoupling regulators, there 
should be certain criteria: (1) the candidate messenger should be able to either start or 
stop the reactions directly related to the uncoupling process; (2) the candidate 
messenger should exist in skeletal muscle; (3) it should increase or decrease to reflect 
the thermogenic status of the tissue in order to switch on or off the uncoupling 
process. Neither ATP nor AMP fits in the third criterion. Other metabolites, such as 
CrP, Cr, ADP or lactate, may have a role to play in regulating muscle thermogenesis 
because they are the inherent compounds on the metabolic pathway and responded to 
muscle energetic status (Table 7-2). This argument is supported by the data in Table 
3-2 (Chapter 3) which show that lactate/pyruvate ratio decreases whilst CrP tends to 
increase when NE stimulates V02 in the constant-flow perfused hindlimb. 
Above all, the tolerance of resting skeletal muscle to ischemia seems to 
suggest that its energy demand could be strongly compensated for by the large 
amount of HEC or switched into a partial arrest state when blood flow to the tissue is 
restricted. On the other hand, skeletal muscle metabolic rate can be accelerated far 
beyond its basal demand by increasing perfusion flow or type A vasoconstrictors 
(Clark et al., 1994; Chapters 3, 4 & 6) to generate heat. Skeletal muscle 
thermogenesis is somewhat independent of its energy charge, which normally exerts 
strong controls of the metabolic rate (Atkinson, 1968). Skeletal muscle is the largest 
tissue in the body, yet it contains the highest level of HEC. The tolerance to ischemia 
suggests that the energy demand of this tissue at rest is very low. Thus most of the 
increased V02 by vasoconstrictors or/and flow rate (as shown in Chapters 3, 4 & 6) 
could be expected to contribute to NST. The degradation profiles of aorta, such as 
quickly declined energy charge and earlier plateau of lactate and CrP/CR ratio, 
suggest that blood vessel it is an energetically active tissue with a quick turnover rate 
of metabolites even under unstretched conditions. It can be anticipated that more 
muscular vessels such as smaller arteries will be more energy consuming at rest and 
even more so when stimulated. 
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Chapter 8 
Effect of adrenergic agents on whole body thermogenesis of intact 
bettongs 
8.1 Introduction 
Vasoconstrictors have been shown to mediate control of V0 2 in perfused 
hindlimbs of rats, bettongs and toads (Chapters 3, 4 & 6). Such a control also takes 
place in other perfiised tissues such as the rat kidney, intestine (Chapter 5). These data 
suggest that the vasoconstrictor-mediated control of V0 2 may play an important role 
in regulating whole body thermogenesis. 
In the literature, sympathetic hormones have been shown to stimulate 
thermogenesis in humans (Lundholm & Svedymr, 1965; Astrup et al., 1985; Blank et 
al., 1993), rodents (Foster & Frydman, 1978), rabbits (Szreder, 1991), bats (Hayward 
& Ball, 1968), and marsupials such as the potoroo, (Nicol, 1978). However, the 
increased thermogenesis has been attributed to either BAT (Flaim et al., 1977; Foster, 
1984, Rothwell, 1990), or to skeletal muscle and mediated by 13-adrenergic receptors 
(Astrup et al., 1984; 1985; 1989; Thurlby & Ellis, 1986; Blaak et al., 1993). 
Although Loudon et al. (1985) reported the presence of BAT in the 
pouched-young wallaby (Macropus rufogriseus), most studies indicate that 
marsupials (including the bettong) do not have histological BAT (Nicol, 1978; 
Hayward & Lisson, 1992). In addition, attempts to detect thermogenin (UCP) inRNA 
in this species have been unsuccessful (Hayward & Lisson, 1992). Thus, the potential 
lack of BAT makes the bettong a valuable animal model to study whole body 
thermogenesis derived from other tissues. 
In the constant-flow perfused bettong hindlimb (Chapter 4), NE can mediate 
V02 via a-receptors, similar to that in the constant-flow perffised rat hindlimb 
(Colquhoun et al., 1988; 1990). Moreover, in the constant-pressure perfused 
hindlimb, both a- and 0 adrenergic receptors mediate V02 . In order to further assess 
vascular-mediated control of thermogenesis in vivo and the mechanism involved, this 
chapter examined the effect of NE on the metabolic rate in the conscious bettong. 
Both a- and 13- adrenergic agonists were used to identify the adrenergic receptors 
involved. Comparisons were made with the rat to estimate muscle contribution to 
whole body thermogenesis. 
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8.2 Methods 
A limited number of bettongs (body weight: 1.67 ± 0.10 kg) were obtained 
from the University's breeding colony by kind permission of Dr. R.W. Rose, 
Department of Zoology, University of Tasmania. Whole body heat production was 
calculated from 02 uptake (V02) measured at 25°C under conscious conditions by an 
indirect calorimeter according to the method of Weir (1949). This temperature is 
within the thermoneutral zone for both marsupials (Nicol, 1976, Wallis et al., 1992) 
and the rat (Foster & Frydman, 1979, Maxwell etal., 1987). Drugs were freshly made 
in sterile 0.9 NaCl solution. For the administration of drugs to the bettong, a venous 
indwelling cannula (I.D. 0.8 x 25 mm) was inserted into the tail vein with 0.9% NaC1 
solution continuously infused by a pump (LKB, Bronuna) at a flow rate of 0.02 ml.kg -
1 .min-1 . Usually, animals had settled down within 15 min, but 30 min was allowed to 
elapse before collecting data. The details of the methods were described in Chapter 2 
(Sections 2.1 & 2.4). 
For the calculation of heat production from V0 2 , the standard average (4.83) 
of energy (kcal) from mixed food per liter V02 (4.83 kcal=1 liter V02, Brown & 
Grengelmann, 1965) was used. Thus: 
	
1 k.I.kg-l.darl = 	1,000 02 	V02 ml.kg-1 .min-1 
4.184 x 4.83 x 24 
= 	0.0344 V02 ml-kg-1 .min-1 
= 	0.092 V02 1.unol.g-1 .11-1 
8.3 Results 
8.3.1 Resting metabolic rate for the conscious rat and bettong 
Under the resting state, the measured metabolic rates were 249 ± 21 kJ.kg -
1 .day-1 and 566 ± 39 kikg- l-day-1 for bettongs (n=7) and rats (n=14), respectively. 
These values are comparable with the data reported in literature for the same or 
similar species (see Table 1). The calculated results in lakg -0 . 75 .day-1 show that the 
resting metabolic rate of the marsupial (bettong) was lower than eutherian mammals 
(as shown in Table 8-1). 
Table 8-1 Comparison of the resting metabolic rates of the bettong and rat with the values reported for relevant species 
Author Species Body weight VO, Heat production 
(0.kg4 .day4) 
Heat production 
(k.T.kg-0 . 75 -day4) 
Marsupials 
Present study Bettong 1.7 ± 0.10 kg 8.6 ± 0.7 249 ± 21 285 ± 21 
Wallis etal., 1992 Bettong 1.1 ± 0.03 kg 9.6 279 283 
Wallis etal., 1992 Potoroo 1.0 ± 0.03 kg 8.4 245 241 
Wallis etal., 1992 Aepyprymn 3.0 ± 0.16 kg 7.1 205 270 
Nicol, 1976 Potoroo -.1.12 	kg 7.5 ± 1.2 218 ± 34 224 ± 35 
Dawson et al, 1982 Kowari 115 ± 12.0 g 10.8 ± 1.0 313 ± 29 184 ± 15 
Eutherians 
Present study Rat 250± 10.2 g 19.0± 1.3 566 ± 39 400 ± 28 
Dawson eta!, 1982 Mouse 79.8 ± 6.9 	g 17.5 ± 8.3 509 ± 24 296 ± 29 
Foster et aL, 1979 Rat -.370 	g 16.5 ± 0.2 480 ± 6.0 374 ± 4.6 
Maxwell et aL, 1987 Rat -110 	g 26.4 ± 4.2 769± 122 443 ±70 
Gonzalez etal., 1971 Rabbit 2 - 4 	kg 9.2 - 9.5 269 - 277 353 - 365 
Liard, 1989 Dog 20 ± 0.9 kg 6.4 ± 0.7 186± 20 394 ± 40 
Data are presented as mean ± SE. 
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8.3.2 Effects of adrenergic agonists 
The resting metabolic rate of the conscious bettong was generally steady and 
intravenous infusion of 0.9% NaC1 did not cause any marked change (Table 8-2). The 
infusion of norepinephrine (NE) stimulated heat production markedly (Fig. 8-1, top). 
The response was rapid in onset and was sustained for 30-60 min after termination of 
the infusion. Administration of isoproterenol elicited a prolonged response in 
thermogenesis that was usually sustained longer after the removal of infusion (Fig. 8- 
1, middle). More interestingly, phenylephrine (a radrenergic agonist) also elicited 
significant heat production (Fig. 8-1, bottom). 
The dose range for intravenous infusion of NE or phenylephrine to stimulate 
metabolic rates of the conscious bettong were between 10-80 gglg -1 -min-1 (Fig. 8- 
2). Beyond 80 lig.kg-1 .min-1 , some bettongs became unsettled. At the same doses, 
NE-mediated increase in thermogenesis appeared to be bigger than that produced by 
phenylephrine but the difference was not statistically significant within the number of 
bettongs tested. The peak values of heat production in response to the stimulation of 
NE and phenylephrine reached 49 ± 15%, and 32 ± 7% above the resting basal value, 
respectively (shown in Table 8-2). 
Table 8-2 Maximal metabolic rates timulated by adrenergic agonists on the 
bettong 
Basal (n=7) 	NS (n=7) 	NE (n=2) 	Iso. (n=3) 	Phenyl. (n=4) 
249 ± 21 	252 ± 5.6 	373 + 574 	355 ± 39** 	342 ± 26** 
48± 15%1' 	42± 15%t 	32± 6%1' 
The drugs were infused intravenously at a rate of 80 ug-kg -1 .min-1 . 0.9% NaC1 (NS) was infused as 
the control vehicle at a similar flow rate of 0.02 ml.kr4 .min4 . Phenyl: phenylephrine, Iso: 
isoproterenol. Metabolic rate is expressed as k.1.1cg -1 .day4 . Increment percentage is also shown. 
Data are mean ± SE. # P<0.1; ** P<0.01 vs 0.9% NaC1 infusion, paired t-test. 
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Fig. 8-1 Representative tracings for the of NE, isoproterenol and phenylephrine 
on heat production of intact bettongs. Each dot was the average value for 3 
minute. The drugs were infused via an indwelling catheter in the tail vein. Iso: 
isoproterenol, Phenyl: phenylephrine. 80: the infusion rate of agonists 
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Fig. 8-2 Dose-response curves for the effect of NE and phenylephrine on heat 
production of intact bettongs. Data are means ± SE, n=2-4 for NE, n=3-4 for 
phenylephrine (Phenyl). * P<0.05; **P<0.01, paired t test. 
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Fig. 8-3 Effect of phenylephrine on bettong heat production in the presence of 
propranolol. Phenyl (phenylephrine, 40 p.g.kg -1 .min-1), Prop (propranolol, 20 gg.kg-
1 .min-1) were infused from the tail vein. ** P<0.01, P<0.1; paired t test, vs the 
control (0.9% NaC1). 
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8.3.3 Effects of adrenergic antagonists 
Fig. 8-3 shows the effect of propranolol, a I3-adrenergic antagonist, on the 
bettong heat production mediated by phenylephrine. The infusion of propranolol did 
not block phenylephrine-induced heat production. The a-adrenergic stimulation of 
heat production was also observed during the administration of naphazoline, an a 1,2- 
adrenergic agonist (Foster, 1984). In contrast, the heat production mediated by either 
naphazoline or phenylephrine was significantly inhibited by the a 1,2-adrenergic 
antagonist, phentolamine (Fig. 8-4). 
0 
	
1 
	
2 
	
3 
Time (hour) 
Fig. 8-4 Effect of naphazoline on bettong heat production and inhibition of 
phentolamine on the action of naphazoline and phenylephrine. Phenyl: 
phenylephrine. The numbers in the bars represent the infusion rate of drugs (.1g-kg-
L inin-1 , n=1) 
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8.4 Discussion 
Marsupials are capable of maintaining a stable body temperature in variable 
field temperatures. They have a thermoneutral zone around 20-25°C (Nicol, 1976). 
When exposed to the cold, the maximal heat production of marsupials can match or 
exceed that of the rodents of a similar size, although the resting metabolic rate of 
marsupials is lower (Dawson & Dawson, 1982). Careful histological analyses suggest 
that marsupials including the bettong are devoid of BAT (Hayward & Lisson, 1992). 
Molecular biology studies have not identified the expression of UCP in the bettong 
(Hayward & Lisson, 1992). An intensive search for UCP mRNA in bettong adipose 
tissues from the interscapular, periaortic, pericardial, pen-renal, and intestinal as well 
as from brain, heart, liver, kidney, intestine, and testis was unable to identify the 
existence of BAT in this species (Trayhum, personal communication, 1994). It is 
obvious that other tissues must be responsible for the increased thermogenesis, and 
compensate for the contribution made by BAT in eutherian mammals. 
The resting metabolic rates of 566 kJ.kg- l-darl for the rat and 249 kJ.kg -
1 - day-1 for the bettong were similar to the reports in the literature for the same or 
similar species (Table 8-1). A direct comparison in the unit of kJ.kg -1 -clay-1 shows 
that the resting metabolic rate of the bettong was only 44% that of the rat. When 
taking into account the body sizes by converting the unit into k.I-kg -°.75 .day-1 as 
recommended by International Union of Physiological Sciences (Bligh & Johnson, 
1973), the bettong resting metabolic rate was 285 kJ.kg -°.75 -clay-1 , approximately 
70% of the rat (400 kIkg -0 . 75 .day4 ). These results indicate that the resting metabolic 
rate of marsupial bettongs is also lower than most of the reports in literature for other 
eutherian mammals of a similar or bigger size, such as the rabbit (Gonzalez et al, 
1979) and dog (Liard, 1989). These results are consistent with the earlier 
observations in dasyurid marsupials by Dawson & Dawson (1982) who found that the 
basal metabolic rate of small marsupials is lower than that of rodents of similar size. 
It has been noted that the body temperature of marsupials is on average 1-2 ° 
C lower than eutherians (Schmidt-Nielsen, 1975; Hales & Rose, 1988). The lower 
metabolic rate, the lower body temperature and relatively lower muscle V02 
(compared with rats, Chapter 4) would appear internally consistent for the bettong. 
Thus, a close correlation appears to exist between muscle V02 and whole body 
thermogenesis in this species. 
In the perfused bettong hindlimb at 25°C, the measured basal V02 was 4.2 11 
mol• -1 •h-1 (Chapter 4). Assuming that Q i0=2.5, this value would account for 14 pi 
134 
mol. g- 1 . at 37°C. In the red and grey kangaroos skeletal muscle accounts for 52% 
of body mass and is proportionally more than that in other mammals (Tribe & Peel 
1963). If this value (52% of the body mass as skeletal muscle) applies to the bettong 
and the muscle V02 obtained from the perfused hindlimb (Chapter 4) represents the 
value of the entire muscle on average, the total muscle V02 of the bettong would be 
equal to 12.2 nunol/h. This would account for 32% of the resting metabolic rate 
(whole body) of 249 kJ-kg -1 -day-1 (38 tnmol/h) in vivo. By a similar estimate, 6.4 11 
mols-1 •11-1 of rat skeletal muscle V02 at 25°C (Colquhoun et al., 1988 & 1990, 
Hettiarachchi et al., 1992) would be equal to 27.7 gmols -1 .114 at 37°C. This value 
would make up to 2.98 mmol/h of V0 2 for the whole body muscle provided that the 
muscle mass accounts for 43% body weight (Grubb & Folk, 1976). Thus 2.98 mmol/h 
of the whole body muscle V02 would account for 23% of the whole rat resting 
metabolic rate of 566 kJ-kg -1 .day-1 (13 mmol/h) in vivo. Such a comparison suggests 
that skeletal muscle contributes more to the resting metabolic rate in the bettong than 
in the rat. 
However, it should be pointed out that this estimate from the muscle V02 in 
vitro is likely to discount the actual totality of muscle contribution to whole body 
thermogenesis in vivo. For instance, the circulating catecholamines and possibly other 
thermogenic hormones, such as thyroid hormones and insulin can increase the muscle 
V02 in vivo even at rest. In addition, the respiratory movements and posture 
maintenance would not allow all the muscles in a fully relaxed state under conscious 
conditions. By contrast, the basal V02 by perfused muscle was obtained in an entirely 
relaxed state with no circulating hormones (Colquhoun et al., 1988 & 1990, 
Hettiarachchi et al., 1992; Chapter 4). Accordingly, the actual muscle V02 in vivo 
could be expected to account for a higher contribution of body metabolic rate than the 
calculated values above. Nonetheless the comparative estimates would be expected 
still to be valid under the same conditions for the bettong and the rat. 
In the red kangaroo, the blood flow to the muscle varies considerably in 
response to the environmental temperature. The distribution of cardiac output to 
skeletal muscle increased 5 times at 7-10°C compared to its distribution at 33-37°C 
(Needham & Dawson, 1984). An increase in blood flow to the muscle would not only 
enhance muscle thermogenesis (Chapter 3), but would also provide more oxygen and 
nutrients to meet the increased metabolic demand and improve heat transport to other 
parts of the body (Trayhurn, 1994). Thus, these observations together with the results 
in the present study seem to suggest that skeletal muscle is relatively more 
thermogenic in marsupials than eutherians. 
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In constant-flow perfused hindlimbs of the rat and bettong (Colquhoun et al., 
1990; Hettiarachchi et al., 1992; Chapter 4), NE-induced V02 is mediated by a-
adrenergic receptors. On the other hand, 0-adrenoceptors were also found to mediate 
V02 in the constant-pressure perfused rat hindlimb (Hardeveld et al., 1980; Chapter 
6). Consistent with the findings in the perfused hindlimb in earlier chapters (3, 4 & 6), 
both a- and 0-receptors were found to be responsible for NE-stimulated heat 
production in the intact bettong, as shown by the stimulation of thermogenesis by 
isoproterenol and phenylephrine (Figs 8-1, 8-2; Table 8-2). 
The effect of 13-receptors in the NE-mediated elevation in heat production in 
vivo has been well established in the rat and human (Rothwell et al., 1982; Astrup et 
al., 1986, 1989; Himms-Hagen, 1990; Blaak et al., 1993). 13-Adrenergic stimulation 
of whole body metabolism has also been found in marsupial (Nicol, 1978). In 
comparison, the effect of a-receptors on whole body thermogenesis has not been well 
defined and is still controversial. Flaim et al. (1977) found that both phenylephrine 
and isoproterenol depolarized brown adipocyte membrane potential and raised 
interscapular brown fat temperature in intact rats. Foster (1984) reported an auxiliary 
effect of a-adrenergic stimulation on the positive thermogenesis of the rat BAT in 
vivo by 13-adrenergic agonists. In unanaesthetized dogs an intravenous infusion of 
phenylephrine increases blood pressure associated with a significant rise in V0 2 
(Liard, 1989). Furthermore, a-adrenergic stimulation of whole body metabolism has 
strongly suggested by the evidence that phenylephrine is able to increase whole body 
thermogenesis in the rat (Rothwell, 1990). However, these investigators have 
attributed a-adrenergic mediation of whole body thermogenesis to BAT (Flaim et al. 
1977; Foster, 1984; Rothwell, 1990). Hence, direct evidence for a-adrenergic 
stimulation of skeletal muscle heat production in vivo is still ambiguous. 
Most studies in the human forearm have so far failed to show a conclusive 
effect of a-adrenoceptors on V0 2 (Astrup et al., 1989; Kurpad et al., 1994). In the 
marsupial potoroo Nicol (1978) reported that NE-stimulated thermogenesis was 
blocked by intramuscular injections of propranolol but not phenoxybenzamine. 
Consequently, a question arises: does the a-receptor-mediated increase in V0 2 
observed in the perfused hindlimb (and other perfused tissues such as the kidney) have 
an influence on whole body energy expenditure? 
The results in the present experiments (Figs. 8-1 & 8-2, Table 8-2) clearly 
demonstrate a marked increase in heat production in the conscious bettong during the 
intravenous infusion of phenylephrine (a radrenergic agonist). The maximal rise in 
heat production reached 32% above the basal value. The stimulation of a-adrenergic 
receptors in whole body thermogenesis is strongly supported by the data in Fig. 8-3 
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which shows that propranolol did not block phenylephrine-elicited heat production. 
Further support came from the fact that phenylephrine- or naphazoline- mediated 
increments in heat production were inhibited by phentolamine, a general a-adrenergic 
antagonist (Fig. 8-4). However, this latter observation needs to be repeated when the 
animal becomes available again. 
Since there is no detectable BAT in marsupials including the bettong (Nicol, 
1978; Hayward & Lisson, 1992, Trayhurn 1994 personal communication), the a-
adrenergic stimulation of whole body thermogenesis observed in the present study 
must derive from other tissues. In the perfined bettong hindlimb V02 is increased 
during the stimulation of a-adrenoceptors (Chapter 4), thus skeletal muscle is likely to 
be one of the major tissues accounting for the a-adrenergic-mediated increase in heat 
production in intact bettongs. 
The mechanism(s) for a-adrenergic agonists (and perhaps some other 
vasoconstrictors) on the heat production is still a matter of debate. Since a-adrenergic 
receptors are located predominantly on the vascular smooth muscle and responsible 
for NE-induced vasoconstriction (Martin et al., 1990), the present results in the intact 
bettong imply that whole body thermogenesis is closely linked to the functions of the 
vascular system in vivo, possibly analogous to the mechanism discussed for the 
perfused hindlimb (Chapters 3, 4, 5 & 6). In fact, the effect of vasoconstrictors on 
oxygen metabolism was found in the conscious dog in which intravenous infusion of 
phenylephrine and angiotensin II increased both V02 and arterial blood pressure 
(Liard, 1989). NE-mediated increases in metabolic rate and blood pressure are both 
blocked by either prazosin (a-adrenergic antagonist) or the vasodilator, NP, in rabbits 
(Szreder, 1993; Korolkiewicz etal., 1993). 
Overall, the present study suggests that not only 13-adrenergic receptors but 
also a-adrenergic receptors are responsible for NE-stimulated thermogenesis in the 
marsupial bettong. The a-adrenergic stimulation of whole body thermogenesis 
probably originates from skeletal muscle or mircovessels. Combined with the data 
from the perfused hindlimbs of the rat and the bettong (Chapters 3 & 4), calculated 
estimates are that the skeletal muscle contributes significantly more to the body 
metabolic rate in the marsupial than in the eutherian mammals. This might be an 
alternative thermogenic strategy to compensate for the lack of BAT in evolution. 
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CHAPTER 9 
Final discussion 
9.1 Approaches for the present study 
Vasoconstrictors such as norepinephrine, vasopressin, phenylephrine and 5-
Hi' together with vasodilators (ie. nitroprusside) were used to assess vasoconstrictor-
mediated control of V0 2 in different perfused tissues, especially in the hindlimb. In the 
constant-flow perfusions, observations were first made in the rat hindlimb followed by 
the hindlimb(s) of the bettong (an endotherm without BAT) and cane toad (an 
ectothermic animal). The experiments were then extended to kidney, intestine and 
mesenteric artery of rats. The effects of the vasoconstrictors on muscle thermogenesis 
were further evaluated in the constant-pressure perfused rat hindlimb. In addition, the 
degradation of high energy phosphate compounds of skeletal muscle was 
characterized by comparing muscle tissues like the heart, intestine and blood vessels 
during ischemia. Skeletal muscle energy metabolites were compared in different 
oxygenation status (ischemia vs hyperoxemia). Finally, the role of vascular control of 
thermogenesis was examined in whole body via intravenous infusion of 
norepinephrine, phenylephrine, naphazoline, and isoproterenol in a marsupial bettong, 
an endotherm without detectable BAT. 
9.2 Major findings 
Increases in V02 as well as lactate and pyruvate in perfused rat hindlimb were 
induced by increasing perfusion flow rate alone. The flow-mediated increment in V0 2 
(thus thermogenesis) was augmented by vasoconstrictors such as norepinephrine and 
vasopressin but inhibited by vasodilators such as nitroprusside (Chapter 3). 
Vasoconstrictor-mediated increases in V0 2 in association with vasoconstriction also 
occurred in the perfused hindlimbs of other species such as bettongs and cane toads. 
The effect of vasoconstrictors on muscle metabolism in the perfused bettong hindlimb 
(Chapter 4) generally agree with those observed in the rat hindlimb (Clark et al., 
1994): norepinephrine and vasopressin (type A) stimulate V02, lactate and glycerol 
release whereas 5-HT (type B) inhibits these metabolisms during vasoconstriction. In 
the constant-flow perfused hindlimb, norepinephrine-stimulated metabolism was 
mediated by a-adrenergic receptors (Chapter 4). The changes in metabolism and 
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pressure induced by both type A and B vasoconstrictors were reversed by NP 
(Chapter 4). The vasoconstrictor-mediated increase in V0 2 in the perfused rat 
hindlimb was entirely distinguishable from muscle contraction-induced V02 by using 
tubocurarine (Chapter 3). 
Vascular control of V0 2 is not an unique feature of skeletal muscle, and it 
occurs in other tissues as well, such as kidney, intestine and mesenteric artery 
although the stimulatory or inhibitory effects of a vasoconstrictor on V0 2 may differ 
in different tissues (Chapter 5). In the constant-flow perfusion model, norepinephrine 
stimulates V02 in perfused hindlimb but inhibits V02 in the perfused intestine whereas 
5-HT exerts the opposite effects (Chapters 3, 4, & 5). In the perfused rat kidney and 
intestine, nitroprusside markedly inhibited either the increased or decreased V02 , 
lactate and glycerol induced by vasoconstrictors when blocking the increased 
perfusion pressure. However, the inhibition of 1 TO2 is not complete (Chapter 5). 
In the constant-pressure perfusion model type A vasoconstrictors 
norepinephrine and vasopressin also stimulated V0 2 even though the perfusion flow 
was slightly reduced from the initial level whilst a type B vasoconstrictor, 5-HT (at 
high concentrations), inhibited V0 2 during vasoconstriction (Chapter 6). These results 
are consistent with the findings from the constant-flow perfusions (Clark et al., 1994; 
Chapter 4). In addition, in the constant-pressure perfusion, 13-adrenergic agonists, 
isoproterenol and BRL35135A were found to stimulate V0 2 independent of perfusion 
flow in the presence of propranolol. At low concentrations, 5-HT increased both 
perfusion flow and V02. 
Skeletal muscle was unique in preserving adenine nucleotides during ischemia 
(Chapter 7). In contrast to the findings in other types of tissues such as the heart, 
intestine and aorta as well as the kidney (Chapter 5) and BAT (Matthias et al, 1994) 
adenine nucleotides were not immediately altered during the early stages (60 min) of 
dramatic changes in 02 supply (Chapter 7). The energy status, as indicated by the 
energy charge, was not significantly different among the normal, peifused (high flow 
plus norepinephrine) and ischemic (for 60 min) muscles, suggesting that rat skeletal 
muscle can be shifted to metabolic arrest state when 02 supply is restricted. Among 
the energy metabolites measured, CrP and Cr were most sensitive to ischemia and 
differed in the three oxygenation states. Accordingly, they are more valuable in 
evaluating the muscle energetic status. 
Similar to the basal metabolisms in the perfused hindlimb, the bettong BMR 
was low lower than that of the rat (Chapter 8). Norepinephrine and isoproterenol 
were shown to elicit heat production in the conscious bettong. More importantly, cci- 
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adrenergic agonists, phenylephrine and naphazoline were also found to stimulate heat 
production. 
9.2.1 Muscle is a thermogenic effector partly controlled by vasculature 
Despite the highest storage of high energy phosphate compounds (Chapter 7), 
the basal metabolic rate of skeletal muscle is very low compared with most other 
tissues such as intestine, kidney, mesenteric artery (Chapter 5), heart and liver. Even if 
subjected to ischemia, the degradation kinetics of its high energy phosphate 
compounds is much slower than that of other muscle tissues (Chapter 7). A 
comparison of the estimated skeletal muscle contribution to BMR in the human, rat, 
bettong the toad is shown in Table 9-1. These indicate that skeletal muscle contributes 
to a high percentage of BMR in the species with no BAT. 
If the value of 6.4 gmol.g - l-h-1 (Colquhoun et al., 1988; 1990; Dora et al., 
1991; Hettiarachchi etal., 1992) reflects V02 at 25°C at the same flow (0.27 ml.min - 
as that in vivo (Armstrong & Laughlin, 1985) represents the basal V02, the 
value of 27 ptmol.g-1 -11-1 at 18 ml/min in the presence of 50 nM norepinephrine would 
suggest that the resting skeletal muscle metabolism can be increased 400% by 
increased flow and norepinephrine stimulation together. This estimate would imply a 
huge potential of skeletal muscle for NST. 
Table 9-1. Estimated muscle contribution to BMR in the rat, bettong and toad. 
Mass % BMR BAT Source of the data 
Rat 43% 23 yes (Chapter 8) 
Marsupial 52% 32 no (Chapter 8) 
Amphibians 35% 60-77 no Flamigan, 1991 
It might be argued that the vasoconstrictor-mediated increase in V02 in 
constant-flow perfused hindlimb is less representative since the perfusion flow can be 
reduced in vivo when vasoconstrictors take action. A reduced flow would offset the 
stimulatory effect of V0 2 . The dose-response curves of norepinephrine, phenylephrine 
and vasopressin (Chapter 6) showed that vasoconstrictors are able to elicit V02 at 
low doses before the perfusion flow is substantially decreased. The maximal V02 
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elicited by norepinephrine reached 30% above the basal even though this basal value 
has been significantly elevated by a high basal perfusion flow rate as indicated in 
Chapter 3. 
Thus, in light of the criteria proposed by Trayhurn (1994, see Section 1.4), the 
present study provides further support for vascular controlled skeletal muscle to be 
operationally thermogenic system in the following two points. Firstly, resting skeletal 
muscle as a whole is able to produce considerable amount of heat far beyond its basic 
requirements. Secondly, this thermogenic process can be rapidly turned on or off by 
vasoconstrictors such as norepinephrine. 
9.2.2 The role of adrenergic receptors in muscle thermogenesis 
Skeletal muscle has both a- and 13- adrenergic receptors (Rattigan et al., 
1986) and a-receptors are prevalent on small arteries (Martin et al., 1990). However, 
the role of adrenergic receptors in muscle thermogenesis is still controversial. A 
number of researchers (Rothwell & Stock, 1980; Blaak et al., 1993; Astrup et al., 
1994) have shown O-adrenergic-mediated rise in muscle thermogenesis. There is also 
evidence that suggests the presence of 0 3-adrenergic receptors in skeletal muscle 
(Emorine et al., 1989; Roberts et al., 1993, Sillence et al., 1993). Conversely, most of 
the studies in the constant-flow perfused hindlimb demonstrated a-adrenergic 
mediation of muscle thermogenesis (Grubb & Folk, 1977; Richter et al., 1982b; 
Colquhoun et al 1990; Hettiarachchi et al. 1992). In fact, some studies in vivo also 
showed a-adrenergic stimulation of thermogenesis in rats (Foster et al., 1984; 
Rothwell, 1990), dogs (Liard, 1989) and rabbits (Szreder et al, 1991). However, this 
has been attributed to an auxiliary effect on BAT thermogenesis (Foster et al 1984; 
Rothwell, 1990). 
The present study also examined the involvement of a- and I3-adrenergic 
receptors in muscle thermogenesis. In the constant-flow perfined hindlimb, 
norepinephrine-stimulated V02 is mediated by a-adrenergic receptors as shown by the 
blockade of the increased V02 by phentolamine but not propranolol (Chapter 4). The 
a-adrenergic stimulation of muscle V02 was similarly demonstrated by the 
enhancement of V02 by phenylephrine in the constant-pressure perfused hindlimb. 
More interestingly, both phenylephrine (a1 agonist) and naphazoline (a 1 , a2 agonist) 
were able to elicit heat production in the bettong (Chapter 8). The lack of detectable 
BAT using histological or molecular biology techniques (Hayward & Lisson, 1992; 
Trayhurn, personal communication) makes it impossible to attribute the a-adrenergic 
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mediated increase in heat production to BAT, strongly suggesting the a-adrenergic 
stimulation of vascular-associated muscle thermogenesis in vivo. 
The experiments in this thesis also showed il-adrenergic stimulation of muscle 
thermogenesis in the constant-pressure perfused rat hindlimb (Chapter 6) and the 
whole body metabolic rate study in bettongs (Chapter 8), but not in the constant-flow 
perfused hindlimb (Chapter 4). A lack of f3-adrenergic stimulation of V02 has also 
been found by other researchers using constant-flow perfised rat hindlimbs 
(Colquhoun etal., 1989; Hettiarachchi etal., 1992; Dora et al., 1994). The reason for 
the disparity of the results of 0-adrenergic stimulation of muscle V02 between the 
constant-flow (once through) and constant-pressure (plus recirculated) perfusions is 
not clear and may be related to the methods. 
One of the major differences between the two perfusion models is the basal 
flow and pressure. For the constant-flow perfusion, both basal perfusion flow rate 
(0.27 ml/min.g) and pressure (25 mm Hg) were much lower than those (2.4-2.6 
ml/inin.g and 80 mm Hg) in the constant-pressure perfusion. Another important 
difference is the circulation models adopted. The constant-flow perfusion was 
performed in an one-through model whilst the perfusate was recirculated in the 
constant-pressure perfusion. It is known perfused hindlimb releases various substances 
such as metabolites [lactate, pyruvate, glycerol (Chapters 3, 4 & 5)], purine and 
pyrimidine compounds (Clark et al., 1990), and possibly vasoactive substances 
(Chapter 6). Consequently, another possible reason for the contradictory results might 
be the involvement of the released substance(s) in 13-adrenergic stimulation of V0 2 in 
the constant-pressure perfused hindlimb. Indeed, I3-adrenergic stimulation of VO2 and 
lactate production has been found in both constant-flow (Richter et al, 1982b) and 
constant-pressure (Hardeveld et al., 1980) perfused rat hindlirnbs in a similar 
recirculated model. 
Nonetheless the results of 13-adrenergic mediation of muscle metabolism are 
probably more representative of in vivo because blood is circulated and blood 
pressure is around 80-100 mm Hg in vivo. Other supportive evidence for 0-adrenergic 
meditation of muscle thermogenesis came from the increase in heat production in the 
intact bettong induced by intravenous infusion of isoproterenol (Chapter 8). Further 
studies on 0-adrenergic mediated increase in muscle thermogenesis revealed that V02 
is mainly mediated by 03- or atypical f3 receptors but other 3—subtypes may be 
involved in other changes such as flow rate and lactate and py -ruvate production 
(Chapter 6). Fig. 9-1 summarizes a proposed mechanism for 13-adrenergic stimulation 
of muscle thermogenesis in vivo. 
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Fig. 9-1 	Proposed mechanism for 13-adrenergic mediation of muscle 
thermogenesis in vivo. 
9.2.3 Vascular control of V 02 in other tissues 
Table 9-2 compares sensitivity of metabolic response to norepinephrine 
infusion of the perfused rat hindlimb, kidney and intestine. The hindlimb (thus skeletal 
muscle) is the first to be affected by norepinephrine. When norepinephrine increases to 
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the level necessary to influence V02 in the kidney and intestine, the V02 has already 
risen to, or above, the half maximal value in skeletal muscle. If this relationship stands 
in vivo, norepinephrine-inhibited V02 in intestine would affect very little of the 
norepinephrine-stimulated thermogenesis derived from other tissues such as skeletal 
muscle. 
Although the response of V02 to norepinephrine is shifted to the left in the 
constant-pressure perfusion, the dose response curve (Fig. 6-2) shows norepinephrine 
does not become inhibitory at 100 nM at which the maximal V0 2 is reached in the 
constant-flow perfusion (Table 9-2). Hence, in vivo, the maximal effect of 
norepinephrine on muscle thermogenesis would probably be achieved at 
concentrations between 10-100 nM in the rat. Such an extrapolation seems to match 
the rat plasma catecholamines measured in vivo. For example, a carefully controlled 
study using both HPLC-EC (electrochemical detector) and radioimmunoassay 
revealed that the plasma norepinephrine and epinephrine in the resting rat are 1.8 and 
1.1 nM, respectively (Eriksson & Persson, 1982). Cold exposure could easily increase 
these values more than four times (Chin etal., 1973). 
Table 9-2 V02 response to norepinephrine concentration in the perfused rat 
hindlimb, kidney and intestine 
VO? start VO? 50% VO, 100% Original data 
Constant-flow 
Hindlimba — 1 nM — 10 nM — 100 nM Fig. 3-5 
Kidneya — 10 nM — 100 nM — 1000 nIVI Fig. 5-1 
Intestineb > 30 nM > 100 nIVI > 1000 n1V1 Fig. 5-6 
Constant-pressure 
Hindlimba — 1 nM — 1.5 nM — 3-10 nIvl Fig 6-2 
Note: a stimulation; b inhibition. 
It is rather interesting that vasoconstrictors other than norepinephrine also 
alter muscle thermogenesis associated closely with vasoconstriction (Chapters 3, 4 & 
6). This is true in other perfused tissues such as the rat kidney and intestine (Chapter 
5). Hence, vascular control of V02 seems to be a general feature of the perfused 
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tissues. These data would also appear to indicate that there might be a common 
mechanism underlying the vasoconstrictor-mediated changes in V0 2 in different 
tissues. 
9.2.4 Vascular control of V02 in the hindlimbs of other species 
Table 9-3 summarizes V02 in perfused hindlimb(s) of rats, bettongs and toads 
in response to norepinephrine at different concentrations. Of these three species, the 
rat hindlimb is most sensitive to the norepinephrine stimulation, and toad hindlimbs 
appear to need the highest concentration. So far, no data are available for plasma 
catecholamine concentrations for the bettong. The values obtained from a small 
carnivorous marsupial (Antechinus stewartii, Bradly, 1994 Personal communication), 
the measured plasma catecholamines (Table 9-2) are approximately four times as high 
as those of the rat. The sum of plasma norepinephrine and epinephrine is 2.9, 14.8 and 
15.1 nM for the rat, the marsupial (Antechinus stewartii) and toad, respectively. The 
hindlimb V02 in response to norepinephrine stimulation in these species (Table 9-2) 
appears match their plasma catecholamine levels in vivo. Furthermore, these 
observations taken together indicate that catecholamines have already started to exert 
a marginal effect on muscle thermogenesis under resting conditions. Any rise in 
plasma catecholamines would immediately have a significant impact on muscle 
thermogenesis. 
Table 9-3 Norepinephrine concentrations to stimulate VO2 in perfused 
hindlimbs and its plasma levels in the rat, marsupial and toad at rest 
Plasma NE Plasma E VO? start VO? 50% VO, 100% 
Rat 1.8 n1V1a 1.1 nMa 1 nM 10 nM 100 nM 
Bettong 10 nMb 4.8 nMb 10 n1V1 50 n1V1 1000 nM 
Toad 2.1 nMc 13 nMc 30 tiM 100 nM 1000 nM 
a: Eriksson & Persson, 1982; b: Bradley, 1994 (Personal communication) for a carnivorous 
marsupial (Antechinus stewartii); c: Withers et al., 1988. Other data are quoted Figs. 3-5, 4-1 & 4-3). 
NE: norepinephrine, E: epinephrine. 
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9.3 	Mechanisms underlying vasoconstrictor-mediated changes in VO2 in 
skeletal muscle. 
Vasoconstrictor-mediated increases in VO2 in skeletal muscle are clearly 
distinguishable from muscle contraction-induced V0 2 . The close association between 
perfusion pressure and V02 strongly suggest that vasoconstriction is tightly linked in 
some manner to this metabolism. Yet the mechanism for the vasoconstrictor-induced 
V02 is still controversial. A priori, to explain the increased V02, there must be an 
increased hydrolysis and subsequent synthesis of ATP, or a stimulated mitochondrial 
uncoupling within the hindlimb analogous to that occurring in BAT. Four general 
possibilities are apparent that could explain the vasoconstrictor-mediated control of 
such processes in the perfused hindlimb. 
Firstly, the vasoconstrictors may act directly on skeletal muscle receptors to 
cause the above metabolic changes independent of the increases in perfusion pressure 
since some vasoconstrictor hormones have receptors on skeletal muscle. However, 
the failure to observe a stimulatory effect of norepinephrine, angiotensin II on V02 by 
incubated or perifused muscles in vitro (Hannon et al., 1963; Eaton 1964; Dubois-
Ferriere etal., 1981; Hettiarachchi etal., 1992) or homoganate (Hannon etal., 1963) 
does not support this argument. 
The second possibility is that the rise in perfusion pressure associated with 
vasoconstriction may redistribute the perfiisate within the hindlimb to previously 
under-perfiised zones and thus by relieving regions of hypoxia, stimulate increased 
V02. This is unlikely because, as discussed earlier, there is no evidence of regional 
hypoxia as Cr, CrP and lactate are normal (Chapters 3, 4, 5 & 6). As shown in 
Chapter 7, a decreased CrP together with an increased Cr would be expected if 
skeletal muscle is ischemic. Besides the Pv02.remained above 200 mm Hg for all of 
the perfused hindlimb experiments which is a partial pressure greater than are 
achieved in vivo. The results in Fig. 6-2 showed that both norepinephrine and 
phenylephrine at low concentrations stimulate V0 2 even though perfusion flow rate is 
decreased at a constant pressure of 80 mm Hg. It would seem more unlikely that 
some regions are still underperfined at physiological pressure plus supraphysiological 
flow and that a fall in flow would improve 'underperfiised' regions. Furthermore, such 
a pressure-induced redistribution of flow to relieve hypoxia, does not accord with the 
inhibition of V02 associated with the vasoconstriction induced by 5-HT (Figs. 4-1 and 
4-5) in the perfiised bettong hindlimb. 
The third possibility is that arterial vasoconstriction is energetically expensive 
and uses the observed V02 . Colquhoun & Clark (1991) proposed that vascular 
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thermogenesis might be one of the mechanisms accounting for vasoconstrictor-
induced VO2 in the perfused rat hindlimb. The relationship between active vascular 
wall tension and V02 has been noted by Paul & Peterson (1975) and discussed in 
Chapters 3 & 6. The evidence for this hypothesis includes: 1) the close correlation 
between V02 and perfusion pressure induced by vasoconstrictors in the constant-flow 
perfused hindlimb, 
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Fig. 9-2 Proposed mechanism of type A vasoconstrictor-mediated increases in 
muscle thermogenesis in vivo. 
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kidney, intestine and mesenteric artery (Chapters 3, 4 & 4); 2) the blockade or 
inhibition of the vasoconstrictor-mediated increase in V0 2 in constant-flow perfused 
hindfimb, kidney and intestine by vasodilators when relaxing vasoconstriction 
(Chapters 4 & 5); 3) flow (thus vascular stretch)-induced V0 2 and the inhibition by a 
vasodilator in the step- and constant-flow perfused hindlimb (Chapter 3); and 4) 
vasoconstrictor-stimulated increases in V02 during small vasoconstriction in the 
constant-pressure perfused hindlimb. 
Thus the key issue for working vascular thermogenesis seems to be a matter of 
how-much. Literature values for V0 2 obtained by Warburg techniques of various 
vascular smooth muscle fragments incubated in vitro at 37°C (Paul, 1980) ranged 
from 1.8-3.0 mols4 .h-1 . However, the calculated V0 2 for canine femoral artery (26 
umols-1 h-1) is more than 10-fold greater than incubated segments [2.4-3.6 mol-g -1 
h-1 , (Kosan et al., 1966)], which may reflect the effect of pressure loading on V02 . 
Isolated unstimulated, nonperfiised brain microvessels have an endogenous rate of 
V02 of 65.4 nmol.h4 .mg4 protein at 37°C (Brendel et aL, 1974). At 150 mg 
protein/g wet wt. this corresponds to 96 umol-g4 h-1 . Such vessels can further 
increase their V02 threefold when given succinate as a substrate (Sussman et al., 
1988) and presumably would use even more when pressure loaded. The calculated 
value from the perfused mesenteric artery (Chapter 5) was 342 !mol• -1 •1-1 . A high 
V02 has also been found in the bovine microvessels [288 gmol•g -1 •h-1 (Sussman et 
al., 1988)] and perfused rat tail artery (Colquhoun & Clark, 1991). 
It is not readily apparent how vascular thermogenesis could explain the 
inhibition of V02 and lactate efflux by 5-HT that accompanies a rise in vascular 
resistance in perfused hindlimbs (Figs. 4-1 & 6-7). However when infused into the 
isolated perfused rat mesenteric artery, 5-HT (as well as norepinephrine and 
vasopressin) caused vasoconstriction and increased V0 2 (Dora et al., 1991; Chapter 
5). These observations led to the idea that 5-HT initiates a state of functional shunting 
of perfusate within the muscle vascular bed away from actively metabolising cells 
(Dora et al., 1991). If so, the areas of microvessels subjected to the increased 
pressure would also decrease, thereby reducing the total mass of working 
microvasculature and V02 . 
The fourth possibility is that vasoconstrictors by selective actions redirect 
flow to particular thermogenic skeletal muscle cells or other thermogenic cells in the 
hindlimb Clark et al., (1994). Type A vasoconstrictors (norepinephrine, vasopressin, 
angiotensin II) act on site-specific receptors on the arterioles to shut down the flow to 
nonnutritive capillaries hence redistributing flow to the areas or cells that are 
metabolically more active. In contrast, type B vasoconstrictors (ie. 5-HT in muscle 
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and norepinephrine in intestine) close down nutritive capillaries to direct flow to 
nonnutritive areas. Consequently, the metabolism is inhibited. According to this 
model, flow-induced V02 (Chapter 3) could be explained as a result of an increase in 
nutritive flow. Similarly, the increased muscle metabolism produced by isoproterenol 
and 5-HT in the constant-flow perfused hindlimb (Chapter 5) may be partially 
attributable to an increased flow to nutritive capillaries via dilating their arterioles. So 
far, such specialised muscle cells have only been described in billfish, in which blood 
going to 
Fig. 9-3 Proposed mechanism of type B vasoconstrictor-inhibited muscle 
thermogenesis in vivo. 
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the retina and brain is heated by a specialized orbital muscle by presumptive calcium 
ion cycling (Block, 1994). Other biochemical bases for this argument have not yet 
been identified at the cellular level although some observations in muscle suggest 
controlled oxidative phosphorylation uncoupling might be possible (Barre et al., 1986; 
Duchamp etal., 1992; Herpin & Lefaucheur, 1992; Matthias et al., 1993). 
However, data from the present experiments, or data from the literature thus 
far, can not discriminate between these two mechanisms of controlling or contributing 
for the involvement of blood vessels in the vasoconstrictor-altered V02 in the 
perfused hindlimbs. They may not be necessarily mutually exclusive. Fig. 9-2 
illustrates the proposed mechanisms (Colquhoun & Clark, 1991; Clark et aL, 1994) 
for the vasoconstrictor-mediated increase in muscle thermogenesis for type A 
vasoconstrictors if they do not significantly inhibit the cardiac output. In comparison, 
type B vasoconstrictors inhibit muscle thermogenesis in the mechanism illustrated in 
Fig. 9-3. 
9.4 Considerations for future studies 
Both vasoconstrictors and vasodilator hormones are involved in controlling 
vascular functions in vivo. The effects of vasodilators in muscle thermogenesis have 
not been the focus of the thesis. There were some contradictions on the role of 
isoproterenol and 5-HT in muscle metabolism between constant-flow (Chapter 4) and 
constant-pressure (Chapter 6) perfusions. Likewise, discrepancies exist between the 
effect of I3-adrenergic receptors on V02 between the constant-flow perfused hindlimb 
(Chapter 4) and the intact animal study (Chapter 8). It is important to examine 
whether vasodilators fall into metabolically positive (type A) or negative (type B) 
categories as proposed for vasoconstrictors. 
In addition to distinct haemodynamics, another important difference between 
these two models was once-through perfusion vs recirculation perfusion. As discussed 
in Chapter 6, recirculation could affect the results of lactate efflux. Hence, it would be 
interesting to further compare effects of vasoconstrictors on muscle thermogenesis in 
constant-flow and constant-pressure perfusion models using a once-through perfused 
skeletal muscle bundle/group. It would also be interesting to compare the results 
obtained at 37°C with those obtained at 25°C. 
The findings from this thesis (Chapter 6) and other works (Clark et al., 1994)) 
have demonstrated that all vasoconstrictors stimulate or inhibit muscle metabolism in 
a dose-dependent manner. Whether a vasoconstrictor such as norepinephrine, 
150 
phenylephrine or vasopressin stimulates V02 or not depends on their concentration 
(Chapter 6). For some vasoconstrictors such as norepinephrine and vasopressin, their 
effect on muscle V02 can be totally opposite at different concentrations (Chapter 6; 
Clark et al., 1994). Thus future studies need to examine the concentrations of these 
vasoconstrictor in the circumstances where thermogenesis occurs. 
To understand the role of a vasoconstrictor on muscle thermogenesis, a better 
knowledge of its effect on cardiac output is also essential. Moreover, the ultimate 
effect of a vasoconstrictor on thermogenesis needs to judged on a whole body basis. 
Comparative studies between animals with and without BAT and between endotherms 
and ectotherms would still be a powerful approach. 
Vascular thermogenesis is a new hypothesis to explain the vasoconstrictor-
mediated increase in V0 2 in the perfused tissues, especially in skeletal muscle. One of 
the problems in addressing this issue is the extreme difficulty of direct measurement of 
V02 or heat efflux at the microvessel (ie. small artery and arterioles) level. The results 
of manipulating vascular contraction or relaxation from the perfused tissues so far, are 
generally but not completely supportive. However, they can be clouded by changes in 
the parenchymal tissues, such as the difference between the effects of norepinephrine 
in the perfused intestine and mesenteric artery (Chapter 5). The data available in the 
literature are mostly obtained from larger blood vessels (Paul 1980). An evaluation of 
vascular thermogenesis using these values would probably lead to substantial discount 
of the true values of the microvasculature. For instance, the values obtained from the 
perfused mesenteric artery (Chapter 5) and bovine cerebral microvessels are much 
higher than those reviewed by Paul (1980) for the larger vessels. If a relationship 
between the size of the artery and its V02 can be established, a better estimate of 
microvessels V02 may be more representative. Other indicators for the capability of 
V02, such as mitochondria content, cytochrome oxidase are also important. It would 
be interesting to compare vascular V02 between warm-adapted and cold-adapted 
animals. Most importantly, vascular thermogenesis needs to be further assessed 
according to vascular V0 2 and its total mass of tissue within the body. 
The notion that vasoconstrictors stimulate muscle V02 by diverting flow to 
specific nutritive areas or cells needs to be further investigated in the following key 
areas: 1) whether the proposed nutritive and nonnutritive capillaries are 
morphologically discernible; 2) whether there are site-specific receptors on the 
arterioles associated with nutritive and nonnutritive capillaries; 3) the energy 
dissipating mechanism at the cellular level; and finally 4) the linkage between 
vasoconstrictor-controlled flow to the "switch" of the energy dissipating process. 
From a broader perspective, there seems to be a need to find out whether any such 
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energy dissipating mechanism in muscle is present in other tissues as well, since 
vasoconstrictor-mediated changes V02 also occurs in other tissues. 
Oxidative phosphorylation uncoupling or decoupling has been considered as a 
possible cellular mechanism for skeletal muscle thermogenesis (Barre, et al., 1987b; 
Herpin & Lefaucheur, 1992). Recent studies using isolated skeletal muscle 
mitochondria in this laboratory appear to support this proposal (Matthias et al, 
1993). A key issue to evaluate this mechanism would be the measurement of the 
changes in ATP turnover rate during vasoconstrictor-mediated increases in V0 2 in the 
perfused skeletal muscle preparation. A comparison of V02 between the 
stoichiometrical value of the changed ATP turnover rate and the directly measured 
value would provide further insight into this hypothesis. 
9.5 Conclusion 
In conclusion, no matter what the mechanism it is, the results of this thesis 
reveal the important potential role of vascular control of thermogenesis in muscle and 
also in other tissues. These findings suggest that vasoconstrictor-mediated control of 
V02 plays an important role in regulating whole body thermogenesis. 
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NORADRENALINE ON OXYGEN UPTAKE BY PERFUSED 
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MESENTERIC ARCADE SUGGESTS THAT IT IS IN PART 
DUE TO CONTRACTILE WORK BY BLOOD VESSELS 
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Abstract-1. The rat hindlimb, kidney and intestine were each perfused in a nonrecirculating mode at 
25°C using an artificial perfusate (initial pressure 85 + 5 mmHg) and the effects of vasopressin and 
noradrenaline on oxygen uptake and perfusion pressure determined. 
2. Both vasopressin (IC" = 0.1 nM) and noradrenaline (K0.5 = 2 nM) increased oxygen uptake as well 
as perfusion pressure by the perfused hindlimb; changes in oxygen uptake were closely matched by changes 
in pressure. The maximum increase in oxygen uptake was approx. 9 pmol/hr per g wet wt of hindlimb. 
3. The perfused kidney also responded to vasopressin and noradrenaline with parallel increases in 
oxygen uptake and perfusion pressure for each agent. The largest increase in oxygen uptake was approx. 
30 pmol/hr per g wet wt but this was not maximal. 
4. Vasopressin increased oxygen uptake and pressure by the perfused intestine over the range 
0.01-2 nM, but the changes in pressure only became significant at doses >0.1 nM. 
5. Noradrenaline inhibited oxygen uptake and increased perfusion pressure in a dose-dependent manner 
at pharmacological concentrations ( > 30 nM) when shunting of perfusate may have contributed to 
unperfused regions. 
6. A network of mesenteric blood vessels estimated to contain approx. 6% vascular tissue by weight, 
with the remainder white fat cells, lymphatics and connective tissue, was also perfused. 
7. Vasopressin (4 5 = 0.3 nM) and noradrenaline (K0.5 = 30 nM) each increased oxygen uptake and 
perfusion pressure in a dose-dependent manner. 
8. Calculations, based on the vascular tissue content and the overall oxygen uptake in the mesenteric 
artery preparation suggest that perfused blood vessels consume oxygen at very high rates (115 pmol/hr 
per g wet wt at 25°C) and that this consumption is further increased by 75% when the smooth muscle 
constricts. 
9. It is concluded that agonist-mediated constriction of blood vessels is energetically expensive and that 
the consumption of oxygen for this process has significant implications for whole body thermogenesis. 
INTRODUCTION 
Our previous experiments using the perfused rat 
hindlimb (Colquhoun et al., 1988, 1989; Ye et al., 
1990) have highlighted the central role of the vascular 
system in the control of hindlimb oxygen uptake and 
raised the novel possibility that a considerable pro-
portion of oxygen consumed by the hindlimb during 
vasoconstriction is taken up by working vascular 
tissue itself (i.e. the "hot pipe" hypothesis). 
The evidence supporting the centrol role of the 
vasculature includes observations where each of the 
vasoconstrictors, noradrenaline, adrenaline, vaso-
pressin and angiotensin II increase oxygen consump-
tion by the hindlimb in conjunction with an increase 
in perfusion pressure (Colquhoun et al., 1988, 1989) 
and where the vasodilators, nitropnisside, nifedipine 
and isoproterenol, which each act by different mech-
anisms, oppose vasoconstrictor-mediator increases 
in both oxygen uptake and perfusion pressure 
(Colquhoun et al., 1989). 
To whom correspondence should be addressed. 
The notion that the vascular tissue itself consumes 
oxygen during constriction, although consistent with 
the observations referred to above, is indirect and 
based on data where oxygen uptake due to skeletal 
muscle contraction appears to be additional to that 
produced by vasoconstrictors (Colquhoun et al., 
1989) and on experiments where near maximal flow-
induced oxygen uptake by the hindlimb is further 
increased by noradrenaline and inhibited by nitro-
prusside (Ye et al., 1990). If the vascular tissue is 
largely responsible for the increase in oxygen uptake 
during vasoconstriction, rates of oxygen uptake 
would approach that of vigorously contracting skel-
etal or cardiac muscle. This would assign a much 
higher respiratory rate to vascular tissue than has 
previously been estimated from fragments of large 
vessels, whether incubated or cannulated (Paul, 
1980). In the absence of direct information on oxygen 
uptake by isolated perfused vascular tissue in the 
presence of vasoconstrictors, the present experiments 
were undertaken to assess whether the vasoconstric-
tor, vasopressin, increases oxygen uptake by perfused 
organs in general. For this study, hindlimb, kidney, 
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intestine and a mesenteric artery network preparation 
were compared. Noradrenaline, the putative physio-
logical thermogenic neurotransmitter/hormone was 
also included. 
MATERIALS AND METHODS 
Animals 
Male hooded Wistar rats (180 + 5 g body wt) were fed a 
commercial diet with water ad libitum. 
Chemicals 
Bovine serum albumin (Fraction V), was obtained from 
Boehringer Mannheim and was dialysed 5 times. against 
distilled water and lyophilized before use. Arginine vaso-
pressin and noradrenaline-HC1 were obtained from Sigma 
U.S.A. All other chemicals were analytical grade. 
Perfusion system for hindlimb, kidney, intestine and the 
mesenteric artery network 
The perfusate consisted of a Krebs-Ringer bicarbonate 
buffer containing 1.27 nM CaC1 2 , 2% bovine serum albumin 
and 8.3 mM glucose and was pumped from a reservoir kept 
at 4°C through a silastic tube oxygenator continuously 
equilibrated against a gas mixture of 95% 0 2 and 5% CO2 . 
The temperature of the perfusate was brought to 25°C by 
passage through a heat exchange coil. Perfusion pressure 
was measured in the pump outflow line proximal to the 
arterial cannula. As indicated all perfusions were conducted 
at a constant flow rate: changes in perfusion pressure were 
assumed to reflect changes in vascular resistance. The 
venous effluent flowed through a 0.5 ml thermostatically 
controlled chamber (25°C) containing a Clark-type oxygen 
electrode. The effluent was discarded following measure-
ment of its oxygen content. The oxygen electrode was 
calibrated before and after each experiment with gas mix-
tures of 100%. 20.9% and 0% oxygen and periodically 
checked with a Radiometer Model ABL300 blood gas 
analyzer. The PO 2 of the venous effluent and the arterial 
perfusion pressure were recorded continuously. Experiments 
were started when these parameters reached steady-state, 
usually within 40 min. Agonists were freshly prepared in 
isotonic saline containing 0.1% ascorbic acid. They were 
infused continuously into the perfusion line prior to the 
bubble trap at a rate not greater than 1% of the rate of 
perfusion. Perfusions were conducted in a temperature. 
controlled chamber at 25 + 0.2°C. 
Surgical preparations 
Rats were anaesthetized with pentobarbital sodium 
(5 mg/100 g body wt, i.p.). Surgery for hindlimb perfusion 
was essentially as described by Ruderman et al. (1971) and 
Richter et a/. (1982). Additional details were as given 
previously (Colquhoun etal., 1988, 1989). The hindlimb was 
perfused at a constant flow rate of 18.6 + 0.2 ml/leg per min 
to give a basal pressure of 80-90 mmHg. 
Details for kidney perfusion were essentially as described 
by Little and Cohen (1974). Ligatures of size 000 silk 
(Ethicon Inc.) were placed around the superior mesenteric 
artery, left renal vein, inferior vena cava below the left renal 
vein, inferior vena cava above the left renal vein, inferior 
vena cava above the right renal vein and right renal artery. 
The right renal artery was cannulated, and a cannula was 
placed in the inferior vena cava between the two ties 
adjacent to the entry point for the left renal vein. The 
cannulae were tied in place and the perfusion commenced. 
Ligatures around the superior mesenteric artery, left renal 
vein, inferior vena cava below the left renal vein, vena cava 
above the right renal vein were tied off. Renal arterial 
perfusion was not interrupted at any time. The kidney was 
perfused in situ at a constant flow rate of 4.7 + 0.4 ml/min 
per kidney to give a basal pressure of 80-90 mmHg. 
For perfusion of the intestine, the abdomen was opened 
along the midline and the large intestine, duodenum, and 
pancreas were surgically removed. The remainder of the 
small intestine was covered with a saline-soaked gauze 
and wrapped with plastic wrap to minimize evaporation 
and tissue dehydration. An intravenous injection of 
heparin (200 IU • 100 g -I ) was made immediately before 
cannulation of the superior mesenteric artery and portal 
vein. The intestine was perfused at a constant flow rate 
of 15.2 + 0.2 ml/min intestine to give a basal pressure of 
80-90 mmHg. 
Details for perfusion of the mesenteric artery network 
were essentially as given above for the intestine except that 
only the superior mesenteric artery was cannulated. In 
addition the mesenteric network (Fig. I) was cut free from 
the intestine and transferred to a perfusion apparatus where 
it was hung from the cannula inside a sealed glass vessel. 
Perfusate draining from the cut ends of the arterial network 
collected at the bottom of the vessel and flowed into the 
oxygen electrode chamber before being discarded. The flow 
rate was 2 mug wet wt of mesentery per min. 
Determination of vascular content 
This was attempted only for the mesenteric artery net-
work. Evans Blue (0.5 g- 100 nil I ) in perfusion medium was 
introduced for sufficient time to fill all of the blood vessels. 
A representative segment of the preparation was blotted and 
weighed. Extraneous tissue was dissected away to leave only 
the dye filled blood vessels which were then weighed. 
Calculations 
Oxygen contents and uptake rates were calculated from 
arteriovenous oxygen differences and measured steady-state 
flow rates. Data are shown as the mean + SE. 
RESULTS 
Oxygen uptake and pressure development by the 
perfused hindlimb 
We have previously reported that the perfused rat 
hindlimb responds to noradrenaline and vasopressin 
with increases in both oxygen uptake and pressure 
development (Colquhoun et al., 1988, 1989). In those 
studies flow rate was constant at 4.0 + 0.1 ml/min and 
basal perfusion pressure 29 + 1 mmHg. In the present 
study perfusate flow was also constant but set so 
—.--...- 
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Fig. I. Rat intestinal mesenteric artery network showing 
white adipose tissue (WAT), lymph node (LN), and the 
cannula positioned in the superior mesenteric artery (MA). 
The broken line shows the original position of the intestine. 
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that pressures approximating in vivo condition were 
attained. Thus the flow rate was 18.6 ± 0.2 ml/min 
and basal pressure 90± 2 mmHg. Under these con-
ditions (25°C) the rate of oxygen uptake was 
14.5 ± 0.4 pmol/h per g hindlimb. This is a little 
more than twice the value at the lower flow rate 
(4.0 ml/min) of 6.4 + 0.2 pmol/h per g wet wt 
(Colquhoun et al., 1989). 
Figure 2 shows dose-response curves for nor-
adrenaline and vasopressin-mediated increases in 
oxygen uptake and perfusion pressure development. 
The increase in oxygen uptake from both agonists 
reached maximal values and concentrations giving 
half-maximal effects were 0.1 nM vasopressin and 
3 nM noradrenaline. The increases in pressure did not 
appear to have reached maximal values even though 
there were parallel trends between pressure and oxy-
gen changes for each agonist (Fig. 1). Thus threshold 
doses for the changes in oxygen uptake and pressure 
development were similar. The maximum rate of 
oxygen uptake was 23 pmol/h per g hindlimb, repre-
senting an increase of 59% over basal. 
Oxygen uptake and pressure development by the 
perfUsed kidney 
As for the perfused hindlimb, a perfusion flow 
rate was set for the kidney to maintain a physiological 
perfusion pressure of approx. 90 mmHg at 25°C. 
This was achieved at 4.7 + 0.4 ml/min per kidney 
and under these conditions oxygen uptake (basal) 
was 70.3 + 3.4 pmol/h per g kidney. This com-
pares reasonably well with published values of 
171-425 pmol/h per g kidney (Cohen et al., 1980; 
Franke et al., 1976) obtained at 37°C and at higher 
CJ 	0 
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Fig. 2. Effect of vasopressin (0) and noradrenaline (•) on 
oxygen uptake (A) and perfusion pressure (B) in perfused 
rat hindlimb. The flow rate was maintained constant at 
18.6 + 0.2 ml/min per hindlimb. Basal values (n = 6) were 
90 ± 2 mmHg and 14.5 ± 0.4 iimol/hr per g hindlimb for 
pressure and oxygen uptake, respectively. The weight of 
hindlimb perfused was 15 ± 2g. Means + SE are shown for 
a total of 6 perfusions involving three with vasopressin and 
three with noradrenaline. When not visible the error bar is 
within the symbol. 
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Fig. 3. Effect of vasopressin (0) and noradrenaline (0) on 
oxygen uptake (A) and perfusion pressure (B) in perfused 
rat kidney. The flow rate was maintained constant at 
4.7 + 0.4 ml/min per kidney. Basal values (rt =6) were 
89 ± 5 mmHg and 70.3 + 3.4 pmol/hr per g kidney for 
pressure and oxygen uptake, respectively. The weight of 
kidney perfused was 0.9 ± 0.1 g. Means ± SE are shown for 
a total of six perfusions. When not visible the error bar is 
within the symbol. 
flow rates (approx. 25 ml/min per g kidney) and 
therefore higher arterial pressure (112-120 mmHg). 
The temperature difference could be expected to at 
least double the rate and the pressure difference 
between 80 and 112 mmHg could be expected to 
increase oxygen uptake by a further 23% (Franke et 
al., 1976). 
Figure 3 shows dose-response curves for nor-
adrenaline and vasopressin-mediated increases in 
oxygen uptake and perfusion pressure development. 
Although dose-dependent, the increases in oxygen 
uptake and pressure did not reach maximal values for 
either agonist. However, it was apparent that changes 
in pressure and oxygen uptake followed each other 
closely; the shapes of the dose-response curves were 
similar for a given agonist. The highest rate of oxygen 
uptake attained was 102 gmol/h per g kidney, repre-
senting an increase of 45% over basal. 
Comparisons between Figs 2 and 3 suggest that the 
hindlimb was at least one order of magnitude more 
sensitive to both agonists than the kidney. 
Oxygen uptake and preSssure development by the 
p`ffused intestine 
Perfusion "conditions for the intestine were also 
chosen to allow maintenance of a pressure approach-
ing physiological. Thus to achieve an arterial per-
fusion pressure of 82 + 2.4 mmHg, the flow rate 
was maintained constant at 15.2 + 0.1 ml/min per 
intestine. Under these conditions (at 25°C) the basal 
rate of oxygen uptake was 33.3 + 1.0 pmol/h per g 
intestine. This value compares with values of 98.5 and 
150.4 pmol/h per g for fasted and fed rat intestine 
in vivo, respectively (Stevenson and Weiss, 1988) and 
60 pmol/hr per g for autoperfused dog intestine 
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(Granger et al.,. 1982). As argued above (for kidney) 
the lower rate observed for intestine in the present 
study would largely be the result of the experiments 
being conducted at 25°C rather than 37-39°C. 
Figure 4 shows dose—response curves for nor-
adrenaline and vasopressin-mediated increases in 
oxygen uptake and pressure development. Nor-
adrenaline infusion results in a dose-dependent in-
crease in pressure (+ 134%) which was accompanied 
by a parallel decrease in oxygen uptake (-24%). As 
discussed below the decrease in oxygen uptake within 
a scenario of increased pressure (vasoconstriction) 
may result from shunting of perfusate away from 
regions of respiring tissue. 
Vasopressin is regarded as a pure intestinal vaso-
constrictor (Richardson, 1984) and in Fig. 4 dose-
dependent increases in both oxygen uptake and 
pressure are shown. However, it is important to note 
that oxygen uptake increased uniformly over the dose 
range of 10 pM-3 nM vasopressin whilst pressure 
changes were relatively small at the lower doses and 
larger at the top end of the concentration range. The 
highest rate of oxygen uptake attained was 39 gmol/h 
per g, representing an increase of 18% over basal. 
Oxygen uptake and pressure development by the 
perjused mesenteric artery network 
The mesenteric artery network was perfused via the 
superior mesenteric artery as shown in Fig. 1. Major 
arteries of this network were severed closely proximal 
to the intestine and the entire network perfused in a 
sealed chamber so the effluent could be collected for 
P02 measurement. Because of the nature of the 
preparation it is likely that most capillaries and 
veins were not perfused. Consequently the perfusion  
pressure was quite low at the relatively high flow 
rate of 2 ml/min per g artery network. Under these 
conditions the basal rate of oxygen uptake was 
6.9 ± 1.5 gmol/hr per g wet wt. 
Figure 5 shows dose—response curves for nor-
adrenaline and vasopressin-mediated increases in 
oxygen uptake and pressure development for . the 
mesenteric preparation. Noradrenaline infusion re-
sulted in a dose-dependent increase in oxygen uptake 
with a half-maximal effect occurring at 0.3 p M. Pres-
sure also increased in a dose-dependent manner but 
did not reach a maximal value and was still increasing 
at the highest. dose used of 3 p M noradrenaline. 
Vasopressin also resulted in a dose-dependent in-
crease in oxygen uptake and pressure development. 
Half maximal responses occurred for both at ap-
proximately 0.3 nM vasopressin. Vasopressin tended 
to have the greatest effect on oxygen uptake and 
at maximum dose the rate of oxygen uptake was 
12.4 pmol/hr per g artery network, representing an 
increase of 80% over basal. 
Comparison of the four tissues indicated that the 
hindlimb was the most sensitive to vasopressin and 
noradrenaline for both oxygen uptake and pressure 
development. However, since the dose—response 
curves were incomplete in some instances quantitative 
comparisons could not be made. 
DISCUSSION 
The present study was undertaken to address the 
possibility that vasoconstrictor-mediated oxygen up-
take by perfused tissue was a general phenomenon. 
Two agonists were used and four tissues compared. 
In all cases except one both vasopressin and 
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noradrenaline increased oxygen uptake in association 
with an increase in perfusion pressure. 
Our previous studies using the perfused rat 
hindlimb have shown that noradrenaline, vasopressin 
and angiotensin II each stimulate vasoconstriction 
and oxygen uptake. Both effects were blocked by 
vasodilators, e.g. nitroprusside, nifedipine or isopro-
terenol (Colquhoun et al., 1988, 1989). In addition, 
oxygen consumption by electrically stimulated skel-
etal muscle was not inhibited by nitroprusside and 
was additive to vasoconstrictor-induced oxygen up-
take (Colquhoun et al., 1989). Furthermore, when 
flow was increased (and therefore perfusion pressure) 
oxygen uptake also increased and the addition 
of noradrenaline or nitroprusside increased or 
decreased, respectively, the oxygen uptake at all flow 
rates (Ye et al., 1990). Together these findings led to 
the conclusion that the vascular system plays a key 
role in the regulation of resting muscle thermogenesis 
and we have considered several possible explanations 
for the data, all of which should be reconsidered in 
relation to the findings of the present study. These are 
(a) heterogenous perfusion of the tissue (in the case 
of the hindlimb this would be the skeletal muscle) that 
is altered by perfusion pressure; (b) redirection of 
perfusate to specialized heat-producing cells in the 
skeletal muscle bed; (c) the presence of receptors on 
the skeletal muscle for the vasoconstrictors that 
activate thermogenic mechanisms; and (d) the vascu-
lar smooth muscle during constriction consumes the 
oxygen. 
We believe the argument in support of heter-
ogenous perfusion is nullified by the use of flow rates 
sufficiently high to exceed the threshold pressure 
(50 mmHg) at which there is a demonstrable decrease 
in the number of capillaries perfused (Lindbom and 
Arfors, 1985). Accordingly the hindlimb, kidney and 
intestine have all been perfused, under basal con-
ditions, at 80-90 mmHg. In addition the argument 
for heterogenous perfusion of the mesenteric artery 
network is weak. If the artery network is tied off 
rather than cut at the points proximal to the intestine 
there is almost no flow at all even though the pressure 
may exceed 200 mmHg (Ye, Colquhoun and Clark, 
unpublished observations). These latter observations 
suggest that there is a minimal potential for arterio-
venous shunting in the mesenteric artery network. 
However, the perfused intestine shows both an in-
crease in oxygen consumption with perfusion pres-
sure (below 60 mmHg) (Anzueto et saL, 1984) and the 
capacity to decrease oxygen uptake with those vaso-
constrictors which decrease blood flow under con-
stant flow conditions (Kvietys and Grangt\r, 1982). 
This latter effect may be due to a decrease in- capillary 
exchange capacity (Kvietys and Granger, 1982) in 
turn a product of shunting of perfusate. 
The presence of specialized heat producing cells 
have recently been described in a modified eye muscle 
of the billfish (Block, 1987). They are proposed to 
heat blood going to the brain and eye. The cells are 
characterized by numerous mitochondria, extensive 
smooth endoplasmic reticulum, and the absence of 
contractile elements as well as thermogenin. This 
specialized muscle also has a very extensive vascular 
counter-current heat-exchanging vascular rate. Block 
(1987) proposes that heat production in these cells  
originates from Ca' cycling by the sarcoplasmic 
reticulum and that this phenomenon may also be of 
thermogenic importance in skeletal muscle generally. 
As yet there is no evidence for this tissue in mam-
malian skeletal muscle and its presence in intestine, 
kidney and the mesenteric artery network would seem 
unlikely. 
A direct receptor-mediated metabolic effect of 
vasoconstrictor agonists on oxidative metabolism is 
often discussed. However, for rat hindlimb muscle 
there appears to be few if any a -adrenergic receptors 
(Rattigan et al., 1986) and the status of vasopressin 
and angiotensin receptors in this tissue is unknown. 
Regardless of the presence or otherwise of receptors, 
the agonist-mediated increase in oxygen uptake 
would have to be blocked by nitroprusside, nifedipine 
and isoprenaline (Colquhoun et al., 1989). In ad-
dition the flow (pressure)-induced increase in oxygen 
uptake (Ye et al., 1990) could be difficult to explain on 
the basis of a receptor-mediated effect on oxidative 
metabolism although stretch-mediated stimulation of 
smooth muscle contraction is well known (Somlyo 
and Somlyo, 1960 and references therein). For intes-
tine, vasoactive agents are considered to have either 
direct or indirect effects on oxidative metabolism 
(Kvietys and Granger, 1982) although the mechan-
isms are not clear. For kidney a stimulatory effect of 
noradrenaline and vasopressin on oxygen uptake due 
to their effects on metabolism (e.g. Roobol and 
Alleyne, 1973) is highly likely. However, a metabolic 
effect of either agonist on oxidative metabolism of 
tissue other than the smooth muscle/endothelial 
cells of the mesenteric arteries would seem unlikely, 
although there is some evidence that the lymph nodes 
can consume oxygen at high rates (Altman and 
Dittmer, 1968) and it is possible this rate may be 
stimulated by noradrenaline and vasopressin. 
Of the four possibilities we believe the present data 
is consistent with the notion that the vascular tissue 
itself consumes the oxygen as it constricts. In support 
of this notion calculations based on the vascular 
content of the hindlimb and the mesenteric artery 
network yield similar results for the estimated rates of 
oxygen uptake. Thus for the hindlimb, and assuming 
a content of 3.4% vascular tissue (Paul, 1980) the 
basal rate of oxygen uptake is 2.65 p mol/g vascular 
tissue per min at 37°C increasing to 7.50 and 9.40, 
respectively with noradrenaline or vasopressin. From 
our estimates of perfused vascular tissue content of 
the mesenteric artery network of 6%, the basal rate 
of oxygen uptake is calculated to be 4.8 p mol/g 
vascular tissue per min at 37°C. This increases to 8.0 
and 8.7 p mol/g per min at 37°C with noradrenaline 
or vasopressin, respectively. 
Conceptually the notion of vascular tissue consum-
ing oxygen in proportion to work done during and 
whilst maintaining constriction is attractive. The 
association between striated muscle work and energy 
consumption is well established (e.g. see Gibbs, 1978 
and references therein) and thus an analogy for the 
vascular smooth muscle/endothelium exists. How-
ever, there are properties of the vascular smooth 
muscle itself as well as the vascular tree of a complex 
organ such as the hindlimb, intestine or kidney which 
make a simple relationship between perfusion pres-
sure (an index of work load) and putative oxygen 
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uptake by the vascular tissue inappropriate. Firstly, 
vascular smooth muscle is considered to have the 
potential for "latch bridge" formation. These are 
noncycling or very slowly cycling cross bridges 
formed when myosin is dephosphorylated (Murphy 
et al., 1983). Such "latch bridges" are envisaged as 
providing an internal resistance to shortening and 
thereby allow conservation of energy. Secondly vas-
cular tissue is considered to undergo vasomotion 
(Wiedman, 1984) characterized by oscillatory con-
striction and dilation. Consequently, the mean 
arterial pressure of a vascular• bed (which may be 
static) may not necessarily reflect the dynamic work 
being performed by the vasculature. - 
At the organ level it seems . likely that thoroughfare 
channels exist and that opening of these may be 
agonist-specific. For example, serotonin, which in the 
perfused rat hindlimb increases perfusion pressure 
also inhibits oxygen uptake. Estimation of perfused 
tissue volume by dye infusion and washout kinetics 
(Dora, Colquhoun and Clark, unpublished obser-
vations) supports the view that serotonin inhibits 
oxygen uptake of the rat hindlimb by closing major 
arterioles causing a pressure rise which in turn opens 
thoroughfare channels. Thus most of the vascular 
tree is not perfused due to the closing of a relative few 
major branch points. Effects of this kind may explain 
the noradrenaline-mediated inhibition of oxygen 
uptake by the perfused intestine (Fig. 4) and the 
attainment of maximal values for oxygen uptake in 
all four tissues even though perfusion pressures were 
continuing to rise (Figs 2-5). 
In conclusion the present data extend our previous 
observations (Colquhoun et al., 1988,1989; Ye et al., 
1990) by demonstrating that the vasoconstrictor 
agents, noradrenaline and vasopressin, not only 
increase pressure and oxygen uptake in perfused 
hindlimb but also in kidney, intestine and the mesen-
teric artery network. Therefore this now appears to 
be a general phenomenon and exceptions, when they 
do occur. may be explained by shunting of perfusate 
(opening of thoroughfare channels). Of the possi-
bilities that can account for the increase in oxygen 
uptake in conjunction with vasoconstriction in these 
four preparations we favour the notion that it is the 
vascular tissue itself (i.e. thermogenesis by "hot 
pipes"). Further, experiments with pressure-loaded 
isolated perfused arteries to directly test this proposal 
are currently in progress. 
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rat hindlimb is inhibited by vasodilators and augmented by norepinephrine: a possible role for the inicrovasculature in 
hindlimb thermogenesis. Can. J. Physiol. Phannacol. 68: 119-125. 
Oxygen uptake in the perfused rat hindlimb was studied at 25°C using an artificial perfusate, and the effects of perfusate 
flow rate, norepinephrine, and vasodilators were compared. Hindlimb oxygen uptake and perfusion pressure each increased 
as the flow rate was increased stepwise from 2 to 18.5 inL/rnin per hindlimb. At each flow rate, the rate of oxygen uptake 
was inhibited by the vasodilator nitroprusside (0.5 m.M) and increased by norepinephrine (5 iiM). A corresponding change 
in perfusion pressure also occurred, with norepinephrine leading to a marked increase and nitroprusside leading to a decrease; 
however, changes in oxygen uptake and pressure were not linearly related. The lactate/pyntvate ratio of the perfusate was 
used as an index of tissue perfusion and was determined at each flow rate. Lactate and pyruvate efflux increased as the flow 
rate was increased stepwise from 2 to 18.5 mL/min per hindlimb. At 2 mL/inin per hindlimb, the lactate/pyruvate ratio was 
15; at flow rates equal or greater than 4 mL/min per hindlimb, the ratio was constant at 9. Nitroprusside had no significant 
effect on the ratio at any flow rate even though a marked inhibitory effect on oxygen uptake was evident. Muscle content 
of high energy phosphates at 8 mL/min per hindlimb did not differ before and after treatment with vasodilators. In addition, 
the vasodilators had no apparent effect on skeletal muscle oxygen uptake or force development during electrical stimulation. 
The findings indicate that oxygen uptake by the hindlimb is not limited by inadequate perfusion and that oxygen uptake can 
be further increased by norepinephrine. The close association of the vasoconstrictive action of norepinephrine with the 
increase in oxygen uptake and the finding that the increase in oxygen uptake is minimal when nitroprusside is present suggest 
a central role of the vasculature in the control of muscle thermogenesis. The novel possibility that a significant proportion 
of oxygen uptake by the resting hindlimb is a consequence of the work done by cells contributing to vasoconstriction (i.e., 
thermogenesis from "hot pipes") is discussed. 
Key words: hindlimb oxygen uptake, oxygen uptake and vasoconstriction, norepinephrine, pressure-induced oxygen 
uptake, nitroprusside. 
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On a examine la consommation d'oxygene par le membre posterieur perfuse du rat a 25°C en utilisant us perfusat artificiel, 
et compare les effets de vasodilatateurs, de la norepinephrine et du debit dans le perfusat. Tant la consonunation d'oxygene 
par le membre posterieur que la spression de perfusion ont augmente quand le debit a ete accru en echelons de 2 a 
18,5 mL/min/membre posterieur. A tous les echelons utilises, le taux de consommation d'oxygene a ete inhibe par le vaso-
dilatateur nitroprusside (0,5 rnM) et augmente par la norepinephrine (5 nM). Des variations correspondantes ont aussi ete 
observees pour la pression de perfusion, qui a ete augment& de facon marquee par la norepinephrine et diminuee par le nitro-
prusside; toutefois, les variations de consommation d'oxygene et de pression n'etaient lineairement relides. La relation lac-
tate/pyruvate dans le perfusat a ete utilisee comme indice de perfusion tissulaire et determinee a chaque debit. L'efflux de 
pyruvate et de lactate a augmente quand le debit a ete accru en echelons de 2 a 18,5 mL/min par membre posterieur. A 
2 mL/min par membre posterieur, le quotient lactate/pyruvate a ete de 15; a des debits egaux ou superieurs a 4 mL/min par 
membre posterieur, ii s'est maintenu a 9. Le nitroprusside n'y a pas eu d'effet significatif a aucun debit, malgre un effet 
marque sur la consommation d'oxygene. La concentration de phosphates riches en energie dans le muscle a 8 mL/min par 
membre posterieur n'a pas differe avant, ni apres le traitement avec les vasodilatateurs. En outre, les vasodilatateurs n'ont 
pas eu d'effet manifeste sur la consommation d'oxygene ou le developpement de force dans le muscle squelettique durant 
une stimulation electrique. Les resultats indiquent que la consommation d'oxygene dans le membre posterieur n'est pas 
limit& par une perfusion inadequate et qu'elle pourrait etre augment& davantage par la norepinephrine. L'etroite association 
entre l'action vasoconstrictive de la norepinephrine et l'augmentation de la consommation d'oxygene, ainsi que la constatation 
que l'augmentation de la consornrnation d'oxygene est minime en presence de nitroprusside suggerent un role cle pour le 
systerne vasculaire dans le contrede de la thermogenese musculaire. On discute de la possibilite qu'une proportion significative 
de la consommation d'oxygene par le membre posterieur au repos soit le resultat du travail effectue par les cellules participant 
a la vasoconstriction (c.-a-d. thermogenese par conduits de chaleur .). 
[Traduit par la revne) 
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Introduction 
Thermogenesis in resting skeletal muscle has been long con-
sidered as a significant contributor to whole body heat produc-
tion (e.g., Jansky 1971; Mejsnar et al. 1980). Indeed data of 
Foster and Frydman (1978), which focused on the role of 
'Author to whom correspondence should be addressed. 
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brown adipose tissue, were also indicative of a substantial role 
for skeletal muscle. Their findings showed that for warm-
adapted and normal rats norepinephrine administration resulted 
in a 30% increase in skeletal muscle blood flow and a 60% 
increase in oxygen consumption. Such data suggested that 
muscle could produce an equal amount of heat to brown fat 
(Foster and Frydman 1979), even though oxygen consumption 
was very much less per gram of tissue. Attempts to address the 
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issue more directly by using the perfused hindlimb have sup-
ported the above conclusions. The perfused rat hindlimb has 
been found to respond consistently to norepinephrine adminis-
tration with a marked increase in the rate of oxygen uptake 
(1'02) (Mejsnar and Jansky 1973; Grubb and Folk 1976; 
Richter et al. 1982a; COte et al. 1985). This response occurred 
at rest when the hindlimb was perfused with erythrocyte-
containing medium at 37°C (Grubb and Folk 1976; Richter 
et al. 1982b) or without erythrocytes at 25°C (Cate et al. 
1985) and at high flow rate at 37°C during muscle contraction 
with erythrocyte-containing perfusate (Richter et al. 1982a). 
A surprising finding has been that the norepinephrine-
mediated increase in rat hindlimb Po 2 was mediated by an 
a-adrenergic receptor mechanism (Grubb and Folk 1977) 
that was invariably associated with an increase in perfusion pres-
sure (Richter et al. 1982a, 1982b). Recently we have reported 
that both vasopressin and angiotensin U stimulated rio2 and 
perfusion pressure in the perfused rat hindlimb with both 
effects blocked by nitroprusside (Colquhoun et al. 1988), 
thereby supporting the possibility that perfusion pressure (and 
possibly flow) controls oxygen consumption. Thus in the 
present study, perfusion flow and pressure have been varied 
over a wide range and the effects of norepinephrine and vaso-
dilators compared during varied flow. 
Since the effects of norepinephrine to increase fio 2 and of 
vasodilators to decrease 1/02 were not diminished as the flow 
approached maximum, it appeared unlikely that changes in 
perfusate distribution were responsible. Other possibilities are 
discussed. 
Methods 
Hindlimb perfusion 
Male hooded Wistar rats (180 ± 5 g body wt.) were fed a commer-
cial diet with water ad libitum and anaesthetized with pentobarbital 
sodium (5 mg/ 100 g body wt., intraperitoneal). Surgery and perfu-
sion details were as described by others (Ruderman et al. 1971; 
Richter et al. 1982a; Cote et al. 1985). Only one limb was perfused 
and a tight ligature was placed around the common iliac artery 
supplying the contralateral hindlimb. To restrict spillover blood flow 
to the lower back muscles with any rise in perfusion pressure, an 
addition ligature was placed around the abdomen of the rat approxi-
mately at the level of the L3, L4 vertebrae. A ligature was also placed 
around the tarsus of the perfused limb. Perfusions were conducted in 
a temperature-controlled chamber at 25 ± 0.2°C (Cote et al. 1985; 
Colquhoun et al. 1988). The perfusate consisted of a Krebs—Ringer 
bicarbonate buffer containing 1.27 mM CaCl2 , 4% bovine serum 
albumin, and 8.3 mM glucose. 
For perfusions where pressure was varied stepwise, the perfusate 
was allowed to flow under gravity from a reservoir kept at 4°C 
through a silastic tube oxygenator continuously equilibrated against 
a gas mixture of 95% 0 2 and 5% CO2 . The temperature of the per-
fusate was brought to 25°C by passage through a heat exchange coil. 
Perfusion pressure was measured in the pump outflow line proximal 
to the aorta. The venous effluent flowed through a 0.5-mL thermo-
statically controlled chamber (25°C) containing a Clark-type oxygen 
electrode and the effluent was discarded following measurement of its 
oxyen content. The pressure was adjusted by relocating the perfusate 
reservoir to predetermined positions above the hindlimb. Flow was 
allowed to vary and was monitored by collection into a fraction 
collector set on time mode. Vo 2 was calculated from the arterio-
venous difference in Po2 and flow rate after allowing for the delay 
in venous Po2 measurement due to electrode characteristics. Pres-
sure readings were corrected for the pressure contributed by the 
aortic cannula (determined without the animal). 
For perfusions where flow was varied, the hindlimb was initially 
equilibrated at 4 mL/min (15 g fresh weight of muscle) for 40 min. 
Flow was then adjusted to 2.0 ['IL/min using a calibrated pump and 
maintained at that rate for 30 min. The flow was then sequentially 
readjusted to 4, 6, 8, and 18.5 mL/min maintaining constant flow 
until steady-state pressure and venous P0 2 were achieved. Venous 
P02 and perfusion pressure were monitored continuously. Other 
details were as described previously (Colquhoun et al. 1988). 
Electrical stimulation 
The gastrocnemius—plantaris—soleus muscle group was stimu-
lated electrically via the sciatic nerve (Richter et al. 1982a). Twitch 
tension was recorded during electrical stimulation (200-ms trains of 
100 Hz applied every 2s; each impulse in the train being of a duration 
of 0.1 ins) adjusted (15-20 V) to attain full fibre recruitment. 
Muscles were stimulated for three periods of 2 mm each with rest 
periods of 30 min between consecutive runs. Venous P02 was moni-
tored continuously and maximum V02 were noted; these occurecl 
1-2 mm after commencement of stimulation. 
Muscle metabolites 
Skin was carefully removed from the hindlimb and the gastro-
cnemius—plantaris—soleus muscle group exposed. The group was 
freeze-clamped from anaesthetized rats (denoted "in vivo") or from 
constant-flow perfused hindlimbs following perfusion at 25°C for 
120 mm with medium at 8 mL/min containing 4% bovine serum albu-
min and the additions indicated. 
Pofusate lactate and pyruvate 
Perfusate samples were taken for analyses when steady state was 
reached as judged by pressure and V02. Lactate and pyruvate were 
determined on neutralized perchlorate extracts (Bergmeyer 1974). 
Statistics 
Significance of difference was assessed using the unpaired Stu-
dent's t-test. 
Results 
Pressure-induced changes in flow and oxygen uptake 
These experiments were conducted to assess the effect of 
changes in pressure on the rates of flow and oxygen uptake. 
The conditions chosen (erythrocyte-free perfusate at 25°C) 
were considered likely to minimize autoregulation of flow and 
the related control of capillary density (e.g., see Chinet and 
Mejsnar 1989). Figure 1 shows the effect of periodically vary-
ing the perfusion pressure from high to low while allowing 
flow to self-regulate. Initially the rat hindlimb was perfused at 
a pressure of 30 mmHg (1 mmHg = 133.3 Pa) for 30 min to 
allow complete equilibration; a constant flow rate of 5.4 mL/rnin 
was attained and the 1/02 was 7.0 ianol •h - I•g - I muscle. 
The perfusate reservoir was then raised to give a new pressure 
of 57 mmHg. Perfusate flow immediately increased to 
13 mL/min then, over the next 30 min, gradually decreased to 
11 mL/min. Po2 , calculated from the arteriovenous difference 
in Po2 and flow rate, peaked at 19.5 tanol/h per g muscle 
immediately following the increase in pressure, then decreased 
gradually over the next 30 min to 8 trmol 11 -1 g - I muscle. 
When the pressure was decreased from 59 to 20.5 mmHg by 
lowering the pc\rfusate reservoir, the flow decreased to 
1.5 mL/min and" then increased marginally to 2.0 mL/min 
(Fig. 1). Po2 decreased immediately following the fall in 
pressure and flow to 0.5 ;awl • h - I • g - I muscle but then 
gradually increased over the next 30 min to 3 ihmol • 11 - I g 
muscle. A similar relationship between pressure, flow, and Po, 
as described above was again evident when the pressure was 
reset to 32 mmHg (Fig. 1). 
Overall the extent of flow regulation in the present system 
was slow when compared with blood perfused systems where 
an increase in perfusion pressure (or flow) is followed by a 
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FIG. 1. Effect of perfusion pressure (A) on flow (B) and Vo2 (C) 
of the perfused rat hindlimb. Data are means ± SEM from four per-
fusions. 
rapid increase (2 min) in resistance to blood flow, and a 
decrease in perfusion pressure (or flow) is followed by a 
reduction in resistance to flow (Stainsby and Renkin 1961). 
The slow responses shown in Fig. 1, sometimes taking 20 to 
30 min to reach steady state, may be those of drift in a passive 
vascular bed but are in the autoregulatory direction. The lack 
of rapid auto regulation may be attributable to the use of arti-
ficial perfusate as well as to the lower temperature (25°C). 
Flow-induced changes in oxygen uptake and pressure 
The relationship between flow and steady-state oxygen con-
sumption and pressure development, as well as the effect of 
vasodilators and norepinephrine on these latter parameters is 
shown in Fig. 2. Perfusate flow rate was set at 2, 4, 6, 8, 
or 18.5 mL/min for at least 15 min and sometimes 40 min 
during which time pressure and oxygen uptake were recorded. 
Figure 2A shows that fro 2 increased as the flow rate was 
increased and that this increase was further augmented by 
5 nM norepinephrine. 
Vasodilators and flow-induced changes 
Three types of vasodilators were chosen for this study. 
Nitroprusside (acting via cyclic GMP), nifedipine (a Ca 2 + 
channel blocker), and isoproterenol (acting via cyclic AMP) 
were used. Figure 2A shows that the increase due to flow was 
inhibited by either 0.5 mM nitroprusside or a combination of 
0.5 mM nitroprusside + 1 AM nifedipine + 1 iM isopro- 
Flow rate (mL/min) 
Fto. 2. Effect of perfusate flow, norepinephrine, and vasodilators 
on Vo2 (A) and pressure development (B). Additions to the perfusate 
were none (0), 5 mM norepinephrine (A), 0.5 rnM nitroprusside 
(•), and a combination of 0.5 rnM nitroprusside, 1 AM nifedipine, 
and 1 AM isoprenaline (A). The number of perfusions are given in 
parentheses. Data are means ± SEM; bars not visible are within the 
symbols. 
terenol. The flow-dependent rise in pressure was also inhibited 
by the vasodilators (Fig. 2B). However, there was no signifi-
cant difference between the effects of nitroprusside alone or 
the three vasodilators together. 
Vasodilators and working skeletal muscle 
Since oxygen uptake by the hindlimb at all flow rates was 
markedly inhibited by the vasodilators, it was considered rele-
vant to assess the effects of these agents on working skeletal 
muscle 1:102 . Table 1 shows that neither nitroprusside alone 
nor the combination of nitroprusside, nifedipine, and isopro-
terenol had any significant effect on the increase in 1:'02 by the 
perftised contracting hindlimb at constant flow (4 mL/min). 
More importantly, the twitch tension force development was 
also unaffected by the vasodilators (Table 1). 
Muscle metabolites 
The experiments of Table 2 were conducted to assess whether 
nitroprusside-induced inhibition of hindlimb 0 2 uptake was 
associated with a decrease in muscle content of high energy 
phosphates. Table 2 shows metabolite concentrations for the 
gastrocnemius —plantaris—soleus muscle group from hind-
limbs freeze-clamped before surgery (in vivo) and following 
perfusion for 120 min with no additions, 0.5 mM nitroprus-
side, and a combination of the vasodilators nitroprusside 
(0.5 mM), nifedipine (I AM), and isoprenaline (1 /AM). None 
of the differences between muscles perfused with or without 
vasodilators or between muscles perfused and muscles in vivo 
was significant. 
Petfusate lactate/pyruvate ratio 
The lactate/pyruvate ratio is considered a reliable indicator 
of muscle oxygenation (Bylund-Fellenius et al. 1981; Shiota 
and Sugano 1986) and was thus used in the present study. 
Twitch tension (g) 
Al./o2 
 
Addition 	 0 min 2 min 	(Arnol • h -1 • g -1 ) 
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TABLE 1. Effect of vasodilators on twitch tension force development and 1 ./62 of the 
hindlimbs 
None 603 ± 132 220±49 3.90±0.38 
0.5 rriM nitroprusside 641±75 ns 200±64 ns 4.50±0.34 ns 
0.5 mM nitroprusside 
+1 AM nifedipine + 
I AM isoproterenol 547±151 ns 217±47 ns 3.86±0.42 ns 
NOTE: Data are mean ± SEM; three hindlimbs per group and perfusions were conducted at 4.0 mL/min; 
not significantly different from "none." 
TABLE 2. Metabolite concentrations in the gastrocnemius-plantaris-soleus muscle group of rat hindlimb 
Metabolite concentration (Amol/g dry wt.) 
Muscle origin n Wet/dry wt. ATP CrP Lactate Pyruvate Lactate/pyruvate 
In vivo 3 4.4±0.1 27.3±1.1 71.9±4.1 10.5±1.6 0.7±0.1 16.8±5.3 
Perfused 120 min 
No additions 5 4.5±0.2 29.7±0.9 72.5±1.9 9.2±1.0 1.0±0.1 9.2±1.1 
Nitroprusside 5 5.3±0.3 27.2±1.7 70.1±2.32 9.7±1.2 1.1±0.1 8.9±1.3 
NM 4 4.9±0.2 26.0±0.9 63.3±0.9 9.0±0.9 0.9±0.2 10.3±2.0 
NOTE: Data are mean ± SEM; perfusions were conducted at 8.0 niUmin. NNI, combination of nitroprusside, nifedipine, and isoprenaline. 
Figure 3A shows lactate and pyruvate release at each flow rate 
±0.5 mM nitroprusside. Lactate release increased as the per-
fusate flow rate was changed from 2 to 18.5 mL/min. Pyru-
vate release also increased over this range of flow rates 
(Fig. 3B). The vasodilator, nitroprusside, had no significant 
effect on either lactate release or pyruvate release. Thus the 
net effects of changing flow rate from 2 to 18.5 mL/min was 
to lower the perfusate lactate/pyruvate ratio from approxi-
mately 15 at 2 mL/min to a constant value of approximately 
9 at 4 mL/min and beyond. In addition, and as shown in 
Fig. 3C, the ratio was not affected by the presence of nitro-
prusside. Overall these data suggest that inadequate oxygen 
supply to the resting perfused rat hindlimb at 25°C occurs only 
at flow rates less than 4 mL/inin. 
Discussion 
In the present study, the effects of perfusate flow rate, 
norepinephrine, and vasodilators on oxygen uptake have been 
assessed using a system where rapid autoregulation has been 
largely avoided (Fig. 1). A principal finding was that oxygen 
uptake by the perfused rat hindlimb increased as flow was 
increased to approach a plateau at 18.5 mL/min or 1.3 mL • 
tnin - I • g - I (Fig. 2). At flow rates less than 8 mL/min, the 
hincilimb data illustrate a widely noted property of perfused non-
contracting skeletal muscle preparations where Po 2 increases 
with an increase in perfusion pressure or flow. This relation-
ship has been reported for rat gracilis muscle (Honig et al. 
1971), dog gastrocnemius-plantaris muscle group at low but 
not high blood flow levels (Stainsby and Otis 1964), dog hind-
limb with (Coburn and Pendleton 1979) or without (Pappen-
heimer 1941) norepinephrine infusion, isolated autoperfused 
preparations of the cat soleus (Whalen et al. 1973) and gracilis 
(Whalen et al. 1973) muscles, resting and isolated gracilis 
muscles of dogs (Beer and Yonce 1972), and hindlimbs of 
lemmings (Grubb and Folk 1978) and rats (Grubb and Folk  
1978; Shiota and Sugano 1986). The relationship appears to be 
readily observed in rat muscle preparations without exception 
(Honig et al. 1971; Grubb and Folk 1978; Shiota and Sugano 
1986) but, for as yet unknown reasons, is not always apparent 
in dogs (Duran and Renkin 1974, 1976; Honig et al. 1971; 
Chapler et al. 1980). 
To date, the dependence of Po2 on blood flow has been 
interpreted as a physiological limitation of 02 consumption in 
resting muscle by 02 transport, owing to the inhomogenity of 
a capillary function (Lindbom and Arfors 1985) and uneven 
distribution of 02 within the organ (Honig et al. 1971; Shiota 
and Sugano 1986). To address this issue we have used a range 
extending from approximately half to four times the normal 
hindlimb blood flow rate of the conscious rat (Armstrong and 
Laughlin 1985). Under these conditions it was noted that nitro-
prusside reduced pressure and inhibited oxygen uptake at all 
flows and particularly at the highest flow where tissue per-
fusion could be expected to be approaching the maximum. 
Furthermore, the effect of norepinephrine to increase Po, and 
pressure was greater at high than low flow rates. It could be 
argued that if areas of the hindlimb were inadequately per-
fused, any shunting effect of norepinephrine would be greater 
at the lowest flow and pressure. This reasoning is based on the 
notion that the increase in pressure due to norepinephrine 
results in increased perfusate 02 delivery to previously under-
perfused regions of t\keletal muscle and that these regions are 
more extensive at loA, pressures. 
The question of tissue underperfusion was also addressed by 
assessing the biochemical indices of hypoxia. Poorly perfused 
muscle has a lower creatine phosphate concentration (Ruder-
man et al. 1971; Challiss et al. 1986) and increased production 
of lactate (Ruderman et al. 1971). Thus, to assess the possi-
bility that nitroprusside-induced inhibition of 02 uptake 
resulted from tissue underperfusion, a representative sample 
of muscle (the gastrocnemius -plantaris -soleus group) was 
freeze-clamped and assayed for the content of ATP, creatine 
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FIG. 3. Effect of perfusate flow and nitroprusside on lactate (A) and 
pyruvate (B) release as well as the perfusate lactate/pyruvate ratio 
(C). Additions to the perfusate were none (0) or 0.5 mM nitro-
prusside (s). The numbers of perfusions are given in parentheses. 
Values in A and B are the product of concentration (Amol/mL) x 
flow rate (mL/min). Data are means ± SEM; bars not visible are 
within the symbols. 
phosphate, lactate, and pyruvate. If the vasodilators decreased 
r/o2 by decreasing the area of skeletal muscle actually per-
fused, then it could be expected that creatine phosphate and 
ATP levels would be lower following this treatment. Despite 
the fact that the vasodilators had resulted in a 40% inhibition 
of 02 uptake under the conditions chosen, there was no sig-
nificant difference between vasodilator-treated and untreated 
muscle with respect to metabolite concentration. 
The lactate/pyruvate ratio is a sensitive index of hypoxia 
(Bylund-Fellenius et al. 1981) and was also used in the present 
study to assess whether the increase in 1'02 by the hindlimb 
induced by the increase in perfusate flow rate was the result 
of increasing 02 delivery to previously underperfused regions. 
Since the ratio was higher at 2 nth/min per hindlimb than at 
all other flow rates and was constant at rates equal to or greater 
than 4 mL/min per hindlimb, it appeared unlikely that hind-
limb tissue was underperfused at flow rates other than 
2 mL/min per hindlimb. It is also worthy of note that 0.5 mM 
nitroprusside which inhibited Po2 at 18.5 mL/rnin per hind-
limb to a value similar to that of the untreated hindlimb per-
fused at 5 mL/min had no effect on the lactate/pyruvate ratio 
at the high flow rate. These data taken together imply that 
flow- and agonist-induced 1'02 results from processes other 
than changes in 02 delivery to skeletal muscle fibres. 
Another finding made in this study was that the vasodilator,  
nitroprusside, did not inhibit oxygen uptake or twitch-tension 
development by working skeletal muscle. This contrasts with 
its marked effect to inhibit oxygen uptake induced by vasocon-
strictors (Colquhoun et al. 1988) or pressure (Fig. 2) where 
dilation of thoroughfare channels might have occurred. How-
ever, the opening of thoroughfare channels would be expected 
to compromise oxygen availability to working skeletal muscle 
and thereby reduce working skeletal muscle oxygen uptake 
and twitch-tension development. Clearly this was not evident 
from the present experiments (Table 1) and thus further inves-
tigations are required. 
A direct effect of norepinephrine on skeletal muscle to 
increase oxygen uptake would be consistent with the observa-
tions made in the present study. However, it must be kept in 
mind that the effect of norepinephrine is mediated by a-adren-
ergic receptors (Grubb and Folk 1977; Richter et al. 1982a) 
and that oxygen uptake by the hindlimb is also increased by 
vasopressin or angiotensin II (Colquhoun et al. 1988). There 
are relatively few, if any, a-adrenergic receptors on striated 
muscle cells (Rattigan et al. 1986) and a biochemical mechan-
ism to account for the large increase in oxygen consumption 
is yet to be defined. Furthermore, the failure to observe stimu-
latory effects of norepinephrine on oxygen uptake by isolated 
(unperfused) muscles in vitro (Hannon et al. 1963; Eaton 
1964) or homogenates (Hannon et al. 1963) comparable to 
those reported for the perfused hindlimb (Mejsnar and Janslcy 
1973; Grubb and Folk 1976; Richter et al. 1982a; COte et al. 
1985; Colquhoun et al. 1988) suggests a complex mechanism, 
possibly dependent upon a functioning vascular system. 
It is interesting that there has been no discussion by other 
researchers in this field of the possibility that work performed 
by the vascular system in holding or resisting the perfusion 
pressure could contribute to the f/o2 . This may be because the 
possibility has not been directly explored, or that 17o2 by iso-
lated vascular smooth muscle preparations so far tested 
appears to be considerably lower than that required to account 
for pressure- or agonist-induced changes in Po2 . Literature 
values for Vø2 obtained by Warburg techniques of various 
vascular smooth muscle fragments incubated in vitro at 37°C 
(see review by Paul 1980) range from 0.03 to 0.15 Amol • g - I 
wet wt. • min - I. However, 1'02 for cannulated canine femoral 
artery (0.446 Amol • g - I wet wt. • min -1 ) is more than 10-fold 
greater than incubated segments (0.040-0.051 i.anol • g -
wet wt. • min - (Kosan and Burton 1966), which may reflect 
the effect of pressure loading of the vessel. Microvessels also 
have the potential for considerable rates of oxygen uptake. Iso-
lated unstimulated, nonperfused brain microvessels have an 
endogenous rate of oxygen uptake of 10.9 nmol min - I • mg - I 
protein at 37°C (Brendel et a. 1974). At 150 mg protein/g v7et 
wt. this corresponds to 1.6 amol • g - I wet wt. • min - I. Such 
vessels can further increase their oxygen uptake threefold 
when given succinate as a substrate (Sussman et al. 1988) and 
presumably would use even more oxygen when pressure 
loaded-rtalculations based on the data of Fig. 2A indicate that 
the maximal norepinephrine-induced increase in P0 2 of the 
hindlimb would be comparable to the above values. Thus the 
difference in oxygen uptake values between norepinephrine 
and nitroprusside at a flow rate of 18.5 mL/min of 10.4 timol - 
h -1 • g - I muscle tissue at 25°C would equate to 5 AMO1 • 
min - I • g I vascular tissue if this latter tissue was 3.4% of 
the hindlimb muscle mass (Paul 1980). At 37°C, with a Q 1 10 
of 2.5 (Paul 1980) it would correspond to 12.7 Arno' • min - I • 
g vascular tissue. Working muscle is capable of high rates 
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of oxygen consumption and rates of approximately 6 Amol • 
min -1 • g - I have been reported for contracting dog gastro-
cnernius muscle in situ (Stainsby et al. 1984) and the Langen-
dorff perfused beating rat heart at 60 nunHg aortic pressure 
(Randle and Tubbs 1979). Even higher rates of oxygen uptake 
(approximately 14 Amol min - I g - I) have been reported for 
the Langendorff perfused beating rat heart at 120 mmHg aortic 
pressure (Randle and Tubbs 1979). Thus the key issues are the 
actual hindlimb content of vascular smooth muscle and its 
inherent oxidative capacity during contractile activity. Histo-
chemical properties of arteriolar smooth muscle are consistent 
with this tissue being capable of higher rates of oxidative 
metabolism than surrounding skeletal muscle (Granger et al. 
1984). 
Within the context of whole body thermogenesis, it is rele-
vant to consider the hindlimb oxygen uptake data in relation 
to similar studies on brown adipose tissue. The difference in 
oxygen uptake values between norepinephrine and nitroprus-
side at the flow rate of 18.5 mL/min of 10.4 Amol • h - I • g - I 
muscle tissue at 25°C (Fig. 2A) can be used to calculate the 
maximum component of nonshivering thermogenesis that 
might be attributable to vascular control for the intact warm-
acclimated rat. The increase in oxygen uptake of 10.4 umol • 
h' muscle corresponds to 1.32 W/kg muscle at 25°C, 
assuming a standard average energy value of 4.83 kcal/L 02 
at STP (1 kcal = 4.1855 kJ) (Brown and Brengelmann 1965). 
At 37°C, with a Q lo of 2.5 (Paul 1980) this would equate to 
3.3 W/kg muscle, and for a 200-g rat with 43% of the body 
mass as muscle to 0.28 W. For comparison, brown adipose 
tissue content of the warm-acclimated rat of approximately the 
same body weight is 1.22 g (Smith and Horwitz 1969; Hinuns-
Hagen 1970; Bukowiecki et al. 1980) and has a total capacity 
for catecholamine-stimulated thermogenesis of 1.5 mL 0 2/min 
(Bukowiecki et al. 1980). This would correspond to 0.37 W. 
Thus the potential contributions from muscle tissue and brown 
adipose tissue are similar and together could account for 65% 
of the thermogenic response to catecholamines of adult warm-
acclimated rats weighing 200-250 g of 3 mL 0 2/min or 1 W 
(Bukowiecki et al. 1980). 
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Vasoconstrictors alter oxygen, lactate, and glycerol 
metabolism in the perfused hindlimb of a rat kangaroo 
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Departments of Biochemistry and Zoology, University of Tasmania, 
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Colquhoun. Vasoconstrictors alter oxygen, lactate, and glyc-
erol metabolism in the perfused hindlimb of a rat kangaroo. 
Am. 1. Physiol. 268 (Regulatory Integrative Comp. Physiol. 
■ 71: R1217-R1223, 1995.—The Tasmanian bettong (Betton- 
gaimardi) is a small marsupial rat kangaroo without 
:ectable brown adipose tissue (BAT). The hincilimb was 
perfused with constant flow at 25'C after cannulation under 
anesthesia of the femoral artery and vein to one hindlimb. 
Norepinephrine (NE, 25 ruM-2.5 1..M) and vasopressin (VP, 10 
paNI) each increased perfusion pressure, oxygen con-
sumption (V02), and lactate and glycerol efflux of the perfused 
hindlimb. NE-mediated increases in V02 and the efflux of 
lactate and glycerol were unaffected by propranolol (10 I.LIM) 
but were completely blocked by the further addition of phentol-
mine (10 1.1.M). In contrast, serotonin (5-HT; 0.1-2.5 MM) 
.hib ited V02 and inhibited lactate efflux. The changes induced 
Jy NE, VP, and 5-HT were all rapidly reversed by nitroprus-
side. These results suggest that resting thermogenesis in 
bettong hindlimb can be differentially controlled by the vascu-
lature, which may also contribute to the induced V02. This 
vascular control of skeletal muscle Vo2 appears widespread in 
homeotherm evolution. 
marsupial: Bettongia gaimardi; vasoconstriction; energy me-
tabolism; thermogenesis: skeletal muscle 
MARSUPIALS ARE A DIVERSE GROUP of mammals with 
well-developed thermoregulation. The Tasmanian bet-
tong (Bettongia gaimardi) is a rat kangaroo closely 
related to the larger kangaroos and wallabies. At birth, 
the bettong is ectothermic. The young becomes progres-
sively endothermic before it finally vacates the pouch 
(25). Intramuscular injection of norepinephrine (NE) 
elicited a significant increment in oxygen consumption 
(Vo2 ) in vivo in the potoroo Potorous tridactylus (Kerr), 
a close relative of the bettong, and this increase was 
blocked by propranolol but not by phenoxybenzamine 
(23). Hayward and Lisson (15) have presented strong 
anatomic and microscopic evidence that marsupials, 
including bettongs, do not possess brown adipose tissue 
(BAT), which is a major contributor to nonshivering 
thermogenesis in most newborn and small eutherian 
mammals. This characteristic makes the bettong a valuable 
animal for the study of nonshivering thermogenesis occur-
ring in tissues other than BAT, such as skeletal muscle. 
The perfused rat hindlimb preparation has proved to 
be a useful model in defining the controlling influences 
for thermogenesis originating from skeletal muscle, 
particularly under resting conditions. Thus in the per-
fused rat hindlimb. we have found that vasoconstrictors 
(excluding serotonin (5-HT)I such as NE. epinephrine 
(Epi), vasopressin. (VP), and angiotensin (ANG) I, II, 
and III, increase Vo 2 within a limited dose range while 
causing vasoconstriction in a constant-flow preparation 
(8, 9, 32, 33). In addition, vasodilators, such as nitroprus-
side, nifedipine, and isoproterenol, blocked the vasocon-
strictor-mediated Vo 2 (7-9). Increasing perfusion flow 
also increased Vo2 , which could be further augmented 
by NE but depressed by nitroprusside (33). 
Thus the concept has emerged (7) that either in-
creased flow to, or vasoconstriction within, the rat 
hindlimb led to enhanced thermogenesis from this 
vascular bed. However, the findings that 5-HT (11) and 
high, but not low, concentrations of NE decreased Vo2 
by the constant-flow perfused rat hindlimb have led to a 
modification of the above proposal (6) and suggested the 
possibility that preexisting vascular tone, particularly in 
vivo, might be under some circumstances inhibitory. If 
so, then vasodilators, such as 6-adrenergic agonists, 
could also exert a positive thermogenic response . by 
decreasing the preexisting inhibitory effect on Vo 2 . 
Alternatively, 0-activation, by increasing cardiac output 
and hence flow to muscle, may increase thermogenesis 
(33). These two explanations are not mutually exclusive 
and could coexist. 
No study on Vo2 in a perfused marsupial hindlimb has 
been found in the literature. As a result of a successful 
breeding program, a small number of bettongs, which 
are legally protected under state law, became available 
for experimentation. Accordingly, the present study 
attempted to examine whether the vasoconstrictive 
hormones. NE, VP, and 5-HT. have any effect on Vo 2 
and on lactate and glycerol efflux from the perfused 
hindlimb of the bettong, as an example of marsupial 
muscle metabolism. 
METHODS 
Animals. Bettongs of either sex were obtained from the 
University of Tasmania breeding colony by R. W. Rose,. The 
experiments were approved by the Ethics Committee of the 
University of Tasmania under the Australian Code of Practice 
for the Care and Use of Animals for Scientific Purposes. The 
animals were housed in room-size cages (approximately 6 x 
m) in an outdoor animal compound with free access to food at -it 
water. During the period of experiment. the seasonal tempera-
ture ranged between 18 and 28°C during the daytime and 
between 10 and 20°C at night. Diet was a choice of apples. 
bread. and Pal dog pellets (Uncle Ben's of Australia,. contain-
ing 15% crude protein and 10% fat. 
Hindlimb perfusion. The animals ( mass 1.2 0.11 kg) were 
anesthetized with an intraperitoneal injection of pentobarbital 
sodium at a dose of 60 mg/ kg. Additional injections were given 
to maintain the anesthesia when required. An incision was 
made distal to the inguinal ligament The femoral artery and 
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vein were exposed. Heparin (1.000 RD was injected into the 
fernoral vein at the level of the inguinal ligament 1 min before 
cannulation, and an arterial cannula and a venous cannula 
were then inserted into the respective vessels just below the 
branch points for the superficial iliac circumflex artery and 
vein. A tight ligature was placed around the circumference of 
the thigh - 1 cm above the two cannulas, and another tight 
ligature around the tarsus. so  that only the muscle bed distal 
to the inguinal ligament of the limb was perfused. The mass of 
muscle perfused was determined for the first three animals by 
excising and weighing dye-containing muscle from the contra-
lateral limb that had been infused with perfusion medium 
containing Evans blue (1% wt/ vol) after the same surgical 
procedures and heparinization of the animal but before the 
perfusion commenced on the remaining hindlimb. A regres-
sion formula was then calculated 1perfused muscle mass (g) = 
[31.87 X body wt (kg)] - 9.05 (r = 0.9993, P < 0.05)1 and was 
applied to the following experimental animals, on the assump-
tion that both hindlimbs were identical in muscle mass. A 
similar surgical strateu was adopted when muscle samples 
were collected from the contralateral hindlimb for the in vivo 
muscle lactate and phosphagen samples. After such sampling 
the femoral artery and vein were ligated together with a 
circumferential ligature around the thigh to prevent any 
hemorrhage before perfusion of the remaining hindlimb. 
The perfusion method was essentially that previously de-
scribed for the rat hindlimb by Colquhoun et al. (9). The 
perfusate consisted of Krebs-Ringer bicarbonate buffer contain-
ing 1.27 mM CaC12, 2% bovine serum albumin, and 8.3 raM 
glucose. The perfusate was pumped from a reservoir kept at 
4°C through a Silastic tube oxygenator continuously equili-
brated against a gas mixture of 95% 02-57c CO2 and a heat 
exchanger connected in series at 25°C. The V02 w„as calculated 
from arteriovenous difference of oxygen partial pressure mea-
sured with a Clark-type oxygen electrode as follows 
Vo2( m.mol • g -1 • lc I) = 1.508 
x (Pa02 - Pv02 )(mmHg)11,000 (m1/1) x muscle mass (g)1 
x 60 ( min/h) x flow rate (nil/min) 
where 1.508 (p.mo1.1 -1 - mmHg-1 ) is the Bunsen coefficient for 
plasma at 25°C (5), and Pao„ and Pvo z are arterial and venous 
oxygen partial pressures, reipectively. 
The Pao, was measured at the beginning and end of each 
perfusion by connection of arterial and venous lines without 
passing through the hindlimb, so that diffusional losses from 
the tubing would be the same during perfusion. Pvo, was 
continuously monitored throughout the perfusion by passing 
the effluent through a Clark-type oxygen electrode with a 
chamber volume of 0.5 ml. The perfusion pressure was also 
continuously monitored through a sidearm connected to the 
perfusion line before the arterial cannula and recorded via a 
pressure transducer. To avoid the perturbation to metabolite 
assays by erythrocytes and to allow comparisons with results 
already obtained in our laboratory from other species (8, 9, 11, 
16), the perfusion was conducted with an erythrocyte-free 
medium at 25°C. The perfusion flow rate per mass of hindlialb 
muscle (0.28 = 0.02 ml g -1 - min -1 ) was adjusted to be as close 
as possible to the flow rate used previously for the perfused rat 
hindlimb (0.27 ml min -1 ) (8, 9, 11, 16). For all perfusions 
the Pv02 remained >200 mmHg, indicating hindlimb flow was 
adequate. 
Calorimetric measurement. The system was composed of a 
sealed respiratory chamber sitting in a water bath, a coil of 
copper piping placed in the water bath to act as a heat 
exchanger for the inlet air, a vacuum pump for controlling air  
flow through the chamber, a sampling pump, and a modified 
02-000 gas analyzer (Datex. Labtech. Helsinki, Finland ). Th ,. 
experiments were performed between 10 A.M. and 6 P.m.. 
which is in the animal's normal sleep and quiescent phase. 
Bettongs were placed in well-ventilated coarse-woven jute 
bags to reduce ambient light influences to a minimum and 
were then moved into the respiratory chamber maintained 
25°C. The flow rate of air through the chamber was adjust-' 
between 6.5 and 8.0 limin to keep the expired CO, below 
The expired air was continuously monitored with th 
analyzer, and the data were collected and stored in a computer 
for every 1-min interval during the period of experiment. The 
resting metabolic rate was taken as the minimum 5-min 
average when the animals stayed quiet. Normally, animals 
settled well within 15 min, but 30 min were allowed to elapse 
before data were collected. For comparison, metabolic rates 
were also determined on rats male Wistar, 180-200 g) in the 
same system. Heat production was calculated from the oxygen 
consumed at rest under conscious condition with the me - .d 
by Weir (30). 
Metabolite assay. For the measurement of muscle met“0.- 
lites, the calf muscle group (gastrocnemius-plantaris-soleus 
group) was freeze-clamped with liquid N2-precooled alumi-
nium tongs. The in vivo samples were taken under anesthesia 
before perfusion from the contralateral leg. The perfused 
samples were taken at the end of the perfusion. Samples, after 
storage at -80°C, were processed by pulverizing under liquid 
N2, and a portion (200 L.-- 20 mg) was homogenized in 2.0 ml of 
perchloric acid (0.42 M), which was then neutralized with 
dipotassium hydrogen phosphate (1.0 M) to pH 6.5. .e 
neutralized perchloric acid extract was then used for the &iy 
of muscle lactate (0.2 ml) and high-energy phosphate com-
pounds (10-20 ill). For the measurement of lactate and 
glycerol release, 2.0 ml of venous effluent were collected either 
at each steady state or at nominated times for the time-
response curves and were frozen ( -20°C) until assay. The 
arterial perfusate was used as the blank in the assays. Lactate 
was assayed according to the method of Gutmann and Wahl-
feld (14). Glycerol was measured enzymatically, essentially as 
described by Wieland (31), using the change in fluoresceni 
NADH measured with an Arninco-Bowman spectrophotoi. 
rometer set at 340 nm (excitation) and 460 nm (emission). 
High-eneru phosphate compounds were determined by high-
performance liquid chromatography (26) with a Nova Pak Cig, 
4-1.arl column (Waters Associates). 
Chemicals. The enzymes, NAD, AMP, ADP. and ATP were 
purchased from Boehringer Mannheim (Germany). NE, VP, 
5-HT, phentolamine, and propranolol were obtained from 
Sigma (St. Louis, MO). Bovine serum albumin (fraction V) was 
obtained from Boehringer Mannheim Biochemicals (Indiani• - 
lis. IN ) and dialyzed five times against distilled water. Soa 
nitroprusside was purchased from Merck. All other chemiu..i. 
were analytic grade from Ajax Chemicals (Australia). 
Statistics. Student's t-test was used for the statistics, and 
P < 0.05 was considered significantly different. All values are 
presented as means SE. 
RESULTS 
Validation of perfusion. Hindlimb perfusions were 
performed on eight bettongs (7 male, 1 female). Tab. 
shows the mean values for body weight of these you...„; 
animals aged 6-8 mo, which have left the pouch for 
some time. The mass of perfused skeletal muscle, as well 
as the Pao,, perfusion pressure, hindlimb Vo 2, and rate 
of release Of lactate and glycerol under basal conditions 
are also shown in Table 1. Perfusion conditions op- 
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Table 1. Basal measurements for perfused bettong muscle 
Body Mass, 
kg 
Perfused 
Muscle Mass. 
Perfusate 
Flow Rate. 
ml • g- • min - 
Perfusion 
Pressure. 
mmHg 
Arterial P02 , 
mmHg 
vo,, 
emolg -h ' 
Lactate 
Efflux. 
AMOI • g- • 
Glycerol 
Efflux. 
ILmol • g- '• h 
1.20 =0.11 	25.0 = 2.34 	0.28 = 0.02 	32.0 = 2.30 
	
685.6 = 10.3 	4.18:0.35 	4.41 = 0.39 	0.28 :t 0.03 
Values are means SE: n 7-8 animals. 
peared stable; Vo2 as well as lactate and glycerol efflux 
remained constant for 3-4 h. Measurement of metabo-
lites in the frozen gastrocnemius-plantaris-soleus muscle 
group at the end of the perfusion period showed that 
there were no significant statistical differences of ad-
enine nucleotides between the muscle samples obtained 
in vivo and after perfusion. In fact, the concentration of 
lactate and creatine decreased (P < 0.01), and the phos-
phocreatine-to-ATP ratio was improved (P < 0.05) af-
ter the perfusion (Table 2). These results show an 
essentially normal metabolite profile of the perfused 
muscle without evidence of hypwda. 
Actions of vasoconstrictors. As shown in Fig. 1, NE, 
VP, and 5-HT each exerted a qualitatively similar 
dose-dependent vasoconstrictive effect in the perfused 
bettong hindlimb. Their other effects on Vo2 and on 
lactate and glycerol efflux aggregated into two different 
sets of responses. Thus qualitatively, NE and VP in-
duced increases in Vo 2 and in lactate and glycerol efflux, 
which appeared to be closely associated with the changes 
in perfusion pressure. NE-induced changes attained a 
maximal value at - 1.0 p.M NE, with increases > 100% 
over the basal in the three variables. Above this dose, 
values of Vo2 tended to decline, although the perfusion 
pressure continued to rise, Similarly, VP stimulated, 
but to a lesser degree, the Vo 2 and the efflux of lactate 
and glycerol, with maximal values occurring at -25 nM. 
Perfusion pressure continued to increase with dose.. In 
contrast to NE and VP, 5-HT significantly inhibited VO2 
(P < 0.05) in the concentration range 0.1-2.5 1.1.M dur-
ing vasoconstriction. However, the inhibition of lactate 
and glycerol efflux by 5-HT was not large in magnitude 
and reached statistical significance only for lactate 
efflux. After termination of infusion of each of the 
vasoconstrictors, values for Pvc, and perfusion pressure 
returned to basal values thrOughout the periods of 
perfusion, which lasted at least 3-4 h. 
Effects of a- and 0-adrenergic antagonists on NE-medi-
ated effects. Changes in perfusion pressure, Vo 2 , and 
lactate and glycerol release in response to NE were rapid 
in onset, sustained, and rapidly reversible (Fig. 2). In the 
- - presence of the 8-adrenergi c antagonist propranolol (10 
p.M DL-racemic), NE-induced perfusion pressure tended 
to be higher, but Vo2 and lactate and glycerol release in 
the presence of NE and propranol were not statistically 
different from values with NE alone. However, the 
additional infusion of the a-adrenergic antagonist, phen-
tolamine (10 completely blocked the rise in perfu-
sion pressure as well as the increases in Vo2 and in 
lactate and glycerol release elicited by NE. 
Effect of nitroprusside. The nitrodilator sodium nitro-
prusside (1.0 mIVI) completely blocked the rise in perfu-
sion pressure and the changes in Vo2 stimulated by NE, 
VP, and 5-HT (Fig. 3). Nitroprusside also blocked the 
increased release of lactate and glycerol elicited by NE 
and VP and reversed the inhibitory effects elicited by 
5-HT on lactate and glycerol efflux (data not shown). 
Metabolic rate. The bettongs studied by indirect calo-
rimetry were slightly larger than those killed for perfu-
sion studies. The weight (mean SE) of the animals 
was 1.7 ± 0.1 kg (n = 7). The Vo2 was 23 ± 2 p.M0i* h -1 - g 
body wt - 1 , which is equivalent to a resting heat produc-
tion of 249 ± 21 kJ • kg-1- - day -1 . Under these conditions, 
the rat Vo2 amounted to 60 ± 1 p.mol g body wt -1 
(i.e., 656 _t 	kJ • kg- i- day -1 ). 
DISCUSSION 
In the present study, bettong hindlimbs were per-
fused at 25°C at flow rates chosen to give a constant flow 
per unit mass of muscle of 0.28 mil min - g-1 (Table 1). 
This constant flow rate was the same as that employed 
by us previously for rat hindlimb perfusions at the same 
temperature (8, 9, 11, 16). Perfusions were performed 
without red blood cells to prevent their contribution to 
lactate production (16). This necessitated a lower tem-
perature of 25°C to allow delivery of sufficient oxygen to 
the preparation, which was stable throughout the experi-
mental period. The characteristics of the perfused hind-
limb preparation, as well as incubated muscle at 25°C for 
the study of muscle metabolism, have been recently 
reviewed, and the data were generally comparable to 
Table 2. Metabolitl of bettong gastrocnemius-plantaris-soleus muscle group 
Amol/g wet wt 
EC 	PCriATP 
Lactate 	Cr 	PCr 	AMP 	ADP 	ATP 
	IAN 	Cr+ PCr 
In vivo 	3.12 = 0.55 71.98 = 1.87 22.51 = 0.44 0.036 =0.003 0.595 = 0.023 5.22 = 0.20 5.85 =0.21 94.48 =6.58 0.943 = 0.002 4.33 = 0.21 
Perfused 	1.21 0.11 59.91:3.01' 23.41 :1.18 0.030:0.004 0.476:0.016 4.68:0.23 5.18:0.23 83.31l4.031' 0.948:0.002 5.03 c0.21t 
Values are means SE: it = 5 samples/ group. Muscle samples were freeze-clamped with liquid N2-precooled aluminium tongs. The in vivo group was 
taken under anesthesia, whereas the perfused samples were taken at the end of the perfusion. Among the perfused group_ 3 muscle samples were taken 
after the removal of vasoconstrictors. 1 in the presence of norepinephrine (0.1 ',M) and the other in the presence of 5-hydroxytryptamine (1.0 uM). As no 
significant differences in the metabolites were found in the presence or absence of the vasoconstrictors. data were pooled in 1 group. ZAN. total adenine 
nucleotides; Cr. creanne: PCr. phosphocreatine: EC. energy charge. EC = (1/2lADP) + fATPIIMAMPl+ ADP] fATPIL where (AMP). [ADM, and IATPI 
refer to concentrations of AMP. ADP. and ATP. respectively. • P < 0.01. tP < 0.05 vs. in vivo. 
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Fig. 1. Dose-response curves for vasoconstrictor-mediated changes in 
perfusion pressure, oxygen consumption (V02), and lactate and glyc-
erol efflux in the perfused bettong muscle. Basal values are shown in 
Table 1. Data are presented as means it SE; nos. in parentheses are 
nos. of samples. Error bars when not visible are within symbols. VP, 
vasopressin; NE, norepinephrine; 5-HT, serotonin. Significance for 
5-HT data is indicated: • P < 0.05, P <0.01. 
those obtained at 37°C by applying a Q 10 of 2.5 (2), where 
Qi0 refers to the rate of change of muscle metabolism 
per 10°C increase in temperature. 
While resting hindlimb perfusion pressures are at 
first sight low, arterial pressures will necessarily be 
lower than in vivo when a cell-free, low-viscosity perfus-
ate is employed. In addition, there is neither resting 
sympathetic tone nor circulating vasoconstrictors in the 
perfused hindlimb. Thus the arterial tree is almost fully 
relaxed as shown by the fact that vasodilators (e.g., 
nitroprusside) do not lower the perfusion pressure (Fig. 
3). The in vivo blood flow rates to the skeletal muscle of 
the bettong's larger relative, the red kangaroo (Macro-
pus rufus), at rest under different environmental tem-
peratures ranged from 0.010 to 0.053 ml min -1 - g-1 
(22). Thus if similar flow rates apply to the bettong, the 
flow rate we employed is approximately 5 to 28 times 
greater than in vivo. Furthermore, because there is little 
diminution of pressure in the dilated arterial and arterio-
lar beds, the capillary exchange pressures will be suffi-
cient. Adequate perfusion and oxygen delivery to the  
hindlimb preparation at rest and under the maxima. 
vasoconstriction or Vo2 are indicated by the normal 
values for intracellular lactate, high-energy phosphate 
compounds, and the calculated energy charge in per-
fused muscle (Table 2). This is further supported by 
values for Pv,a, that at no stage fell below 200 mmHg. 
The basal Vo., of the perfused bettong hindlimb, which 
for calculation we have attributed to the mass of skeletal 
muscle present, was 4.18 ± 0.35 p.mol g-1 - h -1 , which is 
-65 that of perfused rat hindlimb of 6.4 p.mol • g-1 • h - 
(8, 16). When the whole body resting metabolic rate: 
were measured under the same conditions, the meta-
bolic rate of 249 ± 21 ItJ• kg - 1 . day -1 (n = 7) for the 
bettong was 38% that of the rat at 656 ± 10 
kJ- day -1 (n = 7). These latter metabolic rates 
were similar to those obtained by others in a closely 
related species of bettong (29) and in the rat (20). 
Although there are a number of reports on the effect 
of infused NE on Vo 2 in the perfused muscle in euthe-
rian mammals such as the rat (8, 13, 32) and the do, 
(24), to the best of our knowledge this is the first report 
on the effects of vasoconstrictors (i.e., NE, VP, and 
5 -HT) on Vo2 and on lactate and glycerol efflux in 
perfused marsupial hindlimb and hence in a noneuthe-
rian. homeotherinic species. 
In the perfused bettong hindlimb, increases in Vo2 
and in both lactate and glycerol efflux were observed in 
response to NE and VP, whereas decreases in Vo 2 and in 
lactate and glycerol efflux were noted with 5-HT (Figs. 
and 2). The changes in Vo2 and in lactate in response to 
these vasoconstrictors were qualitatively similar to those 
observed previously in the perfused rat hindlimb (8, 9, 
11). A new observation for muscle perfusion was that 
changes in the glycerol . efflux closely paralleled the 
changes in the hindlimb Vo2 and lactate (Figs. 1 and 2). 
The production of lactate and glycerol will have thermo-
genic potential in vivo if they are subsequently taken up 
by other tissues such as the liver and resynthesized • 
carbohydrate or lipid, as these processes would requi: e 
additional energy expenditure. 
Analysis of the dose-response data (Fig. 1) for the 
perfused bettong hindlimb shows that the thermogenic 
response to NE started at 25 riM, which is almost 25 
times higher than that required for the perfused rat 
hindlimb under the same conditions (9). The increase in 
Vo2 stimulated by NE of - 100% above the basal value 
was greater than that of the perfused rat hindlin -  
which increases by approximately 60-70% at the sa: 2 
flow rate (9, 16, 33). At present, no data on circulating 
NE are available for the bettong, and in general, data are 
sparse for all marsupials. However, a small marsupial, 
the sugar glider (27), and the platypus (21) show resting 
and stressed values of NE aOrcodmately 3- to 10-fold 
higher than those of the rat - thus the present observa-
tions may be relevant to field conditions. 
Marsupials appear to have more skeletal muscle than 
eutherians. Red and gray kangaroos have 52% of bc v 
mass as skeletal muscle, which is 6-8% more than in ti,e 
wildebeest or Thomson's gazelle and - 20% more than 
in domestic eutherian species (28). The blood flow to the 
marsupial skeletal muscle varies considerably in re- 
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Fig. 2. Effects of a- and lit-adrenergic antagonists on 
NE-mediated perfusion pressure, Vo2, and lactate and 
glycerol efflux. Prop, propranolol (10 aM racemic); Ph, 
phentolamine (10 aM); NE (0.1 uM). Data are means ± SE 
from 3 experiments. 
sponse to the environmental temperature. For example, 
distribution of cardiac output to skeletal muscle in-
creased from 4% at 37°C to 23% at 7°C (22). When 
exposed to the cold, the maximal heat production of 
mm Hg 
Fig. 3. Representative tracing of inhibitory effect (n 2-3) of nitro-
prusside (NP, 1.0 mM) on partial pressure of venous oxygen (Pv0.,; 
Lop) and perfusion pressure (bottom) mediated by NE (0.1 aM), 5-HT 
(2.5 aM), and VP (25 nM). 
small marsupials can match or exceed that of rodents of 
similar size (10). Thus the present study, when taken in 
conjunction with these observations, suggests that mar-
supial skeletal muscle may contribute a larger propor-
tion to whole body thermogenesis than the skeletal 
muscle in eutherian species. As the bettong and other 
marsupials have been shown not to possess histologi-
cally apparent BAT (15), the bigger relative increase in 
NE (or other vasoconstrictor)-induced energy metabo-
lism and the greater proportion of skeletal muscle may 
compensate for the lack of BAT in these species. 
Unexpectedly, the NE-induced glycerol release was 
found to be mediated through a-adrenergic receptors as 
shown by its blockade by phentolamine plus propranolol 
but not by propranolol alone (Fig. 2). Activation of 
lipolysis by Epi has been reported in the perfused mouse 
hindlimb, and 13-adrenergic receptors were thought to be 
responsible (3). We are unaware of any study so far that 
characterizes increased glycerol efflux mediated by a-ad-
renergic receptors, VP, or its inhibition by 5-HT. On the 
contrary, inhibition of adipose tissue lipolysis has been 
associated with activation of the a2-adrenergic receptor 
(17). A recent autoradiographic study indicates that 
3-receptors were predominantly distributed on skeletal 
muscle cells while the a-receptors were much more 
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sparse and were 30 times higher on arterioles than in 
the surrounding skeletal muscle (19). Nevertheless, the 
NE-mediated Vo 2 and lactate and glycerol efflux in the 
present experiment is a-receptor dependent rather than 
(3-receptor dependent (Fig. 2), suggesting blood vessels 
are somehow involved in the increased metabolism. The 
close parallel relationship between vasoconstrictor-
mediated glycerol release and Vo 2 change implies that 
the vasoconstrictors may play a role in modulating lipid 
mobilization either directly by receptor activation or 
indirectly by association with smooth muscle contrac-
tion to adjust the fuel sources for skeletal muscle 
thermogenesis. We have recently made similar prelimi-
nary findings of NE-mediated increases in glycerol efflux 
in the perfused rat hindlimb in the presence of proprano-
lol (6). Chin et al. (4) have shown that infused lactate 
can lead to increased glycerol production in the perfused 
rat hindlimb. Hence in the present study, which uses a 
once-through perfusion, another potential source of 
glycerol would be the conversion of a small proportion of 
lactate to glycerol downstream from the site of lactate 
production. 
The lack of a P-adrenergic stimulation of Vo 2 in 
perfused bettong hindlimb (Fig. 2), which was also 
found in the perfused rat muscle (8), contrasts with the 
well-known stimulation of Vo2 by P-adrenergic agonists 
in vivo in the rat'and in another marsupial rat kangaroo, 
the potoroo (23). This discrepancy might in part be 
explained by noting that in general, P-adrenergic excita-
tion is known to elevate cardiac output and, relax blood 
vessels in vivo. These effects could result in increased 
blood flow to skeletal muscle. Increased flow to skeletal 
muscle has been shown to increase Vo 2 by perfused 
skeletal muscle in the rat (33). In addition, other 
thermogenic tissues, such as liver, might also contribute 
to P-adrenergic stimulation of the whole body metabolic 
rate (18). Alternatively, 13-stimulation leading to vasodi-
lation in vivo may oppose a preexisting pattern of 
vasoconstriction that inhibits Vo 2 as observed with 
5-HT and high concentrations of NE in the perfused rat 
hindlimb (6). 
The action of the nitric oxide generator, nitroprus-
side, to block both vasoconstriction and the changes in 
1,7°2 , whether they be increased or decreased (Fig. 3), 
strongly suggests that vasoconstriction is tightly linked 
in some manner to these phenomena. Yet the mecha-
nism for the vasoactive hormone-induced increase in 
Vo2 is still controversial. A priori, to explain the in-
creased Vo 2 , there must either be an increased hydroly-
sis and subsequent synthesis of ATP or a stimulated 
mitochondrial uncoupling within the hindlimb analo-
gous to that occurring in BAT. Four general possibilities 
are apparent for the bettong and other species that could 
explain the vasoconstrictor-mediated control of such 
processes in the perfused hindlimb. 
First, the vasoconstrictors may act directly on skeletal 
muscle receptors to cause the above metabolic changes 
independent of the increases in perfusion pressure 
because some vasoconstrictor hormones have receptors 
on skeletal muscle. This possibility appears to be un-
likely because for NE, 13-receptors are predominantly 
distributed on skeletal muscle cells while a-receptors are  
much higher on arterioles than on surrounding skele. 
muscle (19). Moreover, results from Fig. 2 show ,,. 
rather than (3-receptors are responsible for NE-induced 
metabolism in the perfused bettong hindlimb. Further 
evidence suggesting that the vasoconstrictor receptors 
coupled to Vo 2 appear not to be present on skeletal 
muscle comes from the observations that NE had little 
or no effect on Vo2 from perifused mouse skeletal muscle 
(12), nor did NE or angiotensin stimulate Vo 2 or lactRi 
production from perifused rat skeletal muscle (16). 
The second possibility is that the rise in perfus. . 
pressure associated with vasoconstriction may redistrib-
ute the perfusate within the hindlimb to previously 
underperfused zones and thus, by relieving regions of 
hypoxia, stimulate increased Vo 2 . This is unlikely be-
cause, as discussed earlier, there is no evidence of 
regional hypoxia as the high-energy nucleotides are 
normal (Table 2). Furthermore, such a pressure-
induced redistribution of flow to relieve hypmda d • 
not accord with the inhibition of Vo 2 associated with 
vasoconstriction induced by 5-HT (Figs. 1 and 3). 
The third possibility is that arterial vasoconstriction 
is energetically expensive and uses the observed Vo 2 . We 
have previously hypothesized vascular thermogenesis in 
the perfused rat hindlimb (7); The possibility of direct 
blood vessel smooth muscle Vo 2 during constriction is 
consistent with the close association of vasoconstriction 
and increases in Vo 2 and lactate and glycerol efflux and 
the block of all these changes by the vasodilator nit 
prusside (Figs. 1-3). It is not readily apparent how 
vascular thermogenesis could explain the inhibition of 
Vo2 and lactate efflux by 5-HT that accompanies a rise in 
vascular resistance in the bettong hindlimb (Fig. 1) or 
the rat hindlimb (11). However, when infused into the 
isolated perfused rat mesenteric artery, 5-HT (as well as 
NE and VP) caused vasoconstriction and increased Vo 2 
(11, 32). These observations led to the idea that 5-HT 
initiates a state of functional shunting of perfus 
within the muscle vascular bed away from active., ■ 
metabolizing cells (11). Similarly, functional shunting 
may occur in the bettong hindlimb in response to 5-HT. 
The fourth possibility is that vasoconstrictors by 
selective actions redirect flow to particular thermogenic 
skeletal muscle cells or other thermogenic cells in the 
hindlimb. This would provide more oxygen to those cells 
to allow activation of increased levels of uncoupling, ion 
pumping, or increased substrate cycles. So far, sv 
specialized muscle cells have only been described 
billfish, which heat blood going to the retina and brain 
by presumptive calcium ion cycling (1). However, data 
from the present experiments cannot discriminate be-
tween these two mechanisms of controlling or contribut-
ing for the involvement of blood vessels in the vasocon-
strictor-altered Vo 2 and lactate and glycerol efflux in the 
perfused bettong hindlimb. They may not be necessarily 
mutually exclusive. 
In summary, the present experiments show I. 
vasoconstrictive hormones play an important role in 
controlling and/or contributing to Vo 2 and lactate and 
glycerol efflux in marsupial (bettong) muscle. There 
appears to be a greater contribution from skeletal 
muscle vascular bed to the whole body thermogenesis in 
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the bettong than in the eutherians both at rest and in 
response to NE, which may in vivo compensate for its 
lack of BAT. The responses, however, do not relate in a 
simple way to the degree of vasoconstriction because 
there are both increases and decreases in the metabolic 
parameters depending on the vasoconstrictor employed. 
The present findings on perfused bettong muscle when 
taken together with other studies on perfused rat muscle 
raise the possibility of vasoconstrictor control of Vo 2 and 
metabolism as an entrenched and widespread physiologi-
cal mechanism in evolution. 
The authors thank A. Oakley for experimental assistance. 
This work was supported in part by the Australian Research 
Council and the National Health and Medical Research Council of 
Australia. 
Present address for S. J. Edwards: Dept. of Physical Sciences, 
University of Tasmania at Launceston. Launceston, Australia. 
Address for reprint requests: E. Q. Colquhoun, Dept. of Biochemis-
try. Faculty of Medicine and Pharmacy, University of Tasmania at 
Hobart. GPO Box 252C, Hobart, Tasmania 7001, Australia. 
Received 30 December 1993; accepted in final form, 7 December 1994. 
REFERENCES 
1. Block. B. A. Billfish brain and eye heater: a new look at non-
shivering heat production. News Physiol. Sci. 2: 208-213, 1987. 
2. Bonen. A., M. G. Clark, and E. J. Henriksen. Experimental 
approaches in muscle metabolism: hincilimb perfusion and iso-
lated muscle incubations. Am. J. Physiol. 266 (Endocrinol. Metab. 
29): E1-E16. 1994. 
3. Chan, T. M., J.P. Dehaye. and A. Tatoyan. Activation of 
lipolysis by epinephrine and electrical stimulation in the perfused 
hindquarters of lean and obese-diabetic (dbl di)) mice. Biochim. 
Biophys. Acta 751: 384-392, 1983. 
4. Chin. E. FL, M. I. Lindinger, and G. J. F. Heigenhauser. 
Lactate metabolism in inactive skeletal muscle during lactacido-
sis. Am. J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 
30): R98-R105. 1991. 
5. Christoforides, C., L. H. Laasberg, and J. Hedley-Whyte. 
Effect of temperature on solubility of 02 in human plasma. J. 
Appl. Phvsiol. 26: 56-60, 1969. 
6. Clark.M. G.. E. Q. Colquhoun. K. Dora, S. Rattigan, T. P. D. 
Eldershaw, J. Hall. A. Matthias. and J.-M. Ye. Resting 
muscle: a source of thermogenesis controlled by vasomodulators. 
In: Temperature Regulation Advances in Pharmacological Sci- 
ences, edited by A. S. Milton. Basel: Birkhauser. 1994. p. 315-320. 
7. Colquhoun, E. Q., and M. G. Clark. Open question: has 
thermogenesis in muscle been overlooked and misinterpreted? 
News Physiol. Sci. 6: 256-259. 1991. 
8. Colquhoun. E. Q., M. Hettiarachchi, J.-M. Ye, S. Rattigan, 
and M. G. Clark. Inhibition by vasodilators of norepinephrine 
and vasoconstrictor-mediated. but not skeletal muscle contraction-
induced, oxygen uptake in the perfused rat hindlimb: implications 
for non-shivering thermogenesis in muscle tissue. Gen. Pharma-
col. 21: 141-148. 1990. 
9. Colquhoun. E. Q., M. Hettiarachchi. J.-M. Ye, E. A. Rich-
ter, A. J. Hniat, S. Rattigan, and M. G. Clark. Vasopressin 
and angiotensin II stimulate oxygen uptake in the perfused rat 
hindlimb. Life Sci. 43: 1747-1754. 1988. 
10. Dawson, T. J.. and W. R. Dawson. Metabolic scope and 
conductance in response to cold of some dasyurid marsupials and 
Australian rodents. Comp. Biochem. Physiol. A Comp. Physiol. 
71A: 59-64. 1982. 
11. Dora. K. A.. E. Q. Colquhoun. M. Hettiarachchi. S. Ftatti-
gan, and M. G. Clark. The apparent absence of serotonin-
mediated thermogenesis in the perfused rat hindlimb may result 
from vascular shunting. Life Sci. 48: 1555-1564, 1991. 
12. Dubois-Ferriere. R.. and A. E. Chinet. Contribution of skel-
etal muscle to the regulation of non-shivering thermogenesis in 
small mammals. Pfluegers Arch. 390: 224-229, 1981. 
13. Grubb. B.. and G. E. Folk. The role of adrenoceptors in 
norepinephrine-stimulated Vo 2 in muscle. Eur. J. Pharmacol. 43: 
217-223. 1977. 	 . 
14. Gutmann. I.. and A. W. Wahlfeld- 	1-Lactate, determina- 
tion with lactate dehydrogenase and ISIAD. In: Methods of Enzy-
matic Analysis (2nd Ed.), edited by H. U. Bergrneyer. New York: 
Academic. 1974. vol. 3, p. 1464-1468. 
15. Hayward. J. S.. and P. A. Lisson. Evolution of brown fat: its ' 
absence in marsupials and monotrernes. Can. J. Zool. 70: 171.-
179. 1992. 
16. Hettiarachchi. M., K. M. Parsons, S. M. Richards. K. A. 
Dora, S. Rattigan. E. Q. Colquksoun, and M. G. Clark. 
Vasoconstrictor-mediated release of lactate from the perfused rat-
hindlimb. J. Appl. Physiol. 73: 2544-2551, 1992. 
17. Lafontan, M.. M. Sedan. Galitzicy, and J.-L. Montastruc. 
a2-Adrenoceptors in lipolysis: arantagonists and lipid-mobilizing 
strategies. Am. J. Clin. Nutr. 55:219S-227S, 1992. 
18. Ma. S. W. Y., B. E. Nadeau, and D. 0. Foster. Evidence for 
liver as the major site of the diet-induced thermogenesis of rat fed 
a "cafeteria" diet. Can. J. Physiol. Pharmacol. 65: 1802-1804, 
1987. 
19. Martin. III, W. H., T. K. Tolley, and J. E. Saffitz. Autoradio-
graphic delineation of skeletal muscle aradrenergic receptor 
distribution. Am. J. Physiol. 259 ( 1-leart Circ. Physiol. 28): 
H1402-H1408. 1990. 
20. Maxwell, G. M.. S. Nobbs, and D. J. Bates. Diet-induced 
thermogenesis in cafeteria-fed rats: a myth? Am. J. Physiol. 253 
(Endocrinol. Metab. 16): E264-E270. 1987. 
21. McDonald. L R.. K. A. Handasyde. and B. K. Evans. Adrenal 
function in the platypus. In: Platypus and Echinas. edited by M. 
L. Augee. Sydney, Australia: The Royal Zoological Society of New 
South Wales, 1992, p. 127-133. 
22. Needham, A. D.. and T. J. Dawson- Influence of environmental 
temperatures on the blood flow distribution in the red kangaroo 
Macropus rufus. In: Thermal Physiology, edited by J. R. S. Hales. 
New York: Raven. 1984, p. 275-278. 
23. Nicol. S. C. Non-shivering thermogenesis in the potoroo. Po-
torous tridactylus (Kerr). Comp. Biochem. Physiol. C Comp. 
Pharmacol. 59: 33-37, 1978. 
24. Pappenheimer, J. R. Vasoconstrictor nerves and oxygen con-
sumption in the isolated perfused hinollimb muscles of the dog. J. 
Physiol. Land. 99: 182-200, 1941. 
25. Rose. IL W. Reproductive energetics of two Tasmanian rat-
kangaroos (Potoroinae:Marsupialiai. Symp. Zool. Soc. Land. 57: 
149-165, 1987. 
26. Shellevold, 0. F. M.. P. Jynge, and K. Aarstad. High perfor-
mance liquid chromatography: a rapid isocratic method for deter-
mination of creatine compounds and adenine nucleotides in the 
myocardial tissue. J. Mol. Cell. Cordial. 18: 517-527, 1986. 	- 
27. Stoddart. D. M., and A. J. Bradley. Measurement of short-
term changes in heart rate and in plasma concentrations of 
cortisol and catecholamine in a small marsupial. J. Chem. Ecol. 
17: 1333-1341. 1991. 
28. Tribe, D. E.. and L. Peel. Body composition of the kangaroo 
(Macropus sp.). Aust. J. Zool. 11:273-289. 1963. 
29. Wallis. I. R.. and D. J. Farrell. Energy metabolism in potoroine 
marsupials. J. Comp. Physiol. B Biochem. Syst. Environ. Physiol. 
162: 478-487. 1992. 
30. Weir. J. B. New method for calculating metabolic rate with 
special reference to protein metabolism. J. Physiol. Land. 109: 
1-9. 1949. 
31. Wieland. 0. ,plycerol, UV method. In: Methods of Enzymatic 
Analysis (2nd ed.), edited by H. U. Bergmeyer. New York: 
Academic. 1974. p. 1404-1409. 
32. Ye. J.-M.. E. Q. Colquhotm. and M. G. Clark. A comparison of 
vasopressin and noradrenaline on oxygen uptake by perfused rat 
hindlimb. kidney, intestine and mesenteric arcade suggests that it 
is in part due to contractile work by blood vessels. Gen. Pharma-
col. 21: 805-810, 1990. 
33. Ye. J.-M.. E. Q. Colquhoun. M. Ilettiarachchi, and M. G. 
Clark- Flow-induced oxygen uptake by the perfused rat hindlimb 
is inhibited by vasodilators and augmented by nor-epinephrine: a 
possible role for the microvasculature in hindlimb thermogenesis. 
Can. J. Physiol. Pharmacol. 68:119- 125. 1990. 
